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SIniroJuciion 
Introduction 
1.1 Bromelain 
Bromelain is the collective name for closely related proteolytic enzymes 
found in tissues of the plant family Bromeliaceae, of which pineapple, Ananas 
comosus, is the best known. Two distinct types of pineapple bromelain are 
recognized- stem bromelain (EC 3.4.22.32), the major proteolytic cysteinyl protease 
in pineapple stem, and fruit bromelain (EC 3.4,22.33), 'formerly called bromelin, 
which is the major proteolytic component in pineapple fruit. Stem bromelain has been 
known under a variety of synonyms, namely, pineapple. stem bromelain, ananase, 
bromelase, pinase, extranase, traumanase, pineapple enzyme and juice bromelain. 
1.1.1 Stem bromelain 
A number of studies have indicated that pineapple stem extract contains in 
addition to bromelain several proteolytically active components together with some 
nonproteolytic enzymes, inhibitors and activators (Heinicke and Gortner, 1957; 
Morita et al, 1979; Ako et al, 1981; Lenarcic et al, 1992). Two isoenzymes of 
bromelain were separated by isoelectric focussing of stem extract (Miller et al, 
1970)- a major basic protein with an isoelectric point of 9.55 and a minor acidic 
protein with an isoelectric point of 4.7. The basic glycoprotein with N-terminal Val or 
Ala is designated stem bromelain (EC 3.4.22.32), while the acidic protein v^th N-
terminal amino acid Ala is designated fruit bromelain (EC 3.4.22.33). 
1.1.1.1 Molecular properties 
Physical properties- Stem bromelain has a single polypeptide chain with 
212 amino acid residues (Ritonja et al, 1989) and a molecular mass of 22,828 
Daltons (Table 1.1; Figure 1.1). Stem bromelain contains a single covalently attached 
oligosaccharide moiety per molecule (Murachi et al, 1967; Scocca and Lee, 1969) 
linked to the amino acid sequence - Asn - Asn"^- Glu - Ser - (Yasuda et al, 1970; 
Goto et al, 1976). The terminal sugar chain is attached at Asparagine present as 117. 
The total molecular mass of the glycosylated form of bromelain with an 
oligosaccharide of 1,000 Daltons (Murachi, 1970) is thus 23,800 Dalton (Table 1.2). 
INTRODUCTIOr^ 
Table 1.1 Amino acid composition of stem bromelain 
Amino Acid Residues per mole of stem bromelain 
Alanine 25 
Valine 14 
Leucine 5 
Isoleucine 18 
Proline 11 
Phenylalanine 6 
Tryptophan 5 
Methionine 3 
Cystine 7 
Glycine 23 
Threonine 9 
Serine 17 
Tyrosine 14 
Aspartate 8 
Asparagine 9 
Glutamate 9 
Glutamine 7 
Lysine 15 
Arginine 6 
Histidine 1 
Total 
Molecular mass (Daltons) 
212 
22,828 
Ref.: Vanhoof and Cooreman (1997) 
INTRODUCTIOr^ 
Fig. 1.1 Amino acid sequence of stem bromelain. 
Ala'-Val-Pro-Gln-Ser-Ile-Asp-Trp-Arg-Asp'»-Tyr-Gly-AIa-Val-Thr-
Ser-Val-Lys-Asn-Gln^''-Asii-Pro-Cys-Gly-Ala-Cys"-Trp-Ala-Phe-
Ala^-Ala-Ile- Ala-Thr-Val- GIu -Ser-Ile-Tyr-Lys'«'-Ile-Lys-Lys-Gly-
Ile-Leu-Glu-Pro-Leu-Ser®«-Glu-Glii-Gln-Val-Leu-Asp-Cys-Ala-
Lys-Gly«'»-Tyr-Gly-Cys-Lys-Gly-Gly-Trp-Glu-Phe-Arg^»-Ala-Phe-
Glu-Phe-Ile-Ile-Ser-Asp-Lys-Gly'«'-Val-Ala-Ser-Gly-Ala-Ile-Tyr-
Pro-Tyr-Lys'"- Ala-Ala -Lys-Gly-Thr-Cys-Lys-Thr-Asp-Gly"»-Val-
Pro-Asp-Ser-Ala-Tyr-Ile-Thr-Gly-Tyr"«-Ala-Arg-Val-Pro-Arg-
Asn-Asn^^-Glu-Ser-Ser^'-Met-Met-Tyr-Ala-Val-Ser-Lys-Gln-
Pro-Ile"«-Thr-Val-Ala-Val-Asp-Ala-Asii-Ala-Asp-Phe'^®-Gln-
Tyr-Tyr-Lys-Ser-Gly-Val-Phe-Asn-Gly''"-Pro-Cys-Gly-Thr-Ser-
Ile-Asii-His''»-Ala-Val'<'»-Thr-Ala-Ile-Gly-Tyr-Gly-Gln-Asp-
Ser-Ile""-Ile-Tyr-Pro-Lys-Lys-Trp-Gly-Ala-Lys-Trp'*°-Gly-Glu-
Ala-Gly-Tyr-Ile-Arg-Met-Ala-Arg"®-Asp-Val-Ser-Ser-Ser-Ser-
Gly-Ile-Cys-Gly^""-Ile-Ala-IIe-Asp-Pro-Leu-Tyr-Pro-Thr-Leu^>"-
GIu-Glu^'^ 
Ref.: Vanhoofand Cooreman (1997) 
INTRODUCTIOr^ 
Table 1.2 Physiochemical properties of stem bromelain 
Molecular mass (Dalton) 
Number of residues 
C ; at 280 nm 
Isoelectric pH (pi) 
Secondary structure: 
a-helix 
Antiparallel P-sheet 
Parallel P-sheet 
Turns 
Others 
23,800 
212 
20.1 
9.55 
0.23±0.007 
0.18±0.010 
0.05±0.008 
0.18±0.004 
0.35±0.027 
Vanhoof and 
Cooreman (1997) 
Vanhoof and 
Cooreman (1997) 
Murachi et al. (1965) 
Vanhoof and 
Cooreman (1997) 
Reyna et al. (1994) 
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The oligosaccharide chain contains flicose, mannose, xylose and N-
acetylglucosamines (NAG) (Scocca and Lee, 1969; Yasuda et al, 1970; Harrach et 
I 
al, 1995) (Figure 1.2). The composition of carbohydrate unit, as expressed in nearest 
analogues, is 3 moles of marmose, 1 mole of fucose, 1 mole of xylose and 2 moles of 
N-acetylglucosamine (NAG) per mole of enzyme. The structure of stem bromelain 
oligosaccharide shows interesting features: fiicose is attached to N-acetylglucosamine 
by a 1-3 bond, while the mode of linkage normally is 1-6, and the oligosaccharides 
contain a xylose residue linked to a p-marmosyl residue by |3 1-2 linkage. Occurrence 
of xylose is very rare in Asn-linked sugar chains, and it was infact the first instance in 
which the mode of linkage of a xylosyl residue was established (Ishihara et al, 1979). 
The carbohydrate moiety of stem bromelain is not involved in the catalytic activity 
since oxidative degradation of the carbohydrate residues by sodium periodate did not 
cause much alteration in en2ymic activity towards caSein as well as synthetic 
substrates (Yasuda et al, 1971). 
Stem bromelain contains a single free sulfhydryl group and three 
intrapeptide disulfide bonds (Ritonja et al, 1989; Rasheedi, 2001). The enzyme is 
also unique in having a single histidine residue at position 158 (Table 1.1; Figure 1.1), 
which appears to be located at a distance of 5 A fi-om the active site (Hussain and 
Lowe, 1970). Husain and Lowe (1970) further suggested that due to proximity to 
active site, the thiol and imidazole group act in concert in the hydrolysis of substrates, 
as is the case v^ ath papain. However Murachi et al (1975) have indicated that the 
histidine may not be directly involved in the catalysis. 
There exist great homology between stem bromelain and other members of 
the papain family (Goto et al, 1976; Kamphuis, al, 1985). Alignment of amino 
acid sequence of stem bromelain and papain suggests remarkable homology (Figure 
1.3). The polypeptide chain of stem bromelain can be divided into 3 regions - 2 
strongly homologous regions (N-terminal part 1-81 and C-terminal part 117-212) and 
a middle region 82-116 with virtually no identity or homology with other members of 
papain family (Figure 1.3) (Goto et al, 1976; Kamphuis et al, 1985). Stem bromelain 
contains five tryptophan residues (Ritonja et al, 1989) and extensive sequence 
homology with papain suggests that three tryptophans may be buried in hydrophobic 
core and two located near the surface (Haq et al, 2002). 
INTRODUCTIOr^ 
Fig. 1.2 Structure of the lone oligosaccharide of stem bromelain. 
CHzOH 
/ CH2OH CH2OH 1 
o o 
NHCOCHy NHCOCH3(i|u 
I ^ P Ser 
OH OH 
a-Man(l -••6)-a-Man-(l ^ 6 ) 
P-IVlan-(l ^ 4)-p-GlcNAc-(l^ 4)-p-GlcNAc-(l^N)-Asn~ 
p-Xyl-( l^ 2) a-Fuc-(l ^^ 3) 
INTRODUCTIOr^ 
Fig. 1.3 Alignment of the amino acid sequences of stem bromelain and papain. 
Stretches of identical amino acids for the enzymes are shaded in blue. 
Brom Anaco: Stem bromelain from Ananas comosus; Papa carpa: Papain 
from Carica papaya. (Sequence was extracted from the Swiss Prot protein 
sequence data base). 
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Substrate specificity- Stem bromelain is a member of the cysteine 
proteinases, that depends on the thiol group of cysteine residue for its enzymatic 
activity (Blow and Steitz, 1970). The active site cysteine of stem bromelain is located 
at position 26 (Figure 1.1; 1.4). Stem bromelain has broad substrate specificity, close 
to that of ficin (EC 3.4.22.3), and hydrolyzes a great variety of synthetic and natural 
substrates. It preferentially cleaves peptide bonds in wfiich a hydrophobic group 
occupies P2 position. The sequences containing negatively charged residues in 
position P3' and P4' are not cleaved (Keil, 1992). Accordirig to Schechter and Berger 
(1967), the amino acid residues in a substrate undergoing cleavage are designated as 
PI, P2, P3, etc, in the N-terminal direction and PI', P2', P3', etc. in the C-terminal 
direction from the cleaved bond. The most used synthetic substrates are N-benzoyl-L-
Arg-ethyl ester (BAEE), N-benzoyl-L-Arg-amide (BAA), N-benzoyloxycarbonyl-
Lys-p-nitrophenyl ester, N-benzoyl-L-Arg-p-nitroanilide (L-BAPA), tosyl-L-Arg-
methyl ester (TAME), N-benzoyl-L-Arg-methyl ester (BAME). Casein and 
hemoglobin are the most widely used natural substrates. Other natural substrates 
studied include insulin A and B chain, glucagon, angiotensin, bradykinin, collagen, 
elastin, ovalbumin and somatotropin. 
1.1.1.2 Folding/Unfolding of stem bromelain 
Thermal denaturation of stem bromelain, as studied by means of CD and 
DSC, is completely irreversible and apparently follows a simple two-state mechanism 
of the type N->D (Reyna and Arana, 1995). Stem bromelain when exposed to 
increasing alkalinity, exhibits conformational response through at least three different 
stages due to the ionization of tyrosine hydroxyl groups. In the first stage i.e. from pH 
7.0 to 10.0, the protein conformation remains almost unchanged with 9 out of 19 
tyrosine hydroxyl groups accessible to the solvent. In the second stage i.e. from pH 
1 
10.0 to 12.0, a large change in conformation is indicated by changes in viscosity and 
ORD parameters indicating unfolding of the molecule. Further above pH 12.0 a large 
change in viscosity or in sedimentation coefficient can be observed resulting in an 
extensively denatured form (Murachi and Yamazaki, 1970). These results have 
indicated that no substantial change occurs upto pH 10.0 and above pH 10.0 the 
conformational change proceeds through at least two, mutually distinguishable stages 
with a concomitant loss of activity (Murachi and Yamazaki, 1970). 
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Stem bromelain belongs to the a+p protein class like other cysteine 
proteinases and the highly identical amino acid sequences of papain (Cohen et al, 
1986), actinidin (Came and Moore, 1978), proteinase Q (Dubois et al, 1988; Topham 
et al, 1991), chymopapain (Jacquet et al, 1989; Watson et al, 1990) and stem 
bromelain (Ritonja et al, 1989) indicate that the polypeptide chains of these proteins 
may share a common folding pathway (Anfmsen, 1973). The above has been 
confirmed for the first three proteinases by detailed X-ray diffraction studies (Baker, 
1980; Kamphuis et al, 1984; Pickersgill et al, 1991). Reyna et al (1994) have 
proposed that bromelain forms may have the similar/identical folding pattern shown 
by other members of the papain family since the spectral characteristics and sequence 
characteristics displayed by stem bromelain are comparable to those observed in case 
of papain and proteinase Q. A bilobal structure with an all a and anti-parallel [3 
domains have therefore been proposed for stem bromelain (Kamphuis et al, 1984). 
The N-terminal part (1-81) in good likelihood constitutes an all a domain while the 
C-terminal part (117-212) constitutes the anti-parallel (3 domain (Goto et al, 1976; 
Kamphuis etal, 1985). 
Earlier studies have demonstrated the presence of an irreversible partially 
folded intermediate (PFI) at pH 2.0 and a molten globule like state at pH 0.8 (Haq et 
al, 2002). Furthermore, acid unfolding behavior of stem bromelain revealed that stem 
bromelain exhibits unfolding behavior characteristic of Type I proteins as classified 
by Fink et al (1994). Studies of the effect of various alcohols and salts in inducing 
conformational changes in this partially folded intermediate at pH 2.0 leading to 
formation of molten globule states have also been reported (Rasheedi, 2001; Haq et 
a/., 2003). 
1.1.2 Applications of bromelain 
Bromelain preparations are widely used in medicine, as laboratory reagents 
and to a lesser extent in industry (Lyons, 1982). In medicine, it is frequently used 
against various disease conditions. 
Antiedema action- Bromelain has been used as an anti-inflammatory agent 
and to heal edema from the time it became available as a drug (Taussig et al, 1975; 
Dupaigne, 1975; Cooreman a/., 1976). 
Anti-inflammatory- Bromelain has found application in a wide variety of 
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inflammatory conditions. These include thrombophlebitis, skeletal muscle injuries, 
hematomas, oral inflammations, diabetic ulcers and athletic injuries (Taussig et ai, 
1975; Uhlig, 1981; Hotz et ai, 1989). Bromelain inhibits plasma exudation through 
inhibition of the bradykinin generation at the inflammatory site via depletion of the 
plasma kallikrein system (Minami et al., 1983; Kamakura et ai, 1988). 
Tumor growth inhibition- Bromelain possesses antineoplastic activity 
(Taussig et al, 1985; Batkin et ai, 1988; Maurer et al, 1988) that is attributed to its 
fibrinolytic and platelet aggregation inhibitory activity (Taussig and Batkin, 1988). 
Bromelain also stimulates the production of alpha tumor necrosis fector (Desser and 
Rehberger, 1990). 
By means of immunological techniques, gel permeation chromatography, 
and electrofocusing it has been shown that 40% of the radioactively tagged bromelain 
is absorbed intact in blood and lymph and there it exerts its physiological actions 
(Seifert et al, 1979). The bromelain circulating in plasma appears to be partially 
bound to certain plasma proteins, two of which were identified as a2-macroglobulin 
and al-antitrypsin (Castell, 1995). Theoretically bromelain, as a protein should be 
digested enzymatically in the intestine, however that does not happen to be the case 
rather a significant firaction of ingested enzyme is absorbed intact. Authors have 
debated existence of this enzyme as molten globule state in intestine, which would 
shield it firom gastric and body fluid proteases and at the same time fecilitate its 
absorbtion across membranes. Many proteins are known to traverse body fluids as 
molten globules (Uversky, 1995; Dudich, 1999). 
Bromelain has been used against digestive disorders by means of 
replacement therapy (Otte et al, 1987), and in cardiovascular and circulatory 
disorders (Minami et al, 1983), and it may be protecting the small intestine fi-om 
microbial colonization and disease by modifying intestinal receptor sites and reducing 
the binding properties of intestinal mucosa (Mynott et al, 1996). The antiaggregating 
effect on platelets together with the proteolytic and fibrinolytic activity in blood are 
especially responsible for the observed effect in cardiology (Felton, 1980). An 
interesting application is the use of bromelain in the debridement of third degree 
bums (Houck et al, 1983), in the treatment of blunt injuries to the musculoskeletal 
system (Masson, 1995) and in firostbite eschar removal (Ahlc and Hamlet, 1987), 
Bromelain is also used as a potentiating agent in antibiotic therapy (Bradbrook et al. 
1 1 
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1978). In laboratory medicine it is used extensively in blood group serology (Scott et 
al, 1987) and in immunology research (Hale and Haynes, 1992). 
Industrial use of bromelain is however rather limited. Its most important 
use is in the baking and beer industry (Lyons, 1982). Most wide use of bromelain is in 
facilitating weight loss. Bromelain has excellent capacity to move to any place in the 
body with excess fat and digest the fatty cells. In battle against the bulge it is 
prescribed in form of oral tablets (Example, BioSlim, Thinceutical ACV ultra mega 
fat burner) either alone or as vitamin supplements. These tablets apart from 
facilitating weight loss also serve as digestive aid. 
1.2 Enzyme Immobilization 
Nature is extremely diverse in terms of number and types of organic 
molecules required for life. This .diversity solely relates to the wide catalytic scope of 
enzymes. Enzymes are highly specific and selective catalysts that operate typically 
under mild reaction condition; (e.g., ambient temperature, pressure, pH and ionic 
strength). Such properties have enabled enzymes to become valuable catalysts in 
food, beverage (Reed, 1975) and diagnostic industries (Guilbault, 1982; 1984). The 
principal limitation in the use of the enzyme for various application are their high 
susceptibility to inactivation, high cost, poor recovery and hence reusability. Enzyme 
immobilization technology introduced in the late sixties has circumvented the 
problems to a significant extent and enzymes are being employed as a reusable 
catalysts suited for analytical, biomedical and industrial application. 
The term immobilized enzyme was adopted at the first engineering 
conference held at Hermicker, New Hamphshire in 1971. Enzyme immobilization 
technology has indeed revolutionized the concepts of applied enzymology. Enzyme 
immobilization is one of the most important technique and is a generic term used to 
describe retention of a biologically active catalyst within a reactor or analytical 
system. The biocatalysts as a single enzyme, mixture of enzymes or enzymes present 
inside a living cell are confined within or on a living support material. The 
immobilized enzyme takes on the physical characteristics of the support while 
retaining the catalytic activity of the free catalyst. Thus, in addition to convenient 
handling of enzyme preparations, the two main target benefits are; (i) easy separation 
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of enzyme from the reaction mixture and (ii) reuse of the enzyme (Tischer and 
Volker, 1999). Immobilization very often leads to enhancement in the resistance of 
enzymes against various denaturing factors like extreme pH and temperature, high 
ionic strength, chemical denaturants, proteases, etc by restricting the unfolding of 
protein. 
Studies on various immobilized enzymes have shown that they display 
kinetic behavior subtly different from those of free enzymes. Immobilization thus 
imparts novel characteristics to enzymes and some time even modifying their basic 
catalytic behavior (Clark, 1994). Various natural and synthetic supports like alginate, 
agarose, polacrylamide copolymers, polyvinyl acetate, dextran, cellulose acetate, lipid 
polyamide, PEI-nylon etc are available for enzyme immobilization. The choice and 
properties of the carriers for enzyme immobilization has been reviewed (Mosbach, 
1976; Royer et al, 1976). Additional and more indepth information on 
immobilization methodologies can be found from other sources (Mosbach, 1987 a, b; 
1988; Bimbaum and Mosbach, 1991; Bimbaum, 1992, Gemeiner et al, 1994; Jafri et 
al, 1995; Jafii and Saleemuddin, 1997; Uttenthaler et al, 1998). More recently 
Scouten et al (1995) have reviewed the possibilities for protein immobilization for 
use in biosensors. Enzyme immobilization technology has a remarkable potential in 
increasing usefulness of enzymes (Poulson, 1984). Important industries are currently 
employing immobilized enzymes for production of several useful compounds. 
A large number of strategies are now available for the immobilization of 
enzymes. Considering the diversity of enzyme however no single procedure can be 
considered versatile. The best procedure for the immobilization of an enzyme has to 
be selected taking into consideration the structure and behavior of the enzyme. The 
numerous methods available for immobilizing enzymes on solid supports have been 
classified into five basic categories- adsorptiop, covalent attachment, chemical 
aggregation, microencapsulation and matrix entrapment (Figure 1.5). These have been 
widely reviewed (Chang, 1964; Weetal, 1974; Levy e/ a/., 1980; Lim and Sun, 1980; 
Mattiasson et al, 1983; Founlds and Lowe, 1988). 
Most of the conventional procedures discussed above results in random 
association of enzymes with support leading to preparations containing enzymes 
oriented in a variety of ways, in addition random immobilization methods inevitably 
cause some inactivation due to possible blocking of the active site, crosslinking and 
structural rigidity (Khare and Gupta, 1988a; 1988b). The harsh coupling conditions 
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Fig. 1.5 A schematic representation of the various immobilization techniques. 
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like generation of free radicals, drastic pH and temperature changes, use of organic 
solvents, steric constraints and conformational changes due to multiple point 
attachment to the support are all causes for the reduced enzyme activity. An ideal 
immobilization procedure should not cause above mentioned disturbance to the 
protein conformation and active site should be least affected. Oriented immobilization 
of protein to a great extent can circumvent these problems (Turkova, 1999). 
While the interest in irreversible and covalent methods of immobilization 
continues, bioaffmity based immobilization procedure (Saleemuddin, 1999), several 
of which result in oriented immobilization (by default^y exploiting some intrinsic 
property of protein), are gaining remarkable attention,, especially for analytical 
application (Mattiasson, 1988; Gupta and Mattiasson, 1992). Specific groups that help 
orient the enzyme can be introduced chemically or genetically in the enzyme, or are 
present as nature's default. 
Bioaffmity based immobilization procedures offer many advantages over 
conventional immobilization techniques like ready reversibility, and thus the 
possibility of reuse of the support, simple and mild conditions required during the 
immobilization process and above all, possibility of immobilizing the protein in an 
oriented fashion yielding preparation of high activity and stability. The specific 
affinity pairs those can be exploited for bioaffmity based immobilization of enzymes 
are lectin-carbohydrates/glycoproteins (Ahmad et al, 1973), avidin-biotin (Green, 
1963) and antigen-antibody (Shoemaker et al, 1984). Potential of other affinity pairs 
like immobilized metal ion-surface histidine bearing enzymes (Vijayalakshmi, 1989; 
Arnold, 1991) and cellulose-cellulose binding domain bearing enzyme have also been 
recognized. Ability to bind to appropriate ligands may be an intrinsic property of 
enzymes or may be conferred upon them by linking them to polypeptide that exhibit 
high affinity or alternatively by some mild treatments. Such chimeric enzymes may be 
affinity bound on support bearing suitable ligands (Baneyx et al., 1990). 
1.2.1 Lectin affinity based immobilization of glycoenzymes 
Lectins and glycoenzymes represent the second bioaffinity pair with proven 
potential in the immobilization of the latter. Glycosylation. is the most common post-
translational modification encountered in eucaryotes, archaebacteria and even some 
prokaryotes (Lis and Sharon, 1993) and a large number of enzymes are glycosylated 
to varying extent. The carbohydrate content of glycoproteins may be less than 1% or 
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exceed 60% of the mass of the molecule (Kennedy and White, 1983; Lis and Sharon, 
1993). Most glycoenzymes contain multiple one or more types of oligosaccharide 
attached to protein, on the other hand proteins like stem bromelain (Murachi et al, 
1967; Scocca and Lee, 1969) and ribonuclease are novel in that they have a single 
glycosyl attached to them and constitute 2-4% (w/w) of their masses as carbohydrate. 
To date himdreds of lectins have been isolated from plants, microorganisms 
and animals. The largest and best characterized among the lectins is Con A isolated 
from Jack bean belonging to legume family. Con A has been widely used in the 
affinity purification of variety of glycoenzymes and nearly exclusively in the 
immobilization of glycoenzymes on a variety of supports. Work on the utility of Con 
A in glycoenzyme immobilization has been reviewed (Saleemuddin and Husain, 
1991; Saleemuddin, 1999). 
1.2.1.1 Con A 
Con A is a non-glycosylated oligomeric metalloprotein that exist as 
tetramer or dimer depending on pH and other conditions (Sumner and Howell, 1936). 
Each monomer is 237 amino acids long (Molecular mass, 26.5 kDa) and has sites for 
binding of a transition metal ion and a calciimi ion in addition to the saccharide 
binding site (Goldstein, 1988). Early studies on the lectin indicated that Con A 
recognizes a-D-glucose and a-D-mannose with free hydroxyl at 3-, 4- and 6-
positions (Goldstein et al, 1965) suggesting the structural requirements as shovm in 
figvire 1.6. Glycoproteins comprising of glycosyl chains with Glcal->, Manal^, 
GIcNAcal-^ residues, which are located at the non-reducing termini of the sugar 
chains, and 2GIcal- and 2Manal- residues located within the sugar chain can bind to 
the lectin (Kobata, 1992). Based on the binding of several oligosaccharides and 
glycopeptides, Ogata et al. (1975) suggested that high mannose type of sugar chains 
bind more strongly than those of the complex type and presence of at least two 
binding residues is essential for an oligosaccharide to be retained by a column of 
immobilized Con A. Con A retains its affinity for CEirbohydrates between pH 5.0 or 
lower and pH 9.0 and above (Reeke et al, 1975), making it suitable for the 
immobilization of enzyrties acting over a wide pH range. 
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Fig. 1.6 Carbohydrate units recognized by Con A. 
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1.2.1.2 Immobilization of glycoenzymes using Con A 
The principal strategies of enzyme immobilization with the help of Con A 
are: formation of insoluble lectin-glycoenzyme flocculate and binding to insoluble 
supports precoupled with lectins (Saleemuddin and Husain, 1991). Since enzyme 
glycosyls, through which the enzymes are associated with lectins are not usually 
involved in catalytic process (Lis and Sharon, 1993), the Con A enzyme complexes 
retain high catalytic activity (Ahmad et al, 1973). 
The biological activity of Con A remains unaffected by chemical 
modification of the amino groups (Gunther et al, 1973). Coupling to various supports 
has therefore been achieved mostly via amino groups. A large number of support 
matrices have been used for the coupling of Con A for the preparation of the affinity 
supports (Saleemuddin and Husain, 1991). The most traditional one being activation 
of Sepharose supports by method of Porath et al. (1967) followed by binding of Con 
A through amino groups. This is followed by activation of Con A by method of Yariv 
et al. (1968) rendering the lectin capable of binding glyfcoenzymes. More recently 
Fadda et al. (1992) have shown that Con A can be coupled in high yield to 
commercial aluminium oxide after activation • by means of 3-
aminopropyltriethoxysilane and subsequent reaction with cyanogen bromide. Con A 
has also been shown to bind very strongly to copper (11) iminodiacetic acid functions 
of various supports due to the presence of six histidine residues in each subunit (Rassi 
etal, 1988). 
Binding of Con A to glycoproteins can be prevented/reversed by several 
sugars like methyl-a-D-glucopyranoside, a-D-mannopyranoside or even D-marmose 
or D-glucose which are known to interact with the lectin (Goldstein, 1976; 
Mislovicova et al, 1997). The strength of association between Con A and 
glycoprotein has however been shown to be dependent not only on the nature of 
glycosylation but also on the nature of glycoprotein (Surolia et al, 1975). Some 
glycoenzymes like invertase are heavily glycosylated and exhibit extraordinary strong 
binding and necessitate extra long incubation with the eluting sugar (Mislovicova et 
al, 1995) while those that are poorly glycosylated can easily be eluted. Nevertheless 
several lectin-based analytical devices with reloadable glycoenzymes have been 
described (Farooqi et al, 1997; Sosnitza et al, 1998). 
1 8 
INTRODUCTIOr^ 
1.2.2 Enzyme immobilization on immobilized metal ion supports 
Immobilized metal affinity adsorption (IMA) is a collective term that was 
proposed to include all kinds of adsorption whereby metal atoms or ions immobilized 
on polymers cause or dominate the interactions at the sorption site (Porath and Olin, 
1983; Porath, 1988). IMA has been widely used in the chromatography and 
fractionation of proteins and the potential of IMA in enzyme immobilization is also 
being increasingly realized. It may be more advantageous than biospecific affinity 
I 
(Table 1.3). The principle of IMA (Figure 1.7)-is based on interfacial interaction 
between metal ions immobilized on a solid support which is usually a hydrophilic 
crosslinked polymer and surface fimctional basic group oiF proteins mainly histidine 
resides, but sometimes N-terminal amino groups as well as -SH may contribute to the 
binding although the latter may not be available in the reduced state on the surface of 
majority of enzymes. Considerable evidence has now accumulated to show that 
protein are retained by a metal affinity supports primarily according to the number of 
accessible histidine residue (Hemdan et al, 1989; Arnold, 1991). The histidine 
imidazole nitrogens co-ordinate metals in the unprotonated state hence, in addition to 
the number of accessible histidines, their ionization state, that is in turn dependent 
upon one nature of surrounding amino acids, influence the> interaction of protein with 
the metal chelate supports. (Hemdan et al., 1989). There have been reports suggesting 
that a number of amino acid residues indeed may contribute to metal affinity binding 
especially at higher pH even though at the commonly used pH (around neutrality), 
their contributions may be quite small (Arnold, 1991). There are two ways in which 
other amino acids could contribute to apparent metal affinity i.e. by directly binding 
the metal or indirectly by virtue of their effect on histidine accessibility, pKa as well 
as solvation of metal ion and histidine. Aromatic side chains are known to contribute 
indirectly (Martin, 1979) by enhancing the metal-histidyl interactions. Histidine is one 
of the less abundant amino acids of protein and most globular proteins contain not 
more than 2% histidine (Klapper, 1977). Considering that less than half of histidine i 
residues of proteins are located at the surface, most proteins on the average have only 
about one exposed residue for every 100 amino acids. It is therefore natural that many 
proteins do not bind to metal chelates inasmuch lack surface histidine. However, it 
has been shown that a single histidine present on surface may be adequate to retain a 
protein strongly on metal chelate supports (Arnold, 1991) (Table 1.4). 
Immobilized metal affinity adsorbents for proteins are available in the form 
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Table 1.3 A comparison of IMA with biospecific affinity 
Property Metal affinity Biospecific affinity 
Ligand stability High Low 
Protein binding High Low 
Elution condition Mild Often extreme 
Ligand recovery after Complete Generally incomplete 
regeneration 
Selectivity Low or medium High 
Cost Low High 
Ref.: Vijaylaxmi (1989). 
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Fig. 1.7 A diagrammatic representation of the principle of IMA. 
1: Loading of Metal 
2: Protein adsorption 
3: Protein desorption 
4: Regeneration of support 
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B: Chelating group 
Me: Metal ion. 
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Table 1.4 Protein surface histidines and their affinity for immobilized metal 
ions 
Presence of histidine on surface Metal ions providing adsorption 
No His -
One His 
More than one His 
Clusters of His Cu^^ 
Ref.: Sulkowski (1985). 
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of oxides, sulfides, salt such as carbonates, silicates and phosphates. However, 
organic polymers that contain hydroxyl group are more versatile since they can be 
functionalized under controlled conditions and their physical and chemical properties 
easily characterized. Metal ions are fixed to the insoluble polymers via covalently 
bonded chelators out of which carboxymethylated amine or chelones are widely used. 
Higher chelones such as carboxymethylated tetraethylene pentamine, covalently 
linked agarose, are capable of forming extra stable metal complexes, thus may be 
exhaustively used to deplete aqueous solution of heavy metal ions. These chelating 
ligands bind tightly to metal ions in particular to first row of transition metals (Ni^ "^ , 
Zn^ ,^ Co^ ,^ Cu^ ,^ Fe^^). The number of linkages formed between a metal ion and an 
immobilized chelator determines the overall affinity of adsorbent for proteins. The 
effective adsorption centers of an IMA-support are the available coordination sites of 
metal, which are occupied by weakly interacting anions or solvent molecules and 
account for its precise affinity towards protein. The stronger the immobilization of 
metal ion, the weaker is the interaction with proteins. The difference in the adsorption 
sites affects their selectivity and capacity to bind proteins (Porath and Olin, 1983). 
Besides the number of atoms involved in a chelate formation, determine the stability 
of the metal complex (Figure 1.8). Thus it is advisable to select a chelator ligand that 
can follow a maximum number of 5 or 6 numbered ring system while leaving a 
sufficient number of coordination sites available for interaction with proteins. The 
affinity of IMA absorbent for protein follows the order: 
Me-IDA> Me-CM-ASP> Me-TED> Me-CM-TEPA (Porath, 1988). 
which is exactly the inverse order of the metal affinity characteristics of the 
immobilized chelating group themselves. As is evident, IDA would be best choice as 
a chelator. IDA is a trident chelator that binds metal ions through its nitrogen and two 
carboxylate oxygen (Figure 1.8). As the metal ions coordinate 4-6 ligands, the 
remaining of coordination sites are occupied by water molecules and buffer ligands", 
which are available for replacement by appropriate surface group (Arnold, 1991). The 
metal ion involved in coordination follows the order. 
Cu (II) > Ni (II) > Zn (II)~ Co(II) (Porath, 1988). 
The formation of a ternary complex between the chelate with the bound metal ion and 
protein leads to retention in IMA (Yip et al, 1989). 
Extremes of pH, buffer types and ionic strength, have been used to suppress 
the interaction between protein and metal supports (Sulkowski, 1985). Proteins bound 
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Fig. 1.8 Postulated planar metal ion chelate with IDA as a chelating group. 
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to chelated metals are eluted using lewis acids (H"^ , Zn^ "^ ), which compete with the 
metal for protein, or by introducing lewis bases (imidazole), which compete with the 
protein for the metal. Elution can also be performed with strong chelators of metal 
ions like EDTA (Arnold, 1991). Detergents when necessary can also be used with 
advantage in IMA (Sulkowski, 1985; 1989). 
1.3 Immobilization on soluble supports 
Various immobilization method so far discussed render enzyme insoluble 
and therefore are generally not appropriate to be employed for enzymes acting on 
I 
large molecular weight or insoluble substrates inasmuch as insoluble enzyme 
preparation without exception suffers from difflisional limitation. Various methods for 
soluble immobilization have been attempted. These include immobilizing enzymes 
without derivatization by maintaining their natural state simply by physically 
confining them within semipermeable membranes in hollow fibers or other 
ultrafiltration devices. Another strategy in which derivatized soluble enzymes are 
prepared by chemical modification without loosing their solubility in water has been 
widely undertaken earlier by linking enzymes to soluble supports like acryl polymers, 
linear polystyrene and polyethyleneglycol polymers and alginate (Toy and Janda, 
2000). 
Fab' monomer also promise to serve as potential soluble support for 
respective antigen. Recently use of polymerizable Fab' antibody fragments for 
targeting of anticancer drugs (Lu e/ al., 1999; 2001) and in other clinical applications 
has been reported (Reff and Heard, 2001). Plethora of literature is also available on 
the usefulness of antigen binding Fab' fragments of the antibodies in the purification 
of proteins (Prisyazhnoy et al, 1988). 
1.3.1 Immunoglobulin G 
Immunoglobulins (Ig's) are soluble glycoproteins that circulate freely in 
blood and exhibit properties that contribute specially to immunity and protection 
against foreign material. Kabat (1970) showed that the antibodies, which are present 
in gamma globulin fraction, are slowest migrating proteins of serum in an 
electrophoretic field. IgG is the predominant immunoglobulin in blood, lymph fluid, 
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cerebrospinal fluid and peritoneal fluid. The four chain structure of IgG was proposed 
by Porter (1959) and its complete sequence by Edelman (1969). They are multimeric 
proteins with a molecular weight of 1,50,000 corresponding to a sedimentation 
coefficient of 7S. IgG is made up of two gamma (y) heavy chains and two light 
chains, either kappa (K) and lambda (A,) linked together by disulfide bonds. Based on 
minor differences in the aminoacid sequence of heavy chains, there are four IgG 
subclasses in humans namely IgGl, IgG2, IgG3 and lgG4. Mice also synthesizes four 
subclasses of IgG designated as IgGl, IgG2a, lgG2b and IgG3. 
The constant region of the gamma chain is constructed from three 
homology units designated CHI, CH2, and CH3. The constant region of gamma chain 
contains a stretch of aminoacid residues between ChI and Ch2, i.e. the hinge region 
that shows no homology with any of the homology units. This region is rich in proline 
residues and also contains the cysteine residues that link the two heavy chains 
together. The region acts a site for proteolytic cleavage, as'the amino acid residues in 
this region are exposed to the surroimding medium (Figure 1.9). 
1.3.2 Antigen-antibody interaction 
The ability of protein to form specific, stable complexes with other proteins 
is fiindamental to many biological processes. Understanding the molecular basis of 
protein-protein recognition requires knowledge of individual interactions at the 
interface between the proteins (Chen et al, 1999; Jiang and Lai, 2002). One may 
define two broad categories of protein-protein interfaces- ones which resemble cross 
section through folded proteins in which hydrophobic residues are in the interior and 
hydrophilic ones at the periphery and in which productive |)inding is mediated largely 
by the former and those in which polar and non polar residues are interspersed 
throughout the interface and in which both residue types make comparable 
contribution to complex stabilization (Goldman et al, 1997). 
An antibody molecule combines with its antigen through the 
complementarity determining region (CDRs). Since the repertoire of antigen to which 
it combines is large, it is understandable that the amino acid residues comprising the 
CDRs have greater functional versatility. These residues have both polar and non 
polar groups in them and generally the non polar end is buried and the polar end 
protrudes out. These polar atoms have the potential of forming hydrogen bonds and 
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Fig. 1.9 Diagrammatic representation of rabbit IgG. 
Rabbit IgG showing into constituents chains, domain structure, variable and 
constant region, sites of proteolytic cleavage, nomenclature of chains and 
fragments and pathways for their isolation. 
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additional stability of the complex is provided by hydrophobic interactions. The 
interaction of the antibody with the antigen is highly specific and involves non-
covalent interactions such as hydrophobic interactions and hydrogen bonding (Oss 
and Absolom, 1984; Davies et al, 1990). 
With the availability of data on crystal structure of several antibody-antigen 
complexes (Table 1.5), it is possible to quantify these interactions. Some of the 
common features of antigen-antibody complexes have been solved. In crystal 
structures of several antibody-antigen complexes only about a dozen hydrogen bonds, 
and very few (0-3) salt linkages have been recognized betv^een the contact surfaces of 
protein antigen or antibody. There is a close fit between the svirfaces of antibody and 
antigen so that water is almost excluded from the contact region (Davies et al, 1990; 
Ahmad and Salahuddin, 1994). This would imply that the interaction is fairly 
hydrophobic. However other reports (Bhat et al, 1994) have indicated the presence of 
water molecules buried at the interface. This lessens the importance of hydrophobic 
interactions stabilizing the complex. There have therefore been conflicting reports 
about proportionate contribution of hydrophobic and electrostatic interactions. Infact 
it is often difficult to exactly quantify the contribution of various non covalent 
interactions, although the preponderance of one can be established over another. 
Studies of antigen-antibody complex is often limiting inasmuch as study of precipitin 
reaction has to be taken into account (Ansari and Salahuddin, 1973; Ahmad, 1995), 
which happens to be a circuitous way of understanding the phenomenon. 
1.4 Protein folding 
Studies on denaturation of protein have long been used to elucidate the 
folding-unfolding transitions. They have also contributed considerably to the 
understanding of the role of various stabilizing and destabilizing forces that are I 
responsible for their unique folded structure in Solution (Kim and Baldwin, 1990; 
Jennings and Wright, 1993; Reyna and Arana, 1995). Also they help elucidate the 
molecular mechanism of the spontaneous folding of proteins from a random 
polypeptide chain to a well ordered native conformation. Results of kinetic refolding 
experiments in vitro as well as theoretical considerations suggest that folding of large 
proteins is a sequential hierarchical process (Kuwajirna, 1989), in which protein 
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Table 1.5 Monoclonal antibodies against protein/peptide antigen 
Antibody Antigen Epitope Reference 
D 1.3 Lysozyme 18-27, 116-129 Amit etal, 1986 
HyHEL-5 Lysozyme 41-53,67-70, 84 Sheriff er al, 1987 
HyHEL-10 Lysozyme 15-21,63,73-
75,88-99 
Padlan etal, 1989 
D11.15 Lysozyme 21-23, 103-106, 
112-119 
Chitarra a/., 1992 
E225 D-1.3 idiotope 
(against lysozyme) 
FvDl.3 Bentley etal, 1990 
NC41 Neuraminidase 325-330, 343-
347, 366-372, 
399-403,431-
435 
Tulip et al, 1992 
B 1312 Myohemerythrin 
Peptide 
69-75 Stanfield a/., 1990 
17/9 Influenza virus 
hemagglutinin 
peptide 
100-108 Rini etal., 1992 
131 Angiotensin II 
Peptide 
1-8 Garcia era/., 1992 
409. 5.3 730.1.4 idiotope 
(against feline 
infectious peritonitis 
virus) 
Fv Ban etal, 1994 
TE33 CTP3 (Cholera 
toxin peptide 3) 
1-15 Shoham, 1993 
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folding proceeds according to the established hierarchy of the native structure i.e. that 
involving secondary and tertiary structures (Ptitsyn, 1987). The partially folded 
intermediates can be made to accumulate in equilibrium by mild concentrations of 
chemical denaturants, low pH, covalent trapping or by protein engineering (Sanz and 
Gimennez, 1997). In contrast, a non-hierarchical model of protein folding assumes 
that the native structure is not necessarily formed sequentially. It supports the 
occurrence of non-native structures and subsequent reorganization towards the native 
ones (Konishi et al, 1982; Goldenberg and Creighton, 1985). Interactions stabilizing 
the native structure can be categorized into local and non-local interactions. Local 
interaction occur between nearby amino acids while non-local interactions between 
residues distant in amino acid sequence. 
It has been shown in many instances that the temperature, urea, GdnHCl 
and acid induced transitions in small globular proteins can be described in terms of 
two state model (Privalov, 1979). It is now generally accepted that protein folding 
involves a discrete pathway v^th intermediate states between native and denatured 
states (Kim and Baldwin, 1990). Considerable effort has been focused on the 
determination and characterization of intermediates populated during the folding 
process to understand protein folding. Several common features have emerged from 
these studies, particulaiiy that compact collapsed states with significant amount of 
secondary structure content form very rapidly for a number of proteins (Kuwajima et 
al, 1993; Varley et al, 1993). These species have at least some characteristics of 
partially folded states observed at equilibrium for a large number of proteins under 
mild denaturing conditions (Hughson et al, 1990; Harding et al, 1991; Buck et al, 
1993). The above intermediate states of different proteins, of different structure type, 
having common characteristics are termed as "molten globule" to emphasize the 
possible occurrence of such an intermediate as a general physical state of globular 
proteins (Ptitsyn et al, 1990; Arai and Kuwajima, 1996). Characterization of a molten 
globule state is helpful in identifying the other transition states believed to be located 
between molten globule and native state or molten globule and denatured state (Goto 
et al, 1990; 1993). The intermediate states are important not only for the folding and 
stability of proteins, but also for a myriad of biolpgical functions both under normal 
and pathological conditions. Intermediate states may be involved in the recognition of 
specific ligands and in creation of large insoluble fibres called amyloid plaques 
associated with a variety of neurodegenerative disease. 
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Little information is however available about molten globule state in 
multidomain proteins and its role in the protein folding. It is proposed that the 
domains of the protein are independent folding units that assemble and produce native 
molecule (Garel, 1992). These structural regions (subdomains and domains) are 
expected to fold independently when they are isolated or together. The study of the 
different conformational states in the unfolding-refolding of multi-domain proteins is 
important for an understanding of the principles governing protein folding (Baldwin, 
1991;Dobson, 1992). 
1.4.1 Properties of the molten globule 
The development of a broad range of sophisticated techniques has led to the 
identification and characterization of stable folding intermediates in several proteins. 
One such intermediate termed as "molten globule", has been shown to be a compact 
collapsed structure with pronounced secondary structure but lacking rigid tertiary 
structure (Ptitsyn, 1987; Kuwajima, 1989; Goto et al, 1990). The following properties 
are necessary to fully characterize a specie as a molten globule: 
a. A compactness much closer to that of the native state than the unfolded state, 
measured by techniques such as intrinsic viscosity, dynamic light scattering, size 
exclusion chromatography, or small angle X-ray scattering. 
b. A substantial amount of secondary structure as revealed by techniques such as CD 
or FTIR. 
c. Little or no native-like tertiary structure as evidenced by the lack of a near UV-CD 
signal or an ID NMR spectrum indicative of substantial side-chain equivalence. 
Recent evidence however supports the idea that the molten globule may also 
possess well defined tertiary contacts (Kay and Baldwin, 1996; Wu and Kim, 
1998; Shortle and Ackerman, 2001). 
d. Significant exposed hydrophobic surface area compared to the native state leading 
to a propensity for aggregation and to the ability to bind hydrophobic dyes such as 
ANS. 
e. A significant energy barrier between the putative molten globule and the native 
and unfolded states (in order to distinguish the molten globule from a compact 
form or of the unfolded state). Monitoring of parameters like enthalpy, heat 
capacity, thermal unfolding of all these states provide valuable data. Thermal 
unfolding of molten globule is effectively non-cooperative 
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1.4.1.1 Possible physiological roles for the molten globule 
Bychkova et al. (1988) and more recently Goot et al. (1992) have reviewed 
evidence that the molten globule state may be involved in membrane translocation. 
The 'A' state of a-lactalbumin has been shovra to induce fusion of phospholipid 
vesicles (Kim and Kim, 1986). Low pH (as in lysosomes) has been shown to play an 
important role in membrane penetration by toxins, such as the diphtheria toxin. It has 
been shown that diphtheria toxin forms a molten globule in the vicinity of pH 5 and 
that fusion with membranes correlates with formation of the molten globule 
conformation (Jiang et al, 1991). Similarly, it has been shown that membrane 
insertion of colicin A correlates with its transition to the molten globule (Goot et al, 
1991, Lakey et al, 1992). The membrane traversing potential of molten globule may 
be due to increased hydrophobic surface area. 
Transient and equilibrium molten globules are likely to play a significant 
role in the folding of proteins in vivo. It is expected that when an unfolded protein is 
placed under native-like conditions it will very rapidly collapse to a compact state 
such as the molten globule (Dill and Shortle, 1991). In addition, molten globule like 
conformations would be expected to be found for nascent polypeptides bound to hsp 
70 chaperones (Beckman et al, 1990) and perhaps to hsp 60 chaperones (Martin et 
al, 1991). In fact, it is possible that molten globules are the substrates for some 
chaperones. Molten globules are also believed to be real protein folding intermediates 
(Hirota et al, 1997). After synthesis in endoplasmic reticulum proteins may adopt 
molten globule state during translocation to golgi complex which directs their folding. 
This may be due to protective potential of molten globule against proteases. Many 
other proteins are known to traverse body fluids as molten globule as they are 
believed to be resistant to body fluid proteases. 
1.4.2 Mechanism of acid induced denaturation 
The major driving force for unfolding is intramolecular charge repulsion 
which may/may not overcome the interactions favoring folding such as hydrophobic 
forces, disulfide bonds, salt bridges and metal ion protein interactions (Goto et al, 
1990). The exact mechanism of a given protein at acid pH is a complex interplay 
between a variety of stabilizing and destabilizing forces. The acid denaturation of 
proteins often results in denatured states that are less unfolded than those obtained 
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with high concentrations of GdnHCl or urea (Aune et al, 1967; Tanford et ai, 1967; 
Tanford, 1968). Three major types of conformational states have been observed under 
acid-denaturation conditions imposed on proteins: • 
a. Native-like state (N) 
b. Partially folded intermediate/Acid-unfolded state (Ua) that retains somewhat more 
secondary structure than the corresponding GdnHCl denatured protein. 
c. Acid-denatured state (A) that is relatively compact and exhibits a high level of 
secondary structure and minimal tertiary structxire. The degree of compactness, as 
well as the extent of folding varies substantially among different 'A' states. The 
more compact 'A' states have the properties of molten globules (Ptitsyn, 1987; 
Kuwajima, 1989; Christensen and Pain, 1991). 
On this basis five different classes representing three major types of behaviors have 
been identified- Type I A, Type I B, Type I C, Type II and Type III proteins (Fink et 
al., 1994). 
Since the pK of most carboxyls is > 3, proteins become maximally 
positively charged upon decreasing the pH from neutrality to approximately pH 2.0 
and enter into partially folded intermediate/acid-unfolded state (UA state). Further 
addition of acid adds both protons and anions to the solution. Since the protein is 
already maximally protonated, the addition of more protons has no effect on its 
ionization state. However, the addition of more anions may effect protein 
conformation by reducing the repulsion by: 
a. Debye-Huckel screening effects. 
b. Interactions with positive charges by ion pair formation. I 
c. Effect on water structure (Goto et al., 1990). ' 
This decreases the internal repulsive forces that favor unfolding, and 
consequently the intrinsic hydrophobic interactions manifest themselves. These result 
in the protein folding to adopt a compact structure wdth decreased hydrophobic 
surface area (Peng et al, 1995) leading to 'A' state. This pattern is prevalent in Type I 
protein. In other cases there is a direct transition from native to 'A' state (Type II 
proteins). In still others proteins might be resistant to high concentrations of acid and 
remain in native like state (Type III protein). 
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1.4.3 Mechanism of alcohol/TFE induced folding 
The study of effects of alcohols on proteins and peptides are usefiil for 
considering how protein-specific structures are stabilized in an aqueous environment 
(Dill et al, 1995; Shiraki et al, 1995). Alcohols denature proteins but also stabilize a-
helical conformation in the unfolded proteins. Alcohol induced denaturation can be 
interpreted in terms of two processes: 
1. Disruption of native state. 
2. Induction of a-helical conformation. 
Alcohols with bulky alkyl groups are more effective than those with small 
alkyl groups in denaturing/inducing a-helix in proteins, suggesting that hydrophobic 
interactions are involved in the process (Hippel and Wong, 1965). Alcohols weaken 
non-local hydrophobic interactions and enhance local polar interactions i.e. hydrogen 
bonds of proteins. Therefore, alcohol induced denaturation results in stabilization of 
extended helical rods in which the hydrophobic side chains are exposed, whereas 
polar amide groups are shielded from solvents. Alcohols also induce significantly 
higher helical structures in partially or completely unfolded protein as compared to 
folded proteins (Bhakuni, 1998). 
In aqueous solution of water miscible alcohols, the latter associate so as to 
minimize their contact with water, leading to the formation of micelle like assembly. 
Unfolded polypeptides have many hydrophobic groups exposed. By interacting 
directly with unfolded protein side chain hydrophobic groups, the hydrophobic 
alcohols decrease the environmental polarity around polypeptide. This results in 
stabilization of local hydrogen bonds and consequently amphiphilic helical 
conformation. 
TFE is a protein denaturant, which has also been shown to induce molten 
globule state in many proteins (Buck et al, 1993; Fan et al, 1993). Among various 
alcohols TFE is often preferred in such studies because of its high potential for 
stabilizing a-helical structure. Numerous recent investigations on proteins and 
isolated peptide fragments have shown that TFE can induce helices in the proteins and 
peptides that are either helical in the native state or are predicted to possess properties 
to form helix (Segawa et al, 1991; Dyson et al, 1992; Kemmink and Creighton, 
1995; Shiraki et al, 1995). The high ability of TFE suggests that F atom is important 
for enhancing the effects of alcohols (Nelson and Kallenbach, 1986; Dyson and 
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Wright, 1993; Hamada et al, 1995). The secondary structure stabilized by TFE are 
assumed to reflect conformations that prevail during early stages of protein folding 
(Fan et al, 1993; Hamada et al, 1995; Shiraki et al, 1995). A number of authors 
have suggested that solvents such as TFE mimic some characteristics of the in vivo 
system and therefore attach relevance to structural studies performed in this solvent 
(Waterhous and Johnson, 1994). 
TFE is a highly polar molecule with enhanced hydrogen bond accepting 
capability and decreased donating capability relative to water (Llinas and Klein, 
1975). It raises the free energy of random coil state, because TFE-water mixtures are 
less able to solvate the amide group of peptide backbone. In other words, as TFE is a 
slight strong proton donor and much weaker proton acceptor than water, adding TFE 
will primarily decrease the solvents ability to compete with peptide carbonyl acceptor. 
Therefore, TFE favors states where backbone amide group form intramolecular 
hydrogen bonds with peptide carbonyl resulting in the formation of a-helix 
conformation (Nelson and Kallenback, 1986; Goodwin, 1996). Addition of TFE has 
been found to induce a conformational transition in the acid induced/ intermediate 
states as it amplifies the helical tendency of proteins (Hirota et al, 1997). 
The effect of TFE in inducing helical conformation is not nonspecific and 
the fragments arising from helical regions of native structure have a high tendency to 
form a-helix in presence of TFE, whereas p regions have low tendency to do so. 
These results suggest that native like secondary structures are formed in some regions 
of unfolded protein and serve as initiation sites of protein folding. Studies on effect of 
TFE on all p sheet protein has revealed that protein folding follows a non hierarchal 
model in which transient formation of a helical structure precedes the formation of 
native P structure (Khan et al, 2000). Interestingly, a recent report describes the 
existence of native like p structure in the partially folded state of tendamistat induced 
by TFE (Schonbrurmer et al, 1996). Effects of TFE are best modeled as mainly 
weakening the non-local hydrophobic interaction and slightly enhancing local helical 
interactions. 
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1.5 Objective of the present work 
Bromelain is a well-studied endoproteinase with several clinical and 
industrial applications. Since the natural substrates of bromelain are proteins, 
immobilization of the enzyme vide attachment to solid support is expected to yield 
I 
preparations with low activity on the substrate. -Attempts were therefore made to 
prepare immobilized bromelain in a manner that facilitated high expression of enzyme 
activity. For this purpose the natural structural features of bromelain of having a 
single oligosaccharide chain and single histidine residue, which does not participate in 
catalytic action of enzyme, has been made use of The lone glycosyl residue provided 
an opportunity for orienting the enzyme favorably and in a uniform manner on Con A 
support. IDA support was used to immobilize the enzyme predominantly via lone 
histidine residue. The behavior of bromelain immobilized on Con A-Sepharose 
support via its lone glycosyl and on IDA-Sepharose primarily through the lone 
histidine has been investigated. 
Antienzyme antibodies have been used int several studies for the 
immobilization and stabilization of several enzymes. Complexing of enzymes and 
polyvalent antibodies generally yield insoluble immobilized preparation. Efforts were 
therefore made to prepare monovalent Fab' fragments of anti-bromelain IgG for the 
formation of soluble complexes with the enzyme. It was envisaged that complexing 
with monovalent Fab' fragment would yield a stable and soluble enzyme preparation 
with potential for use in enzyme therapy, etc.. 
In case of many proteins, molten globule states are considered real protein 
folding intermediates. An unusual characteristic of bromelain is its ability to be 
absorbed readily in the intact form from the intestine and it has been suggested that 
the conformations similar to molten globule may facilitate the absorption. Information I 
on the molten globule state of bromelain is scarce and efforts have been made to 
characterize the same. 
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MATERIALS 
The chemicals used in the study were obtained from various sources as detailed 
below. Glass distilled water was used in all experiments. 
Chemical 
Acetic acid 
Acetone 
Acrylamide 
Agarose 
Aldolase 
Ammonium sulphate 
Ammonium per sulphate 
l-anilino-8-naphthalene sulphonic acid 
(ANS) 
Blue dextran 
Bovine serum albumin 
Bromophenol blue 
Calcium chloride 
Casein 
Concanavalin A 
Coomassie brilliant blue R-250 
Copper sulphate 
Cupric chloride 
Cytochrome C 
L-cysteine HCl 
Diethylaminoethyl cellulose 
Di-hydrogen sodium phosphate 
Di-sodium hydrogen phosphate 
Ethylene diamine tetraacetic acid (EDTA) 
Folins ciocalteu's phenol reagent 
Formaldehyde 
Source 
Qualigens Fine Chemicals, India 
Qualigens Fine Chemicals, India 
Sisco Research Lab., India 
Sisco Research Lab., India 
Sigma Chemical Co., USA 
Qualigens Fine Chemicals, India 
Sisco Research Lab., India 
Sigma Chemical Co., USA 
Pharmacia Fine Chem., Sweden 
Sisco Research Lab., India 
B.D.H., Poole, England 
Qualigens Fine Chemicals, India 
Sisco Research Lab., India 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Qualigens Fine Chemicals, India 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Sisco Research Lab., India 
Qualigens Fine Chemicals, India 
Qualigens Fine Chemicals, India 
Qualigens Fine Chemicals, India 
Sisco Research Lab., India 
Qualigens Fine Chemicals, India 
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Freund's complete adjuvant 
Freimd's incomplete adjuvant 
Glycerol 
Glycine 
Glutaraldehyde 
Goat anti-rabbit immunoglobulin, horse 
radish peroxidase conjugate 
Guanidine hydrochloride (GdnHCl) 
P-galactosidase 
Hydrochloric acid 
IDA-Sepharose 6B 
lodoacetamide 
Isopropanol 
Magnesium chloride 
Manganese chloride 
Methanol 
aD-methylmarmopyranoside 
P-mercaptoethanol 
N'N', Methylene bisacrylamide 
Molecular weight markers 
Nickel chloride 
Ovalbumin 
Papain 
Sephacryl S-300 HR 
Sephadex G-lOO 
Sepharose 4B 
Silver nitrate 
Sodium acetate 
Sodium bicarbonate 
Sodium carbonate 
Sodium chloride 
Sodium hydroxide 
Sodium lauryl sulphate 
Difco Lab., USA 
Difco Lab., USA 
Qualigens Fine Chemicals, India 
Sisco Research Lab., India 
Sigma Chemical Co., USA 
Genei Pvt. Ltd., Bangalore 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Qualigens Fine Chemicals, India 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Qualigens Fine Chemicals, India 
Qualigens Fine Chemicals, India 
Qualigens Fine Chemicals, India 
Qualigens Fine Chemicals, India 
Sigma Chemical Co., USA 
E-Merck, Germany 
Sisco Research Lab., India 
Genei Pvt. Ltd., Bangalore 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Qualigens Fine Chemicals, India 
Qualigens Fine Chemicals, India 
Sisco Research Lab., India 
Qualigens Fine Chemicals, India 
Qualigens Fine Chemicals, India 
Qualigens Fine Chemicals, India 
Qualigens Fine Chemicals, India 
3 8 
MATERIALS 
Sodium potassium tartarate 
Sodium thiosulphate 
Soyabean trypsin inhibitor 
Stem bromelain 
Sulphuric acid 
Tetramethyl benzidine/H202 substrate 
Trichloroacetic acid 
Tris (hydroxymethylaminoethane) 
2,2,2-trifluoroethanol (TFE) 
Zinc chloride 
Sisco Research Lab., India 
Qualigens Fine Chemicals, India 
Sigma Chemical Co., USA 
Sigma Chemical Co., USA 
Qualigens Fine Chemicals, India 
Genei Pvt. Ltd., Bangalore 
Qualigens Fine Chemicals, India 
Qualigens Fine Chemicals, India 
Sigma Chemical Co., USA 
Qualigens Fine Chemicals, India 
All other chemicals used were of analytical grade. 
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Methods 
2.1 Enzyme Immobilization 
2.1.1 Immobilization of Con A/stem bromelain on Sepharose 4B 
Sepharose was activated as described by Porath et al. (1967). 5.0 g of 
Sepharose was washed thoroughly in a sintered glass funnel with distilled water. The 
gel was sucked dry and then suspended in 5.0 ml of 2.0 M sodium carbonate. The 
slurry was stirred at room temperature for 15 min by placing it on a magnetic stirrer. 
1.0 g of CNBr dissolved in 1.0 ml of acetonitrile was added to the beaker containing 
Sepharose and mixed thoroughly in cold for 10 min. The whole mass was rapidly 
transferred to a glass-sintered funnel and washed successively with 0.1 M sodium 
bicarbonate buffer, pH 8.5. 
Appropriate amount of Con A/bromelain was dissolved in 0.1 M sodium 
bicarbonate buffer, pH 8.5 and added to the CNBr activated Sepharose. The 
suspension was stirred gently for 24 hrs at 4°C. The Sepharose bound protein was 
separated by centrifugation and the protein in the supernatant quantitated by the 
procedure of Lowry et al. (1951). The protein-coupled matrix was thoroughly washed 
with 0.1 M bicarbonate buffer, pH 8.5 containing 1.0 M NaCl and then with 0.1 M 
bicarbonate buffer, pH 8.5. The washed suspension was then treated with 0.1 ml of 
98% (v/v) ethanolamine or 0.1 M glycine. The matrix was washed with 0.1 M 
bicarbonate buffer, pH 8.5 containing 1.0 M NaCl, distilled water and finally with 0.1 
M sodium acetate buffer, pH 5.2 (for Con A-Sepharose) or 0.2 M sodium phosphate 
buffer pH 7.0 (for bromelain coupled matrix). The amount of protein/enzyme units 
immobilized was calculated by subtracting the amount of protein/enzyme units added 
to support from that remaining in the supernatant and washings. 
2.1.2 Activation of Sepharose 4B bound Con A 
Matrix bound Con A was activated by the method of Yariv et al. (1968). 
Con A-Sepharose was suspended in 0.1 M sodium acetate buffer, pH 5.2 containing 
1.0 mM each of CaCb, MgCb, MnCb and 0.15 M NaCl and stirred for 12 hrs in cold. 
M E T H O D S 
2.1.3 Immobilization of stem bromelain on Con A-Sepharose 4B 
Appropriate units of bromelain in 0.2 M sodium phosphate buffer, pH 7.0 
were added to 2 ml of activated Con A-Sepharose (3 mg of Con A was bound per ml 
of Sepharose) and incubated overnight at 4°C. The bromelain-Con A-Sepharose 
complex was then washed to remove unbound/excess bromelain, which was, 
quantitated for calculating bound enzyme units. 
2.1.4 Preparation of crosslinked stem bromelain 
Appropriate units of bromelain were incubated with 1% (w/v) 
glutaraldehyde in 0.2 M sodium phosphate buffer, pH 7.0 for 2 hrs at room 
temperature with constant stirring. The crosslinked preparation was treated with 1% 
(w/v) ethanolamine/glycine for 1 hr to neutralize the residual aldehydic groups. The 
crosslinked preparation was then subjected to extensive dialysis to remove excess 
glutaraldehyde and ethanolamine/glycine. 
2.1.5 Immobilization of soluble/crosslinked stem bromelain on immobilized 
metal ion support 
IDA-Sepharose 6B was thoroughly washed with distilled water and loaded 
with various divalent metal ions by the procedure described in the Instruction Bulletin 
of Pharmacia Biotech, Uppsala, Sweden (1997). 1.0 ml of chelating sepharose was 
loaded witli equal volumes of 0.1 M solutions of CuCb, NiCh or ZnCb and stirred at 
room temperature for a period of 30 min. The matrix was washed 4 times with 
appropriate volumes of distilled water and finally with 0.2 M sodium phosphate 
buffer, pH 7.0. The matrix was then mixed with appropriate amount of 
soluble/crosslinked bromelain preparation and stirred at room temperature for two 
hours, centrifiiged at 2,000 rpm for 30 sec and supernatant collected. The matrix was 
finally washed repeatedly with 0.2 M sodium phosphate buffer, pH 7.0, until no 
detectable activity remained in the washings. Finally the matrix was suspended in the 
same buffer. The immobilized enzyme units were calculated by subtracting the 
remaining units in the supernatant and washings from those added to chelating 
Sepharose matrix. 
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2.1.6 Effectiveness factor 
The effectiveness factor (ti) value of the immobilized preparation 
represents the ratio of actual to theoretical activity of the immobilized enzyme (Muller 
and Zwing, 1982). Actual activity value of the enzyme was determined by assaying an 
appropriate aliquot of the immobilized preparation. The theoretical activities of 
enzyme preparations were calculated by subtracting the soluble enzyme units 
remaining (after immobilization) from that added for immobilization. Effectiveness 
factor of an immobilized enzyme is a measure of internal diffusion effect and reflects 
the efficiency of immobilization procedure. 
2.2 Immunological Methods 
2.2.1 Preparation of the antigen 
For the immunization of rabbits, the antigen (bromelain, 300 i^ g/O.S ml) in 
50 mM sodium phosphate buffer, pH 7.0 was mixed with Freund's complete adjuvant 
in the ratio of 1:1. Booster doses of the antigen were prepared by mixing 150 |ag/0.5 
ml solution of antigen with equal volume of Freund's incomplete adjuvant as 
described by Freund (1947). The oil-buffer mixture was thoroughly emulsified by 
using a 21-gauge syringe. 
2.2.2 Immunization 
Healthy albino rabbits weighing between 2-3 Kg were used for 
immunization. The rabbits were bled prior to immunization and the sera obtained 
served as control. Rabbits were injected subcutaneously with the antigen (bromelain) 
prepared with Freund's complete adjuvant and the animals were rested for 15 days. 
Booster doses were given weekly for four weeks. After resting of the animals further 
for one week, blood was collected by cardiac puncture or through ear vein and clot 
formation allowed at room temperature for 3 hrs. The blood was centrifuged to collect 
antiserum, which was stored in small aliquots at -20'^C. 
2.2.3 Ouchterlony double diffusion 
The procedure described by Ouchterlony (1949) was used. Agar plates were 
prepared by pouring 25.0 ml of 1% (w/v) agarose solution in normal saline. The gel 
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was allowed to solidify and wells punched. Bromelain (about 30|ag) was loaded in the 
central well and 5-15 |il of adequately diluted antiserum was added in the peripheral 
wells. The antigen was loaded after 4 hrs of application of antiserum. The plates were 
incubated initially for 4 hrs at room temperature and subsequently overnight in a 
refrigerator. 
2.2.4 Direct binding enzyme-linked immunosorbent assay (ELISA) 
The titre/generation of antigen specific antibodies was measured in the sera 
of immunized rabbits by the ELISA. Ninety-six well microtitre plates (Immunol 2HB, 
Dynex, USA) were coated with 100 |al of bromelain at a concentration of 5 |ag/ml in 
0.05 M carbonate-bicarbonate buffer, pH 9.6 for 2 hrs at room temperature and 
overnight at 4°C. The plates were washed three times with TBS-Tween (0.14 M NaCl, 
2.7 mM KCl and 20 mM Tris pH 7.4 with 500 ^il/lit Tween) to remove unbound 
antigen. Unoccupied sites were blocked with 150 |al of 1.5% (w/v) BSA in TBS for 3 
hrs at room temperature. The plates were washed vdth TBS-Tween and serially 
diluted antiserum samples (100 |al/well) in TBS to be tested were added to each well 
(1:1,000 -> 1:10,24,000). The plates were incubated for 2 hrs at room temperature. 
After the usual washing steps, the peroxidase reaction was initiated by the addition of 
the substrate tetramethyl benzidine/H202, the reaction arrested by the addition of 4.0 
N H 2 S O 4 and absorbance at 450 nm measured in an ELISA reader. Each sample was 
coated in duplicate, and the results were expressed as mean of A test - A control. (A = 
Absorbance at 450 nm). 
2.2.5 Purification of IgG and Fab' monomers 
2.2.5.1 Purification of IgG 
Twenty five ml of control serum was mixed with equal volume of 20 mM 
sodium phosphate buffer, pH 7.2 and solid ammonium sulphate was added to make 
the mixture 20% saturated. After 6 hrs the sample was centrifiiged at 5,000 rpm for 20 
min and the supernatant made 40% saturated with respect to ammonium sulphate. 
After 4 hrs at 4°C the precipitate was collected by centriftigation at 5,000 rpm for 20 
min. Most of the gammaglobulins were present only in the 20-40% pellet, which was 
dissolved in minimum volume of 20 mM sodium phosphate buffer, pH 7.2 and 
extensively dialyzed against the buffer with several changes and stored at 4°C. 
4 3 
M E T H O D S 
DEAE-cellulose was suspended in 10 volumes of 0.5 N HCl for 1 hr and 
washed in a Biichner funnel with distilled water till the filtrate had neutral pH. The 
exchanger was then treated with 0.5 N NaOH for 1 hr and again washed with distilled 
water till the filtrate had neutral pH. The DEAE-cellulose was then resuspended in 20 
mM sodium phosphate buffer, pH 7.2 to obtain homogenous slurry. Fine particles 
were removed by decantation and the slurry poured in a vertically mounted column 
(1.8 cm X 10 cm). The flow rate was gradually increased to 30 ml/hr, the buffer 
carefully removed fi-om the surface and the dialyzed protein sample was applied. 
After washing the column with one bed volume by 20 mM sodium phosphste buffer, 
pH 7.2, 3.0 ml fractions were collected and analyzed for protein content (Catty and 
Raykundalia, 1998). The homogeneity of purified protein was assessed by PAGE. 
2.2.5.2 Purification of Fab' monomers 
Purified IgG (10 mg/ml) from the control serum was dialyzed against 0.1 M 
sodium phosphate buffer, pH 7.0. Cysteine HCl (1 mg/10 mg IgG), EDTA (0.5 mg/10 
mg IgG) and papain (1 mg/lOOmg IgG) were added to the dialyzed IgG and the 
mixture incubated for 4 hrs at 37°C. The digest was rapidly frozen to inhibit further 
digestion and was later dialyzed against 0.01 M sodium phosphate buffer, pH 8.0 
overnight at 4°C. DEAE cellulose was regenerated as detailed above and equilibrated 
with 0.01 M sodium phosphate buffer, pH 8.0. The dialyzed digest was applied to the 
column and a gradient of phosphate buffer was run from 0.01-0.3 M at pH 8.0. The 
first peak to emerge was predominantly that of Fab' monomer followed by the peak 
containing the Fc fragment (Catty and Raykundalia, 1988). 
2.2.6 Immunoafflnity purification of IgG and Fab' Monomers 
Bromelain was coupled to CNBr activated Sepharose by method of Porath 
et al. (1967). The preparation obtained thus contained 5.0 mg bromelain per ml gel. A 
column was packed in a 5.0 ml glass syringe by carefully adjusting the flow rate. 
Affinity purification of specific IgG was achieved by employing bromelain 
coupled to Sepharose following the procedure of Stults et al. (1989) with some 
modifications. Briefly, the bromelain specific antiserum was allowed to bind to 
bromelain-Sepharose affinity column. The column was washed thoroughly with 0.1 M 
Tris HCl, pH 8.9 containing 3.0 M NaCl to remove any unbound or non-specifically 
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associated protein. The bound IgG were eluted with 0.1 M glycine HCl buffer, pH 3.5 
and the eluate immediately neutralized with Tris buffer. Specific Fab' fragments were 
isolated by applying the papain treated IgG digest (prepared as detailed above) to the 
bromelain-Sepharose affinity column followed by washings and subsequent elution. 
Fc fragment did not bind to the support and was eluted in the washings. 
2.2.7 Preparation of stem bromeIain:Fab' complex 
Bromelain and antibromelain Fab' fragment were mixed in desired molar 
ratio in 0.2 M sodium phosphate buffer, pH 7.0 and incubated for 6 hrs at 4°C. A 
preparation of bromelain incubated with non-specific Fab' served as control. 
2.3 Determination of molecular weight and Stokes radius 
2.3.1 Determination of molecular weight of stem bromelain/IgG and 
derivatives 
The molecular weight of stem bromelain/IgG and derivatives were 
calculated by the procedure of Weber and Osbom (1969) using SDS-PAGE 
(reducing). The standard proteins used were phosphorylase b (PB), 97.4 IcDa; bovine 
serum albumin (BSA), 68 kDa; ovalbumin (OA), 43 kDa; carbonic anhydrase (CA), 
29 kDa, soyabean trypsin inhibitor (STI), 20 kDa; lysozyme (LY), 14.3 kDa. The 
mobilities of marker proteins determined under identical condition were plotted 
against the logarithm of molecular weights. The analysis of data indicated a linear 
relationship between logarithm of molecular weights (Log M) and relative mobility 
(Rm) and the plot was used in calculating the molecular weights. 
2.3.2 Determination of the molecular weight of stem bromelain:Fab'complex 
Bromelain and specific polyclonal Fab' monomers were added in 1:3 molar 
ratio and incubated for 6 hrs at 4°C as described above. The molecular weight of the 
complex formed was determined by gel filtration on a Sephadex G-lOO column (1.7 
cm X 80 cm). Alternatively the weight of the complex was determined by incubating 
bromelain and Fab' in equimolar amounts and passing through Sephacryl S-300 HR 
column (2.1 cm x 82 cm). The columns were calibrated by determining the elution 
volume of several globular proteins {aldolase (AL), 158 kDa; P-galactosidase (GL), 
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116 kDa; bovine serum albumin (BSA), 66 kDa; ovalbumin (OA), 45 kDa; soyabean 
trypsin inhibitor (STI), 20 kDa, cytochrome C (CC), 12.4 kDa}. The bromelain:Fab' 
complex was eluted with 0.01 M sodium phosphate buffer, pH 7.0, at a flow rate of 15 
ml/hr. Fractions were collected and monitored at 280 nm. The data was analyzed 
according to theoretical treatment of Andrews (1964) and the linear plot between 
VeA^o and log M was used in calculating the molecular weight of complex. 
2.3.3 Determination of Stokes radius of stem bromelainrFab'complex 
Size exclusion chromatography on Sephadex G-lOO (1.7 cm x 80 cm) or 
Sephacryl S-300 HR column (2.1 cm x 82 cm) column equilibrated with 0.01 M 
sodium phosphate buffer, pH 7.0 was used to determine the Stokes radius of 
bromelain:Fab' complex formed as detailed above. The flow rate was maintained at 
15 ml/hr and the absorbance of the eluant was monitored at 280 nm. The Stokes 
radius of the complex was determined by the method of Laurent and Killander (1964). 
The standard proteins used were aldolase (AL), 48.1 A ; bovine serum albumin (BSA), 
35.5 A ; ovalbumin (OA), 27.3 A ; soyabean trypsin inhibitor (STI), 22.6 A ; 
cytochrome C (CC), 16.4 A . The value of Kav of each marker proteins was calculated 
from the formula 
Kav = Ve-Vom-Vo 
Where: 
Ve (elution volume) 
Vo (void volume) 
Vt (total volume of column) 
A graph of the square root of the negative logarithm of Kav versus Stokes radii gave a 
linear plot which was used in calculating the Stokes radius of bromelain:Fab' 
complex. 
2.4 Polyacrylamide gel electrophoresis (PAGE) 
2.4.1 Non-Denaturing PAGE 
PAGE was performed essentially according to the method of Laemmli 
(1970) using a slab gel apparatus manufactured by Bangalore Genei, India. Stock 
solutions of 30% (w/v) acrylamide containing 0.8% (w/v) bis-acrylamide and 1.5 mM 
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Tris, pH 8.8 were mixed in appropriate order and proportions to give the desired 
percentage of gel. It was then poured into the mould formed by two glass plates (8.5 
cm X 10 cm) separated by 1.5 mm thick spacers. Bubbles and leaks were avoided. A 
comb providing a template for 7 wells was quickly inserted into the gel film and 
polymerization allowed to occur. After 15-20 min, the comb was removed and wells 
cleaned and overlaid with running buffer. Protein samples (15-35 |j,g) were mixed 
with equal volume of the sample buffer {containing 10% (v/v) glycerol, 62 mM Tris 
HCl, pH 6.8 and traces of bromophenol blue as tracking dye} and were applied to the 
wells. Electrophoresis was performed at 100 V in buffer containing 25 mM Tris and 
0.2 M glycine until the tracking dye reached the bottom of the gel. 
2.4.2 SDS-PAGE (reducing) 
SDS-PAGE (reducing) was performed by the Tris-glycine system of 
Laemmli (1970) using slab gel electrophoresis apparatus manufactured by Bangalore 
Genei, India. Concentrated stock solution of 30% (w/v) acrylamide containing 0.8% 
(w/v) bis-acrylamide, 1.5 M Tris, pH 8.8 and 10% (w/v) SDS were prepared and 
mixed in the appropriate proportion to give the final required percentage. It was 
poured in the mould formed by two glass plates (8.5 cm x 10 cm) separated by 1.5 
mm thick spacers avoiding leaks and bubbles. A comb providing a template for 7 
wells was inserted into the gel before the beginning of polymerization and removed 
once the polymerization was complete. The wells were subsequently overlaid with 
rurming buffer. Protein samples (15-35 |a.g) were mixed with equal volumes of sample 
buffer {containing 10% (v/v) glycerol, 1% (w/v) SDS, 5% (v/v) (i-mercaptoethanol, 
62 mM Tris HCl, pH 6.8 and traces of bromophenol blue as tracking dye} and were 
boiled at 100°C for 5 min. Electrophoresis was performed at 100 V in electrophoresis 
buffer containing 25 mM Tris and 0.2 M glycine and 0.1% (w/v) SDS till the tracking 
dye reached the bottom of the gel. 
2.4.3 Staining procedures 
After the electrophoresis was complete, the gels were removed and protein 
bands visualized by staining. 
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2.4.3.1 Coomassie brilliant blue staining 
Protein bands were detected by staining with 5 gel volumes of 0.1% (w/v) 
coomassie brilliant blue-R-250 in 40% (v/v) isopropanol and 10% (v/v) acetic acid for 
at least 4 hrs. For destaining, the gels were incubated with shaking in 5% (v/v) 
methanol and 7.5% (v/v) acetic acid at room temperature. 
2.4.3.2 Silver nitrate staining 
The procedure described by Nesterenko et al. (1994) was followed with 
few modifications. After electrophoresis the protein bands were fixed by rapidly 
immersing the gel in a mixture of 50% (v/v) acetone, 1% (w/v) trichloroacetic acid 
and 0.015% (v/v) formaldehyde for 10 min with constant shaking. The gel was then 
washed 3 times with distilled water. This was followed by second incubation in 50% 
(v/v) acetone, which was further followed by pretreatment with 0.016% (w/v) 
Na2S203.5H20 in order to prevent surface staining and to ensure a clear background. 
The gel was then impregnated in silver staining agent which is a mixture of 0.27% 
(w/v) AgNOs and 0.37% (v/v) formaldehyde for 16 minutes with constant shaking. 
The impregnation of the gel with silver nitrate is the basic step and the level of 
sensitivity relies, in part, on the level of background staining. The gel was then rinsed 
with distilled water. The washed gel was then immersed in developer mixture 
containing 0.18 M sodium carbonate, 0.015% (v/v) formaldehyde and 0.004% (w/v) 
Na2S203.5H20 for upto 60 sec till brown precipitate against protein bands appear. The 
reaction was immediately stopped by addition of 1% (v/v) glacial acetic acid. The gel 
was washed 4-5 times with distilled water. The gel was incubated for 15 min in 1 % 
(v/v) glycerol and dried imder vacuum between two cellophane sheets. 
2.5 Colorimetric/Spectrophotometric estimations 
2.5.1 Determination of protein concentrations 
Protein concentrations were determined either spectrophotometrically or by 
the method of Lowry et al. (1951) using bovine serum albumin (BSA) as the standard. 
Protein concentration of stem bromelain was determined using an extinction 
coefficient jso nm ^ 20.1 (Reyna and Arana, 1995). The molecular mass of stem 
bromelain was taken as 23,800 Da (Vanhoof and Cooreman, 1997). Protein in the 
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column fractions was monitored at 280 nm as O.D (Optical density). 
2.5.2 Assay of Stem bromelain 
Proteolytic activity of bromelain was measured using casein as a substrate 
(Murachi et al, 1964). The standard incubation mixture contained 0.2 M sodium 
phosphate buffer of pH 7.0/7.5, 5.0 mM L-cysteine, 0.1 M KCl and appropriate 
quantities of bromelain in a total volume of 0.5 ml. Enzyme preparation were pre-
incubated for 5 min at 37°C and the reaction initiated by addition of 0.5 ml of 1% 
(w/v) casein. Reaction was stopped with 1.0 ml of 10% (w/v) trichloroacetic acid. The 
resulting soluble peptides were quantitated by the procedure of Lowry et al. (1951). 
The enzyme activity of immobilized bromelain was determined in a similar manner 
except that the reaction mixture was continuously stirred during the reaction. 
Appropriate aliquots containing nearly equal number of enzyme units of native (free) 
and various immobilized preparation were taken for comparison of various stability 
parameters. One unit of bromelain was the amount that resulted in change of 0.001 
O.D per min under the condition. 
2.6 Chemical modification of stem bromelain 
To avoid complications due to autocatalysis, enzyme samples were 
irreversibly inactivated by the method of Sharpira and Amon (1969) with the 
modification as reported earlier by Haq et al (2002). Reduction was carried out in 
0.32 M 2-mercaptoethanol for 4 hr at room temperature, followed by addition of solid 
iodoacetamide to give a final concentration of 43 mM. After stirring for 30 min at 
4'^ C, the solutions were dialyzed overnight against 10 mM sodium phosphate buffer, 
pH 7.0. This inactive modified (pseudo-native) preparation along with unmodified 
stem bromelain (native) was used throughout the present study. All preparations 
unless otherwise mentioned should be considered as unmodified. Acid induced states 
of modified preparation and unmodified preparation were achieved by dialysis against 
10 mM glycine HCl buffer, pH 2.0. 
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2.7 Spectroscopy 
2.7.1 Fluorescence spectroscopy 
Intrinsic fluorescence and ANS binding was studied using a Shimadzu 
spectrofluorometer model RP-540 equipped with a data recorder DR-3 or on Hitachi 
spectrofluorometer, model F 2000. All solutions of protein were in range of 0.1-0.5 
mg/ml. Requisite volumes of methanol, NaCl, 2,2,2-trifluoroethanol (TFE), GdnHCl 
were taken. For the intrinsic tryptophan fluorescence, the excitation wavelength was 
set at 280 nm and the emission spectra recorded in the range of 300-400. Binding of 
ANS to bromelain preparations was studied by exciting the dye at 380 nm and the 
emission spectra recorded from 400-600 nm. Excitation and emission slit widths were 
5 nm. A stock solution of ANS in distilled water was prepared and the concentration 
determined using an extinction coefficient of £ ^^  = 5000 M"'.cm'' at 350 nm 
(Khurana and Udgaonkar, 1994). The molar ratio of protein to ANS was 1:50. Since 
ANS shows emission in TFE and all related spectra were corrected for blanks. 
2.7.2 Circular dichroism spectroscopy 
All the circular dichroism (CD) measurements were carried out at 25°C 
using a Jasco spectropolarimeter model J-720 using a Sekonic XY Plotter (model-
SPL-430A), with a thermostatically controlled cell holder attached to a Neslab water 
bath model RTE 110 with an accuracy of ± 0.10°C. The instrument was equipped with 
a microcomputer and precalibrated with (+)-10-camphorsulfonic acid. The spectra 
were collected with a scan speed of 20 nm.min"' and with a response time of 1 sec. 
Each spectrum was recorded as an average of two scans. Far-UV CD spectra and the 
near-UV CD spectra were taken at a protein concentration range of 0-0.5 mg/ml and 
0.5-1.0 mg/ml with 1 mm and 10 mm path length cell respectively. CD spectra were 
recorded in wavelength range of far-UV 210-250/190-250 and for near-UV 250-
330/250-310. The CD results are expressed as such in millidegree or as mean residue 
ellipticity (MRE) in degrees, cm^. dmol"', which is defined as: 
MRE (9) = Oobs (mdeg)/( 10 x n x 1 x Cp) (1) 
Where, Gobs is the CD in millidegrees n is the number of amino acid residue (212), 1 is 
the pathlength of the cell in cm and Cp is the mole fraction. 
For near-UV CD temperature transition studies, a water-jacketed 10 mm pathlength 
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cell was used attached to the RTE-110 water bath interfaced with a microcomputer. 
The same protein concentration was used in all CD measurements. The thermal 
denaturation of different preparation was monitored by the ellipticity changes at fixed 
wavelength (280 nm), as a function of temperature. This latter parameter was 
continuously varied at a selected constant rate (1.5°C/min) by carefully adjusting the 
heating control of water bath. Each reading at the desired temperature was recorded 
after an incubation time of 10 min at the temperature. 
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Results and Discussion-I 
3.1 Immobilization of bromelain on Sepharose 4B/Sepharose 4B 
coupled Con A 
Sepharose when activated with CNBr readily forms covalent Unkages with 
free amino group containing substances including proteins (Porath et al, 1967). A 
preparation containing bromelain coupled covalently to Sepharose was obtained by 
coupling of the enzyme to CNBr activated Sepharose. On the other hand an affinity 
bound bromelain preparation was prepared by exploiting the unusual feature of this 
enzyme, i.e., presence of single covalently attached heterooligosaccharide unit 
(Murachi et al, 1967; Scocca and Lee, 1969). Con A after covalent attachment to 
Sepharose and activation by method of Yariv et al. (1968) provided a support on to 
which the the bromelain could be bound through the single glycosyl chain thereby 
immobilizing bromelain in uniformly oriented manner. 
As shown in Table 3.1 higher T| value exhibited by affinity bound 
bromelain preparation over the covalently coupled bromelain preparation suggests 
higher accessibility of enzyme to the casein substrate in case of the former. This can 
be due, to good steric accessibility and proper spatial organization resulting from 
.Con A and single glycosyl chain acting as long spacer in the affinity bound 
preparation. Absence of such spacer and coupling of enzyme to the Sepharose via 
multiple linkages may restrict the accessibility of the enzyme to substrate and lead to 
low r| values in case of covalently coupled preparation. Bromelain contains 15 lysine 
residues (Vanhoof and Cooreman, 1997) and theoretically these can form the points 
of contact with the support. Overall the low r) value of the immobilized preparations 
are explainable also on the basis of high exclusion limit of the support, which results 
in the binding of protein moieties not only at the surface but also in the interior of 
beads thereby causing some internal diffusional limitation (Farooqi, 1999). Use of 
macromolecular substrate further adds to this feature. 
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Table 3.1 Immobilization of bromelain on -Con A-Sepharose and activated 
Sepharose* 
Immobilization Units" Units'' in Bound bromelain Effectiveness 
Procedure added/ml wash/ml (units''/ml gel) factor (ti) 
gel 
Theoretical' Actual" 
gel 
m m. 
(B/A) 
Affinity binding 11550 6870 4680 3002 0.64 
Covalent 
coupling 
11550 5600 5950 2666 0.45 
® Each value represents the mean of at least three independent experiments 
performed in duplicate. 
'' Bromelain was assayed as described by Murachi et al. (1964) with few 
adaptations as detailed in methods. By convention one enzyme unit is the quantity 
of enzyme that brings about a change of 0.001 absorbance unit on incubation with 
fresh assay mixture per minute. 
Determined by subtracting the number of units of enzyme remaining in the 
supernatant and washings after incubation from those added. 
^ Determined by assaying appropriate aliquots of the immobilized enzyme under 
Standard assay conditions with continuous agitation. 
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3.1.1 Effect of Temperature 
3.1.1.1 Activity at various temperature 
Temperature activity profiles of native, covalentiy coupled and affinity 
bound bromelain preparations were studied and compared. Both native and covalentiy 
coupled preparations were optimally active at 60°C, but there was a shift in the 
optimum to 70°C in case of the affinity bound preparation (Figure 3.1). While the 
covalentiy coupled preparation was slightly more stable at higher temperature over 
the native preparation, the affinity bound preparation retained markedly higher 
fraction of activity at higher temperatures. 
3.1.1.2 Thermal stability at 60"C 
Native, covalentiy coupled and affinity bound bromelain preparations were 
also investigated for the ability to resist inactivation induced by incubation at 60°C. 
Both the immobilized preparations show a clear improvement in resistance to 
inactivation at 60®C, although resistance is more marked in case of the affinity bound 
preparation. Thus while more than 50% of initial proteolytic activity was retained 
after incubation for 100 min in case of affinity bound preparation, only 30% and 20% 
activity remained in the covalentiy coupled and native preparations respectively 
(Figure 3.2). 
Plant proteins generally exhibit high optimum temperatures. It is very 
surprising to note that covalentiy coupled bromelain preparation is less stable than 
affinity bound prepaiation at 60°C. Stability of preparation is greatly influenced by 
the number of covalent/non covalent linkages between enzyme and the support (Iqbal 
and Saleemuddin, 1983; Monsan and Combes, 1988; Husain et al, 1992). The 
covalentiy coupled preparation is likely to involve multipoint attachment with the 
support due to presence of large number of side chain amino groups in bromelain 
(Vanhoof and Cooreman, 1997). The affinity bound preparation is expected to be 
linked to the support through the lone glycosyl chain, therefore covalentiy linked 
preparation is expected to unfold less readily at higher temperature and in reponse to 
other form of stress. Stability at higher temperatures in case of affinity bound 
preparation over the covalentiy coupled preparation can be explained on the 
assumption that region near the glycosylation site may constitute a major site of 
initiation of unfolding (Saleemuddin and Husain, 1991; Jafri and Saleemuddin, 1997; 
Vrabel et al, 1997; Saleemuddin, 1999), which may be masked in case of affinity 
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Fig. 3.1 Effect of temperature on native and immobilized bromelain 
preparations. 
Appropriate aliquots of native, covalently coupled and afiBnity bound 
bromelain preparations were assayed for enzyme activity at indicated 
temperatures under standard condition of pH and substrate concentration. 
Each point represents the mean of three experiments carried out in 
triplicate. S.E.M. did not exceed 1.90. 
(— • —) native bromelain 
(—Y—cova len t ly coupled bromelain 
(— • — a f l S n i t y bound bromelain 
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Fig. 3.2 Effect of pre-incubation at 60"C on thermal inactivation of native and 
immobilized bromelain preparations. 
Appropriate aliquots of native, covalently coupled and aflfinity bound 
bromelain preparations were incubated at 60®C for indicated time duration, 
cooled to room temperature and residual activity determined under standard 
assay condition. Activity of aliquots not subjected to heat inactivation was 
taken as 100 for calculation of percent activity. Each point represents the 
mean of three experiments carried out in triplicate. S.E.M did not exceed 
1.70. 
(— • —) native bromelain 
( — T — c o v a l e n t l y coupled bromelain 
(— • —) affinity bound bromelain 
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bound preparation. In case of covalently coupled preparation however attachment 
through such region may not be feasible forasmuch as side chain amino groups in the 
region may be masked by the oligosaccharide chains (Liberatore et al, 1976; Pollock 
et al, 1978). Decline in activity profile of affinity bound preparation at temperature 
higher than may be due to the denaturation of Con A (Sanders et al, 1998), 
release and/or inactivation of bromelain. Higher thermal stability on incubation at 
60°C for different time intervals in case of the affinity bound preparation over the 
covalently coupled preparation can be explained under similar assumption. 
Alternatively it can be explained in light of the fact demonstrated by several workers 
that reactivation of heat denatured enzyme to their native form is facilitated if the 
polypeptide chain undergoes complete unfolding prior to its exposure to conditions 
that facilitate refolding (Klibanov, 1979; Husain et al, 1992). The observed poor 
activity of the covalently coupled preparation after incubation at 60°C may be related 
to its inability to unfold completely due to attachment at several sites on the support. 
It is of interest to note that large number of glycoenzymes have been shown to exhibit 
markedly higher stability if they are immobilized via glycosyl chains rather than 
amino acid side chains (Hsiao and Royer, 1979; Woodward and Zachry, 1982; Iqbal 
and Saleemuddin, 1983, Husain et al, 1992). 
Based on studies of enzyme immobilized through their carbohydrate chains 
(Woodward and Wiseman, 1978; Hsiao and Royer, 1979; Saleemuddin and Husain, 
1991; Jafri et al, 1995; Jafri and Saleemuddin, 1997; Vrabel et al, 1997) showing 
impressive gains against inactivation induced by heat, especially when bound on Con 
A supports (Saleemuddin and Husain, 1991; Vrabel et al, 1997), it had been 
suggested (Jafri and Saleemuddin, 1997; Saleemuddin, 1999) that regions close the 
glycosylation site of enzymes may be important in the unfolding of several 
glycoenzymes. 
3.1.2 Effect of pH 
Activity profiles of native, covalently coupled and affinity bound bromelain 
preparations were investigated in 0.2 M sodium phosphate or tris HCl buffer of 
various pH at 37°C. Optimum pH value of bromelain remained unaltered at pH 7.5 on 
immobilization (Figure 3.3). However unlike the covalently coupled preparation, 
affinity bound preparation displayed improved stability between pH 9.0-11.0, which 
is inconsistent with the model proposed by Murachi and Yamazaki (1970). They 
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Fig. 3.3 pH activity profiles of native and immobilized bromelain preparations. 
Appropriate aliquots of native, covalently coupled and affinity bound 
bromelain preparations were incubated in 0.2 M sodium phosphate buffer 
(pH 5-8) or 0.2 M Tris HCl buffer (pH 9-11) and activity determined under 
standard assay condition. Each point represents the mean of three 
experiments carried out in triplicate. S.E.M. did not exceed 1.80. 
(— • — n a t i v e bromelain 
(—Y—) covalently coupled bromelain 
(— • —) affinity bound bromelain 
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reported that no changes in conformation of bromelain occurs up to pH 10.0 but 
beyond which the conformational change proceeded through at least two mutually 
distinguishable stages with a concomitant loss of activity. Extended stability in case 
of affinity bound in pH range 9.0-11.0 reaffirms that regions close the glycosylation 
site of enzyme may be important in unfolding and may represents sites for pH induced 
unfolding as well. Covalently coupled preparation displayed marginally higher 
stability over the native bromelain. The affinity bound preparation is expected to 
interact with the single oligosaccharide chain of bromelain with Sepharose bound Con 
A, yet it showed considerable resistance against inactivation at alkaline pH. This 
suggests that, as in the case of thermal denaturation of the enzyme, the regions that 
are labile to pH induced denaturation may also occur in the enzymes and blocking of 
the sites may similarly confer remarkable stability to the enzymes at extremes of pH. 
Considering that binding to the support via carbohydrate chains confers remarkable 
stability against inactivation induced both by high temperature and pH, the two sites 
may even be identical or closely positioned. This also confirms the earlier hypothesis, 
i.e., stability is conferred if unfolding sites are blocked by attachment to suitable 
support (Hofman et al., 1993; Arnold et al, 1996). 
3.1.3 Determination of kinetic constants Km and Vmax 
The activity of native, covalently coupled and affinity bound bromelain 
preparation was measured as a function of substrate concentration. A typical 
Michaelis-Menton behavior was observed in case of native and immobilized 
preparations. The Lineweaver-Burk plots indicate Km values for native, covalently 
coupled and affinity bound preparation to be 1.20, 1.75, 0.66 mg/ml respectively 
(Figure 3.4) suggesting maximum affinity for substrate in case of the affinity bound 
preparation and minimum in case of covalently coupled preparation. The values are 
however not different remarkably. The observed slightly low Km value of affinity 
bound over covalently coupled preparation may be due to good steric accessibility 
(glycosyl side chain and Con A acting as spacers) and favorable spatial orientation 
(attachment through single glycosyl chain). Low Km value of affinity bound 
preparation over native is difficult to explain but for assumption that enzyme protein 
may undergo a conformational change that increases its affinity for substrate. Higher 
Km value of covalently coupled preparation over native and affinity bound 
preparations may be due to decreased accessibility of substrate to enzyme and also 
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Fig. 3.4 Lineweaver-Burk plot for casein hydrolysis by native and immobilized 
bromelain preparations. 
Comparable quantities of native, covalently coupled and affinity bound 
bromelain preparation were incubated in a series of tubes with standard 
assay mixture containing various concentration of substrate. After 15 
minute incubation at 37"C, the activity in all preparations was determined. 
Reciprocal concentrations of velocity were plotted as a fiinction of 
reciprocal concentration of substrate to obtain a characteristic Lineweaver-
Burk plot. The lines were extrapolated to cut the X-axis and Y-axis to 
obtain the value of 1/Km and l/Vmax from which Km and Vmax values 
were determined. Each point represents the mean of three experiments 
carried out in triplicate. S.E.M. did not exceed 1.80. 
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due to holding of some fraction of bromelain in unfavorable orientation. Vmax values 
of native, covalently coupled and affinity bound preparation as calculated from figure 
3.4 were quite similar- 10526, 8333, 9523 EU/1 respectively. Significantly lower 
value of Vmax in case of covalently coupled preparation may result from inactivation 
of a fraction of bound bromelain due to unfavorable orientation. These differences in 
Km and Vmax values of different preparations are however in the same order of 
magnitude and therefore not very significant. Small differences in kinetic constants 
have also been reported for other immobilized preparations (Woodward and 
Wiseman, 1978; Montero and Romeu, 1993) 
3.1.4 Agitational effect and reusability 
The effect of agitation at 2,000 rpm for different time intervals on a rotary 
shaker was investigated inorder to study the mechanical stability of the affinity bound 
bromelain preparation. Affinity bound preparation displayed impressive mechanical 
stability. No significant loss in activity of bromelain immobilized in oriented manner 
was observed even when the preparation was agitated at 2,000 rpm for 60 min 
showing the strong association of bromelain on Con A-Sepharose support (Figure 3.5 
A). Further as can be seen from figure 3.5 B affinity bound preparation loses only a 
fraction of activity (25%) after repeated use for 20 times. The preparation was also 
found to be stable for several weeks at Earlier reports of enzymes immobilized 
on Con A supports have also shown impressive gains in resistance to agitation, 
storage and are found to perform long term continuous operations for several weeks 
(Saleemuddin and Husain, 1991; Montero and Romeu, 1993; Vrabel et al, 1997). The 
stability of bromelain immobilized on Con A support is interesting considering that 
unlike other immobilized glycoenzymes preparations binding of bromelain to Con A 
involves a single oligosaccharide-Con A interaction. 
Binding of bromelain on Con A-Sepharose support could be nearly 
completely reversed by incubating the preparation with 0.5 M a-methyl D-mannoside 
and Con A-Sepharose support could be reused. Lectins from other sources have also 
been effectively used for lectin based bioaffinity immobilization (Ahmad et ai, 2001) 
especially where Con A supports bind the glycoenzyme very weakly (Kierstan and 
Bucke, 1977) and also where binding is very strong making the association rather 
irreversible (Mislovicova et al, 1995). In all Con A based immobilization seems 
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Fig. 3.5 (A) Mechanical stability and (B) reusability of affinity bound 
bromelain preparation. 
(A) Appropriate aliquots of affinity bound bromelain preparation in 0.2 M 
sodium phosphate buffer, pH 7.0 were mechanically agitated on a rotary 
shaker at 2,000 rpm for different time intervals, washed with buffer and 
bound bromelain activity determined. Activity of equal aliquots of the 
oriented preparation not subjected to agitation was taken as 100 for the 
calculation of percent activity in the agitated sample. 
(B) Appropriate aliquots of affinity bound bromelain preparation were assayed 
for enzyme activity repetitively. After each assay the preparation was 
recovered by centrifugation at 2,000 rpm, washed with buffer and assayed 
for enzyme activity using fresh assay mixture. Activity of aliquot subjected 
to first assay was taken as 100 for calculation of percent activity in the 
subsequent assays. 
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promising for bromelain. 
3.2 Immobilization of bromelain on immobilized metal ion 
supports 
3.2.1 Immobilization of bromelain on IDA-Sepharose 6B charged with 
various divalent metal ions 
Binding of bromelain was performed on IDA-Sepharose loaded with 
different divalent metal ions Cu^ "^ , Ni^ "^ , Zn^ "^ . Activity measurements enzyme units 
reveal a high effectiveness factor (ri) for bromelain-Cu-IDA-Sepharose followed by 
bromelain-Ni-IDA-Sepharose and bromelain-Zn-IDA-Sepharose, with values of 0.65, 
0.48 and 0.38 respectively (Table 3.2). Further as calculated from table 3.2, addition 
of equal number of enzyme units to IDA-Sepharose charged with various divalent 
metal ions gives maximum immobilization yield/binding capacity for bromelain-Cu-
IDA-Sepharose (84%) followed by bromelain-Ni-IDA-Sepharose (74%) and 
bromelain-Zn-IDA-Sepharose (69%). 
High effectiveness factor obtained in case of bromelain-Cu-IDA-Sepharose 
can be explained in light of the fact that although histidine side chain dominate in 
binding to the chelated metal ion, free -SH group of bromelain may also contribute to 
the binding. While owing to 15 times higher affinity for imidazole for Cu^ "^  (Sundberg 
and Martin, 1974; Yip et al, 1989) over other metal ions, IDA-sepharose loaded with 
Cu^ "^  may predominantly bind with the single histidine at position 158 (Vanhoof and 
Cooreman, 1997), a fraction of IDA-sepharose loaded with Ni or may also bind 
bromelain via the lone free -SH group at the active site causing some inactivation of 
the population of enzyme. Overall low r\ value obtained in immobilized preparations 
is explainable inasmuch high exclusion limit of the support, which results in the 
binding of protein moieties not only at the surface but also in the interior of beads 
thereby causing some minimal internal diffusional limitation (Farooqi, 1999). Use of 
macromolecular substrate further contributes to the steric hindrance. 
Maximal binding capacity in case of bromelain-Cu-IDA-Sepharose can be 
well explained in light of work of Porath et al. (1988) which states that the affinity of 
different metal ions complexed with IDA for protein follows the order Cu (II) > Ni 
(II) > Zn (II) ~ Co (II). Our observed order is in agreement with these works. This 
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Table 3.2 Immobilization of bromelain on IDA-Sepharose charged with 
different divalent metal ions" 
Immobilization 
Procedure 
Units" 
added/ml 
gel 
Units" in 
wash/ml 
gel 
Bound bromelain 
(units''/ml gel) 
Theoretical' Actual'' 
(A) (B) 
Effectiveness 
factor (ti) 
(B/A) 
Br-Cu^^-IDA-
Sepharose 11550 1861 9689 6298 0.65 
Br-Ni^^-IDA-
Sepharose 11550 3046 8504 4082 0.48 
Br-Zn^^-IDA-
Sepharose 11550 3550 8000 3040 0.38 
® Each value represents the mean of at least three independent experiments 
performed in duplicate. 
'' Bromelain was assayed as described by Murachi et al. (1964) with few 
adaptations as detailed in methods. By convention one enzyme unit is the quantity 
of enzyme that brings about a change of 0.001 absorbance unit on incubation with 
standard assay mixture per minute. 
Determined by subtracting the number of units of enzyme remaining in the 
supernatant and washings after incubation from those added. 
^ Determined by assaying appropriate aliquots of the immobilized enzyme under 
standard assay conditions with continuous agitation. 
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may be probably due to maximum number of effective coordination sites available for 
interaction with proteins in the above order. 
Above results indicate Cu-IDA-Sepharose to be the most suitable adsorbent 
for immobilization of bromelain inasmuch as have maximal effectiveness 
factor/immobilization yield for proteins followed by Ni-IDA-Sepharose and Zn-IDA-
Sepharose, moreover by virtue of presence of a single histidine in bromelain, provides 
by default a predominantly oriented immobilized preparation. An absolute oriented 
preparation cannot be expected as N-terminal amino group as well as single free -SH 
group may contribute insignificantly towards binding to chelated Cu^ "^ . However, 
histidine side chain may dominate in bromelain binding ov^ng to higher affinity of 
imidazole for Cu^ "^ . These study also suggest the presence of single histidine at 
surface in a way that it is available for binding. Moreover despite its presence in the 
vicinity of the active site, immobilization through this residue presumably does not 
interfere with catalytic activity as has been suggested by Murachi (1975). 
3.2.2 Immobilization of native and crosslinked bromelain preparation on 
Cu-IDA-Sepharose 
Our choice of Cu-IDA-Sepharose as adsorbent was in consideration of its 
significant merits for immobilization of bromelain as detailed above. Crosslinked 
preparation of bromelain was obtained as detailed in method section 2.1.4. 
SDS-PAGE (reducing) of native and crosslinked (soluble) bromelain 
ascertains the near homogeneity of enzyme preparation and ensures that no autolysis 
has taken place (Figure 3.6 A). Bromelain migrated as a single band corresponding to 
molecular mass of 23.4 IcDa (Figure 3.6 B), which is close to the reported molecular 
mass 23.8 kDa (Vanhoof and Cooreman, 1997). The crosslinked preparation obtained 
showed a slower migration with a rather diffused band corresponding to molecular 
mass of 48 kDa (Figure 3.6 B) suggesting it to be a dimer. 
Attempts were made for immobilization of native and crosslinked 
preparation on Cu-IDA-Sepharose. While native preparation showed impressive 
immobilization as shown in table 3.2, the crosslinked preparation failed to bind to the 
adsorbent. Inability of binding of crosslinked preparation to Cu-IDA-Sepharose may 
be due to masking or shielding of histidine residues due to crosslinking via 
glutaraldehyde. This may in turn be due to proximity of lysine residues to histidine in 
the three dimensional structure of protein. 
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Fig. 3.6 SDS (reducing) gel electrophoresis of native and soluble crosslinked 
bromelain preparations and determination of molecular weight. 
(A) The electrophoretic pattern of native and crosslinked preparations of IgG in 
12.5% SDS (reducing) gel are shown. 0-5 [ig of each protein was 
electrophoresed on slab gel and silver nitrate staining was adopted 
(inasmuch as crosslinked preparation fail to take coomassie brilliant blue 
stain). Lane a: molecular weight markers; Lane b: native bromelain; Lane c: 
crosslinked bromelain. 
(B) Molecular weight determination of native and crosslinked bromelain by 
theoretical treatment of Weber and Osbom as detailed in methods section 
2.3.1. 
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3.2.3 Effect of temperature 
3.2.3.1 Activity at various temperature 
Temperature activity profiles of native, Cu-IDA-Sepharose immobilized 
and crosslinked (soluble) bromelain preparations were studied. All the preparations 
were optimally active at 60°C. While immobilized preparation was slightly stable at 
higher temperatures, crosslinked preparation exhibited significant stabilization 
compared to native (Figure 3.7). 
3.2.3.2 Thermal stability at 60°C 
Native, Cu-IDA-Sepharose immobilized and crosslinked (soluble) 
bromelain preparations were investigated for the ability to resist inactivation induced 
by incubation at SO^C. Temperature stability profile at 60°C as a function of different 
time intervals shows significantly higher retention of activity by cross linked and 
immobilized preparations over the native enzyme during the entire duration of the 
experiment, although it is more marked in case of former. While in case of native 
preparation only 20 min were required for 50% inactivation, crosslinked and 
immobilized preparations retained more than 50% residual activity even after 
exposure at the said temperature for 100 min. Immobilized and crosslinked 
preparations retained 50% and 70% activity respectively after 100 min (Figure 3.8). 
Higher thermal stability in case of crosslinked preparation results from 
holding of the native enzyme at several places in soluble enzyme-enzyme complex by 
virtue of inter- and intra- molecular crosslinks and thereby restriction and prevention 
of enzyme unfolding when subjected to temperature stress. Stabilization of 
immobilized preparation can be explained in light of possibility that histidine is 
present at or near temperature labile region which when coupled to Cu-IDA-
Sepharose blocks the unfolding of enzyme. Other enzymes immobilized on Cu-IDA-
Sepharose have have also shown impressive thermal stability (Sosnitza et al., 1998). 
Decrease in autolysis may also contribute to the obser\'ed stabilization in both 
crosslinked and immobilized bromelain preparations (Arnold and Zhang, 1994; Afaq 
and Iqbal, 2001). 
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Fig. 3.7 Effect of temperature on native, Cu-IDA-Sepharose immobilized and 
soluble crosslinked bromelain preparations. 
Appropriate aliquots of native, immobilized and crosslinked bromelain 
preparations were assayed for enzyme activity at indicated temperatures 
under standard condition of pH and substrate concentration. Each point 
represents the mean of three experiments carried out in triplicate. S.E.M. 
did not exceed 1.70. 
( — • — n a t i v e bromelain 
( — f — ) Cu-IDA-Sepharose immobilized bromelain 
(— • —) soluble crosslinked bromelain 
6 8 
Tempera tu re ( C) 
RESULTS & DISCUSSION - ll| 
Fig. 3.8 Effect of pre-incubation at 60®C on thermal inactivation of native, Cu-
IDA-Sepharose immobilized and soluble crosslinked bromelain 
preparations. 
Appropriate aliquots of native, immobilized and crosslinked bromelain 
preparations were incubated at 6 0 ^ for indicated time duration, cooled to 
room temperature and residual activity determined under standard assay 
condition. Activity of aliquots not subjected to heat inactivation was taken 
as 100 for calculation of percent activity. Each point represents the mean of 
three experiments carried out in triplicate. S.E.M. did not exceed 1.80. 
(— • —) native bromelain 
(—T—) Cu-IDA-Sepharose immobilized bromelain 
(— • —) soluble crosslinked bromelain 
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3.2.4 Effect of pH 
Activity profile of native, Cu-IDA-Sepharose immobilized and soluble 
crosslinked bromelain preparations were investigated in 0.2 M sodium phosphate or 
tris HCl buffer of various pH at SV^C. It is evident from figure 3.9 that immobilized 
and crosslinked preparation differ in optimum pH with the native preparation. 
Optimum pH of native, crosslinked and immobilized preparation were 7.5, 8.0 and 6.0 
respectively. These differences may be attributed to differences in the 
microenvironment of the preparations. Further, the crosslinked preparation was more 
active in the alkaline pH range while the native and immobilized preparations could 
not survive the alkaline pH. Murachi and Yamazaki (1970) reported no changes in 
conformation of bromelain up to pH 10.0 and beyond which the conformational 
change proceeded through at least two mutually distinguishable stages with a 
concomitant loss of activity. Extended stability in alkaline range for crosslinked 
preparation may be due to resistance to unfolding in alkaline range due to inter- and 
intra- molecular crosslinking. 
3.2.5 Determination of kinetic constants Km and Vmax 
The activity of native, Cu-IDA-Sepharose immobilized and soluble 
crosslinked bromelain preparation was measured as a function of substrate 
concentration. A typical Michaelis-Menton behavior was observed in all preparations. 
The Lineweaver-Burk plot indicate Km values for native, immobilized and 
crosslinked preparation as 1.20, 0.78, 1.43 mg/ml respectively (Figure 3.10). This 
indicates maximum affinity for substrate in case of immobilized preparation and 
minimum in case of crosslinked preparation. Low Km value of immobilized over 
native preparation is difficult to explain but for assumption that enzyme protein may 
undergo some conformational change that increases its affinity for substrate. Higher 
Km value of crosslinked preparation over native and immobilized preparation may be 
due to steric hindrance in the approach of substrate because of unfavorable inter- and 
intra- molecular crosslinking. Vmax values of native, immobilized and crosslinked 
preparation as calculated from figure 3.10 are 10526,10510, 8695 EU/1 respectively. 
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Fig. 3.9 pH activity profiles of native, Cu-IDA-Sepharose immobilized and 
soluble crosslinked bromelain preparations. 
Appropriate aliquots of native, immobilized and crosslinked stem 
bromelain preparations were incubated in 0.2 M sodium phosphate buffer 
(pH 5-8) or 0.2 M Tris HCl buffer (pH 9-11) and activity determined under 
standard assay condition. Each point represents the mean of three 
experiments carried out in triplicate. S.E.M. did not exceed 1.90. 
(— • —) native bromelain 
(—T—Cu-IDA-Sepharose immobilized bromelain 
(— • —) soluble crosslinked bromelain 
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Fig. 3.10 Lineweaver-Burk plot for casein hydrolysis by native, Cu-IDA-
Sepharose immobilized and soluble crosslinked bromelain 
preparations. 
Comparable quantities of native, immobilized and crosslinked bromelain 
preparations were incubated in a series of tubes with standard assay mixture 
containing various concentration of substrate. After 15 minute incubation at 
37"C, the activity in all preparations was determined. Reciprocal 
concentrations of velocity were plotted as a function of reciprocal 
concentration of substrate to obtain a characteristic Lineweaver-Burk plot. 
The lines were extrapolated to cut the X-axis and Y-axis to obtain the value 
of 1/Km and lAAmax from which Km and Vmax values were determined. 
Each point represents the mean of three experiments carried out in 
triplicate. S.E.M. did not exceed 1.80. 
(— • —) native bromelain 
(—^T—) Cu-IDA-Sepharose immobilized bromelain 
(— • — s o l u b l e crosslinked bromelain 
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3.2.6 Agitational effect and reusability 
The effect of agitation at 2,000 rpni for different time intervals on a rotary 
shaker was investigated inorder to study the mechanical stability of Cu-IDA-
Sepharose immobilized bromelain preparation. Immobilized preparation displayed 
impressive mechanical stability. No significant loss in activity of bromelain was 
observed even when the preparation was agitated at 2,000 rpm for 60 min showing the 
strong association of bromelain on Cu-IDA-Sepharose support (Figure 3.11 A). 
Further as can be seen from figure 3.11 B immobilized preparation loses only a 
fraction of activity (25%) after repeatedly using it 20 times. The preparation was also 
found to be stable for several weeks at 4°C. 
Elution of bromelain bound to Cu-IDA-Sepharose could be easily 
performed in presence of lOmM EDTA. The carrier recovered could be regenerated. 
In all IMA based immobilization seems promising for bromelain. 
3.3 Implications/Conclusion of the study 
It is now well recognized that enzymes may be employed in large number 
of industrial, biomedical and analytical application. In view of the significance of 
enzymes, it is necessary to develop stable and reusable enzyme preparations, that can 
be efficiently used in biosensors and bioreactors. The soluble enzymes have limited 
use due to their stability and reusability for such applications. 
Limited accessibility to macromolecular substrate is one of the major 
obstacles of using enzymes that act on macromolecular substrate in the immobilized 
state. The problem can be alleviated using a long spacer between the support matrix 
and the enzyme or by favorable orientation of enzymes on solid supports. 
This study suggests that favorable orientation of bromelain on solid 
supports leads to more simple kinetic properties and in many instances are more 
resistant to inactivation induced by various agents. The oriented preparations obtained 
exhibited high activity on casein, nearly unaltered Km and Vmax and a broader pH 
activity profile as compared to the soluble enzyme. The oriented preparations showed 
enhanced resistance to thermal inactivation and retained remarkably high activity 
when exposed to sixty degrees for longer duration. They were remarkably stable to 
mechanical agitation and highly reusable. This study also suggests that region near the 
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Fig. 3.11 (A) Mechanical stability and (B) reusability of Cu-IDA-Sepharose 
immobilized bromelain preparation. 
(A) Appropriate aliquots of Cu-IDA-Sepharose immobilized bromelain 
preparation in 0.2 M sodium phosphate buffer, pH 7.0 were mechanically 
agitated on a rotary shaker at 2,000 rpm for different time intervals, washed 
with buffer and bound bromelain activity determined. Activity of equal 
aliquots of the immobilized preparation not subjected to agitation was taken 
as 100 for the calculation of percent activity in the agitated sample. 
(B) Appropriate aliquots of Cu-IDA-Sepharose immobilized bromelain 
preparation were assayed for enzyme activity repetitively. After each assay 
the preparation was recovered by centrifugation at 2,000 rpm, washed with 
buffer and assayed for enzyme activity using fresh assay mixture. Activity 
of aliquot subjected to first assay was taken as 100 for calculation of percent 
activity in the subsequent assays. 
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glycosylation site of bromelain may contain pH and temperature labile regions while 
that near histidine residue represents temperature labile region. Immobilization of 
bromelain through these regions by attachment to suitable matrices confers 
stabilization against temperature and/or pH. Considering applications of bromelain 
that requires action on macromolecular substrates in both industrial and analytical 
domains, bioaffmity based favorable oriented immobilization seems promising. 
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Results and Discussion-II 
4.1 Isolation of IgG and fragments 
Bromelain, being a plant protein was quite immunogenic in rabbits and 
readily elicited the formation of precipitating antibodies. On immunodiffusion of 
bromelain against the antiserum, single precipitin lines were obtained indicating the 
homogeneity of the preparation (Figure 4.1). Further, while the preimmune serum that 
served as negative control did not show any appreciable binding to bromelain, direct 
binding ELISA revealed a high titre (204173) in the immune sera (Figure 4.2). 
IgG and fragments were purified from non-immunized and immunized 
animals as detailed earlier in methods section 2.2.5 and 2.2,6. Purification was 
followed by polyacrylamide gel electrophoresis both in presence and absence of SDS. 
Native page of whole antiserum and ammonium sulphate fractions show bands 
corresponding to IgG and several other polypeptides but the purified preparation gave 
a single band of IgG from non-immunized and immunized animals on electrophoresis 
(Figure 4.3 A, B). The native Fab' and Fc shows slightly different mobility on PAGE 
under non-denaturing conditions (Figure 4.3 B). 
In order to determine the molecular weight of IgG and fragments, SDS-
PAGE (reducing) of the samples were run along with molecular weight markers 
(Figure 4.4 A). The SDS-PAGE (reducing) of papain treated IgG showed two bands 
corresponding to 24.5 kDa and 26 kDa (Figure 4.4 B). Since the electrophoresis was 
performed in presence of p-mercaptoethanol, the Fab' and Fc are expected to 
dissociate as a result of reduction of disulfide linkage. Assuming the molecular weight 
of heavy and light chain in Fab' monomer is nearly the same and those of two heavy 
chains of Fc identical, the molecular dimension of Fab' and Fc works out to be 49 kDa 
and 52 kDa respectively. The observed slightly lower molecular weight of 
polypeptide chain from Fab' may be related to the fact that the cleavage site in 
immunoglobulin for papain is above the hinge region (Figure 1.9). 
Antibodies and Fab' monomers were not inhibitory towards bromelain even 
at high concentrations. Several anti-enzyme antibodies raised in animals have also 
been shown in earlier studies to be non-inhibitory towards the enzymes (Shami et ai. 
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Fig. 4.1 Ouchterlony double immunodiffusion of bromelain against bromelain 
specific antiserum and IgG fractions isolated there of. 
Rabbits were immunized with bromelain. The antiserum obtained was 
loaded on a Sepharose 4B-bromelain affinity column to isolate y-globulin 
fractions as detailed in the text. The central well contained 30 |j,g of 
bromelain, well 1 was loaded with lOfil of antiserum, well 2 and 3 had 5 
and 10 )j,l of purified IgG. 
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Fig. 4.2 ELISA of bromelain antisera. 
Preimmunized and bromelain immunized rabbit sera were tested by direct 
binding ELISA at different dilutions (1:1000, 1:2000, 1:4000, 1:6000, 
1:8000, 1:16000, 1:32000, 1:64000, 1:128000, 1:256000, 1:512000, 
1:1024000). The wells were coated with a solution containing 5 l^g/ml 
bromelain in 0.05 M carbonate-bicarbonate buffer, pH 9.6. 
(— • —) preimmunized serum 
( — Y — i m m u n e serum 
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Fig. 4.3 Purification of IgG and fragments. 
(A) The electrophoretic pattern of different preparations of IgG in 7.5% non-
denaturing gel are shown. 15-35 |j,g of each preparation was 
electrophoresed on the slab gel and coomassie brilliant blue staining was 
adopted. Lane a: antiserum, Lane b: 20-40% ammonium sulphate fraction, 
Lane c: purified IgG (specific/non specific). 
(B) The electrophoretic pattern of IgG and fragments in 10% in non-denaturing 
gel are shown. 0-5 |j.g of each protein was electrophoresed on slab gel and 
silver nitrate staining was adopted (inasmuch as fragments fail to take 
coomassie brilliant blue stain). Lane a: purified IgG; Lane b: papain treated 
IgG; Lane c: Fab', Lane d: Fc. 
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Fig. 4.4 Molecular weight determination of IgG and fragments. 
(A) The electrophoretic pattern of different preparations of IgG in 12.5% SDS-
PAGE (reducing) are shown. 15-35 |a.g of each protein was electrophoresed 
on the slab gel and coomassie brilliant blue staining was adopted. Lane a: 
antiserum, Lane b: 20-40% ammonium sulphate fraction, Lane c: purified 
IgG, Lane d: papain treated IgG, Lane e: Fab, Lane f: molecular weight 
markers. Lane g: Fc. 
(B) Molecular weight determination of IgG and fragments by theoretical 
treatment of Weber and Osbom as detailed in methods section 2.3.1. 
8 0 
Lane a b e d e f g 
^ r : ^ J 
M 
U 
97.4 kDa 
68.0 kDa 
43.0 kDa 
29,0 kDa 
20.0 kDa 
14.3 kDa 
0) > 
ro 
0) 
1.0 
0.8 H 
E 
£ 0.6 ^ 
in o 
E 
0.4 A 
0.2 A 
0 . 0 
L Y \ Half Fab; Half Fc 
s t N j | 
Light cha in 
O A A 
B 
Heavy c h a l r ^ ^ 
4.2 4.4 4.6 
Log M 
—I— 
4.8 5.0 
R E S U L T S & D I S C U S S I O N - III 
1989). 
4.2 Molecular weight and Stokes radius of the bromelainrFab' 
complex 
The bromelain:Fab' complex was prepared as detailed in methods. The 
molecular weight and Stokes radius of the complex formed was determined by gel 
filtration on a Sephadex G-lOO column (1.7 cm x 80 cm), which was calibrated using 
standard molecular weight marker proteins. The bromelain:Fab' complex emerged 
from the Sephadex G-lOO with an elution volume corresponding to the molecular 
dimension of 79.4 kDa (Figure 4.5 A, B). Considering the molecular weights of 
individual protein components bromelain and Fab', the likely stoichiometry of the 
complex is 1:1 (Figure 4.5 A, B). This suggests that at the protein concentration used, 
binding of a single Fab' on bromelain restricts that of another Fab'. Alternatively the 
epitopes (s) of bromelain may be restricted to a limited region of the enzyme. No high 
molecular weight adducts were observed suggesting that each bromelain molecule 
may not bind more than one Fab'. A single molecule of bromelain can theoretically 
bind several Fab', considering that the latter has been obtained from the polyclonal 
IgG. Small dimension of bromelain may also prevent the binding of additional Fab' to 
the enzyme. The Stokes radius of the complex was 38A that suggests a compact 
structure of the complex (Figure 4.5 C). 
4.3 Effect of temperature 
4.3.1 Inactivation of native bromelain and that incubated with various molar 
ratio of Fab' 
Bromelain preparation incubated with Fab' monomers exhibited significant 
increase in resistance to inactivation induced by exposure to 60®C. The stabilization 
increased with increase in bromelain:Fab' ratios and reached maximum when the ratio 
was 1:3 (Figure 4.6). Considering that the complex formed appears to be of 1:1 
stoichiometry, it is likely that optimum complex formation occurs at the molar ratio of 
1:3. As observed in case of IgG bromelain activity was also not significantly altered 
8 1 
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Fig. 4.5 Size exclusion chromatography of bromelain:Fab' complex. 
(A) ( ) bromelain; (••••••) Fab'; and ( ) bromelain:Fab' (1:3 
molar ratio) were passed through Sephadex G-lOO column as detailed in 
methods section 2.3.1. Peak A: Bromelain:Fab' complex (1:1 
stoichiometry). Peak B: Unbound Fab'. Elution positions of molecular 
weight markers have been shown: (— • —P-galactosidase, (— •• —) 
bovine serum albumin, (— ••• —) ovalbumin, (— •••• —) soyabean 
trypsin inhibitor. 
(B) Molecular weight determination of bromelain:Fab' complex by theoretical 
treatment of Andrews as detailed in methods section 2.3.2. 
(C) Stokes radius determination of bromelain:Fab' complex by theoretical 
treatment of Laurent and Killander as detailed in methods section 2.3.3. 
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Fig. 4.6 Inactivation at 60''C of native bromelain and that incubated with 
various molar ratio of Fab'. 
Appropriate quantities of native bromelain and that incubated with different 
molar ratio of antibromelain Fab' (1:1; 1:2; 1:3; 1:4; 1:5 molar ratio) were 
incubated at 60°C for 40 min, cooled to room temperature and residual 
activity determined under standard assay condition. Activity of aliquots of 
preparation not subjected to heat inactivation was taken as 100 for 
calculation of percent activity. Each bar represents the mean of three 
experiments carried out in triplicate. S.E.M. did not exceed 1.30. 
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on incubation with Fab' at various molar ratios under standard conditions. 
4.3.2 Activity at various temperature 
The temperature optimum of bromelain remained unaltered after incubation 
with Fab' derived from antibromelain IgG or non-specific IgG (Figure 4.7). All three 
preparations were optimally active at 60°C. Increased retention of activity at higher 
temperatures was exhibited by bromelain preincubated with antibromelain Fab'. 
Figure 4.7 has been normalized for the activity of individual preparation at 60°C 
inasmuch as identical activity in terms of enzyme units at this temperature. 
4.3.3 Thermal stability at 60"C 
Bromelain:Fab' complex showed a clear improvement in the resistance to 
inactivation at 60°C. More than 50 min were required for 50% loss of the proteolytic 
activity in case of bromelain:Fab' complex while for bromelain alone or bromelain 
incubated with non-specific Fab' only 15-20 min was required for such inactivation 
(Figure 4.8). Figure 4.8 has been normalized for the activity of individual preparations 
at 60°C inasmuch as identical activity in terms of enzyme units at this temperature. 
Bromelain incubated with non-specific Fab' exhibited slightly higher resistance to 
inactivation over bromelain alone. 
The observed improved temperature stability profile of bromelain incubated 
with antibromelain Fab' may be related to the preferential exclusion of the water 
molecules from protein-protein interface or contact areas owing to the non covalent 
interactions. Davies et al. (1988) have proved the same based on the study on the 
interaction of the influenza virus lysozyme and neuraminadase with their respective 
Fab' fragment. The data suggest that the areas of contact from which water molecules 
are eliminated may be large enough to cover entire epitope comprising of several 
discontinuous oligopeptides or amino acid residues. This may result in effects similar 
to crosslinking and enhancement in protein stability. Protein-protein interaction in 
many instances stabilize proteins by excluding water from the interactive areas 
resulting in lowered free energy and facilitating the formation of the native folded 
conformation (Chothia and Janin, 1975). Moreover, reduction in free energy resuhing 
from bromelain:Fab' interaction howsoever moderate may be sufficient to confer 
stability as free energy changes between the folded and unfolded state lie in the same 
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Fig. 4.7 Effect of temperature on native bromelain and that incubated with 
Fab'. 
Appropriate quantities of native bromelain and bromelain incubated with 
three fold molar excess of Fab' were assayed for enzyme activity at 
indicated temperatures under standard condition of pH and substrate 
concentration. Each point represents the mean of three experiments carried 
out in triplicate. S.E.M. did not exceed 1.80. 
(— • —) native bromelain 
(—^T—bromelain incubated with non specific Fab' 
(— • —) bromelain complexed with antibromelain Fab' 
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Fig. 4.8 Effect of pre-incubation at 60''C on thermal inactivation of native 
bromelain and that incubated with Fab'. 
Appropriate quantities of native bromelain and bromelain incubated with 
three fold molar excess of Fab' were incubated at 60°C for indicated time 
duration, cooled to room temperature and residual activity determined 
under standard assay condition. Activity of bromelain not subjected to heat 
inactivation was taken as 100 for calculation of percent activity. Each point 
represents the mean of three experiments carried out in triplicate. S.E.M. 
did not exceed 1.90. 
(— • —) native bromelain 
(—^T—) bromelain incubated with non specific Fab' 
(— • —) bromelain complexed with antibromelain Fab' 
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range (Shami et al, 1989; Rees et al., 1988). An alternate interesting possibility is 
that Fab' monomers may exhibit chaperon like activity and assist in the refolding of 
bromelain after exposure to high temperature as well as inhibiting enzyme 
aggregation as has been shown earlier in case of some monoclonal antienzyme 
antibodies (Gozansky et al., 1996). 
4.4 Effect of pH 
The pH optimum of native bromelain and bromelain incubated with non-
specific Fab' was pH 7.5 (Figure 4.9). However bromelain:Fab' complex showed a 
shift in the pH optimum to pH 8.0. Further the bromelain:Fab' complex retained far 
greater fraction of proteolytic activity between pH 9.0-11.0. Murachi and Yamazaki 
(1970) reported no changes in conformation of stem bromelain upto pH 10.0 and 
beyond which conformational change proceeded through at least two mutually 
distinguishable stages with a concomitant loss of activity. Extended stability in case 
of complex but not enzyme alone and controls in pH range 9.0-11.0 can be attributed 
to stabilization of the bromelain conformation due to protein-protein interaction in the 
former. Figure 4.9 have been normalized for the highest activity inasmuch as highest 
activity at optimum pH of different preparations were identical. 
4.5 Spectroscopy 
4.5.1 Effect of methanol and NaCl on fluorescence spectra of bromelain:Fab' 
complex and individual protein components 
The fluorescence of the bromelain:Fab' complex remained more or less 
unaltered in the presence of 0-1.8 M NaCl but was quite sensitive to high 
concentrations of methanol (Figure 4.10). The gradual methanol concentration-
dependent increase in the fluorescence intensity of the complex was followed by a 
more rapid rise at 60% (v/v) concentration of the solvent and the fluorescence 
intensity increased over 40 percent. The observed solvent induced increase in the 
fluorescence may be related to the exposure of chromophoric groups of bromelain or 
Fab' to the solvent, resulting either from the dissociation of the complex or to the 
alteration/distortion of the structure of protein or both. However, while the 
87i 
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Fig. 4.9 pH activity profiles of native bromelain and that incubated with Fab'. 
Appropriate quantities of native bromelain and bromelain incubated with 
three fold molar excess of Fab' were incubated in 0.2 M sodium phosphate 
buffer (pH 5-8) or 0.2 M Tris HCl buffer (pH 9-11) and activity determined 
under standard assay condition. Each point represents the mean of three 
experiments carried out in triplicate. S.E.M. did not exceed 1.70. 
(— • —) native bromelain 
(—W—) bromelain incubated with non specific Fab' 
(— • —) bromelain complexed with antibromelain Fab' 
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Fig. 4.10 Effect of NaCI and methano] on fluorescence intensity at 333 nm of 
bromelain:Fab' complex. 
Bromelain and Fab' were in equimolar amounts. 
(••••••) NaCl 
( ) methanol 
INSET Fluorescence emission spectra of ( ) bromelain, (••••••) Fab' 
monomer and ( ) bromelain:Fab'complex (1:1 molar ratio). 
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fluorescence spectrum of bromelain (Figure 4.11 A) was highly solvent sensitive, that 
of Fab' (Figure 4.11 B) did not exhibit appreciable change in the fluorescence 
spectrum in presence of upto 60% (v/v) methanol. The bromelain spectrum (Figure 
4.11 A) was unaffected upto 20% (v/v) methanol but showed very significant increase 
(25%) in fluorescence at 60% (v/v) methanol concentration suggesting 
perturbation/alteration in bromelain conformation which is also evident by 
correspondence with near-UV CD studies as explained in section 4.5.2. Considering 
that increase in the fluorescence of bromelain:Fab' complex between 20 and 60% 
(v/v) methanol is 40%, it is likely that exposure of chromophoric groups at protein-
protein interface contributes towards the difference in increase in fluorescence 
intensity. Bromelain contains five tryptophan residues and extensive sequence 
homology with papain suggests that three of these are buried in hydrophobic core 
whereas two may be located near the surface of the molecule (Ritonja et al, 1989, 
Haq et al., 2002). In good probability one or both of these tryptophans may be masked 
on formation of bromelain:Fab' complex. 
Complex formation with Fab' also restricts alteration in bromelain structure 
resulting from exposure to high ionic strength as evident from the comparison 
between ionic strength induced alteration on free enzyme and the complex. While 1.8 
M NaCl caused only a marginal increase in fluorescence intensity in case of 
bromelain (Figure 4.12 A) there was no appreciable change in fluorescence intensity 
of Fab' (Figure 4.12 B), which is suggestive of some slight conformational 
perturbation in the former. Had the electrostatic interaction been crucial for complex 
formation, the complex would have dissociated into individual protein components at 
high ionic strength followed by increase in fluorescence intensity inasmuch as 
contribution from bromelain or exposure of chromophoric groups {fluorescence 
spectrum of bromelain (A,max 337 nm) was quenched due to complex formation 
(A,max 333 nm) with Fab' (X-max 329 nm); Inset Figure 4.10} or both. However this 
does not happen to be the case suggesting preponderance of hydrophobic interaction. 
4.5.2 Effect of methanol and NaCl on near-UV CD spectra of 
bromelain:Fab' complex and individual protein components 
As shown in Figure 4.13 the near-UV CD spectrum of the complex has 
peaks at 298 nm and at 293 nm and seems to be characteristic of the complex 
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Fig. 4.11 Effect of methanol on fluorescence emission spectra of individual 
protein components. 
(A) Bromelain; (B) Fab'. 
( ) native standard condition 
(— • — 2 0 % (v/v) methanol concentration 
(— •• —) 40% (v/v) methanol concentration 
(— ••• — 6 0 % (v/v) methanol concentration 
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Fig. 4.12 Effect of NaCI on fluorescence emission spectra of individual protein 
components. 
(A) Bromelain; (B) Fab'. 
( ) native standard condition 
(—•• •—) 1.8MNaCl 
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Fig. 4.13 Effect of NaCl and methanol on near-UV CD spectra of 
bromelain:Fab' complex. 
Bromelain and Fab' were in equimolar amounts. 
( —) native complex 
( — ) 1.8 MNaCl 
( ) 40% (v/v) methanol 
(— ••• —) 60% (v/v) methanol. 
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(bromelain incubated with non-specific Fab' monomer fail to give similar spectrum). 
There was little alteration in the peak pattern of the spectrum at 1.8 M NaCl 
suggesting remarkable stability of the complex. However, in the presence 40% (v/v) 
methanol both the peaks decreased markedly while at 60% (v/v) methanol inversion 
and loss of all spectral features of the complex was observed. While perturbation in 
the tertiary structure of bromelain (Figure 4.14 A) was marked even at 40% (v/v) 
methanol and increased further at higher solvent concentration, the near-UV CD 
spectrum of the Fab' (Figure 4.14 B) was stable upto 40% (v/v) methanol and only 
moderate disruption in the tertiary structure was observed when the solvent 
concentration was raised to 60%. Disruption of the tertiary structure of either 
bromelain (Figure 4.15 A) or Fab' (Figure 4.15 B) was marginal upto 1.8 M NaCl. It 
is interesting to note that despite retention of characteristic features of the complex at 
1.8 M NaCl Aere was a shift in CD magnitude, which may presumably be due to 
different behfvior of solvent towards individual protein components and complex; 
furthermore, contribution could be from secondary structure alterations as detailed in 
section 4.5.3. This study while suggesting the sensitivity of the complex to methanol 
cannot discriminate between the solvent effects on bromelain and dissociation of the 
complex. 
4.5.3 Effect of methanol and NaCl on far-UV CD spectra of bromelain:Fab' 
complex and individual protein components 
The far-UV CD spectrum (Figure 4.16) of the complex is characteristic 
with a sharp negative peak at 223 nm and a broad shoulder around 232 nm. There was 
no marked influence on the negative peak in presence of 5% (v/v) methanol, however 
a clear 6 nm shift in the negative peak at 223 rmi, a prominent decrease in ellipticity 
and appearance of two positive peaks at 213 nm and 221 nm were observed in 
presence of 20% (v/v) methanol. This suggests major alterations/rearrangement in the 
secondary structure (Khan et al, 2000). Considering that 20% (v/v) methanol has 
little effect on the tertiary structure of the proteins and only a small effect on the 
secondary structure of either bromelain (Figure 4.17 A) or Fab' (Figure 4.17 B), 
rearrangement of the secondary structure in the complex is a likely explanation. 
Comparable effects on secondary structure are also apparent in presence of 0.9 M 
NaCl. Only moderate alterations in secondary structure of individual protein 
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Fig. 4.14 Effect of methanol on near-UV CD spectra of individual protein 
components. 
(A) Bromelain; (B) Fab'. 
( ) native standard condition 
(— • —) 20% (v/v) methanol concentration 
(— •• — 4 0 % (v/v) methanol concentration 
(— ••• —) 60% (v/v) methanol concentration 
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Fig. 4.15 Effect of NaCl on near-UV CD spectra of individual protein 
components. 
(A) Bromelain; (B) Fab'. 
( ) native standard condition 
(—•••—) 1.8 M NaCl 
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Fig. 4.16 Effect of NaCI and methanol on far-UV CD spectra of bromelain:Fab' 
complex. 
Bromelain and Fab' were in equimolar amounts. 
( ) native complex 
( — ) 0.9MNaCl 
( ) 5% (v/v) methanol 
(— ••• —) 20% (v/v) methanol 
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Fig. 4.17 Effect of methanol on far-UV CD spectra of individual protein 
components. 
(A) Bromelain; (B) Fab'. 
( ) native standard condition 
(— • —) 20% (v/v) methanol concentration 
(— •• —) 40% (v/v) methanol concentration 
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components- bromelain (Figure 4.18 A) and Fab' (Figure 4.18 B) were observed in 
presence of 0.9 M NaCl. Interestingly the bromelain:Fab' complex appears to remain 
stable in presence upto 1.8 M NaCl as revealed by fluorescence and near-UV CD 
spectroscopy. It therefore seems likely that considerable interaction between 
bromelain and the Fab' may be retained even after significant alteration in the 
secondary structure of the two proteins. This may be due to induction of local 
interactions, which in good probability cause alterations in secondary structure 
without causing remarkable changes in the tertiary structure. These local interactions 
causing changes in the secondary structure were however reversible in bromelain:Fab' 
complex and individual protein components. The CD and fluorescence spectra of 
bromelain and Fab' are comparable with those reported elsewhere (Haq et al, 2002; 
Reyna et al, 1994; Jaton et al, 1975; Welfle et al, 1999). 
All these spectral studies taken together are suggestive of methanol sensitive 
hydrophobic interactions (Waseem and Salahuddin, 1983) rather than salt linkages 
playing a crucial role in the binding of bromelain to Fab'. 
4.6 Hydrodynamics 
4.6.1 Size exclusion chromatography of bromelain:Fab' complex against 1.8 
M NaCl, 5% and 10% (v/v) methanol concentration 
Spectral findings were reconfirmed and revalidated by hydrodynamic 
method (size exclusion chromatography). Bromelain:Fab' complex was subjected to 
size exclusion chromatography (Sephacryl S-300HR) under one salt concentration 
(1.8 M) and two methanol concentration (5% and 10%). While 1.8 M NaCl and 5% 
(v/v) methanol had no effect on elution position of complex, at 10% (v/v) methanol 
bromelain:Fab' complex tends to undergo dissociation (Figure 4.19). The dissociation 
is not complete inasmuch as use of polyclonal Fab' monomers having different 
affinity for protein epitope (s) on bromelain. This study further suggest that there is 
preponderance of hydrophobic interactions between bromelain:Fab' complex and 
complements spectral findings. Fig. 4.19 B, C revalidates molecular weight (79.4 
kDa) and stokes radius (3 8A) of the complex to that calculated from size exclusion 
chromatography on Sephadex G-lOO (Fig. 4.5 A, B, C). Choice of Sephacryl S-300 
HR over Sephadex G-lOO to check for stability of complex against high methanol 
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Fig. 4.18 Effect of NaCI on far-UV CD spectra of individual protein components. 
(A) Bromelain; (B) Fab'. 
( ) native standard condition 
(—•• •—) *1.8MNaCl 
Spectra of individual protein components at 0.9 M and 1.8 M NaCl are 
almost overlapping 
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Fig. 4.19 Size exclusion chromatography of bromelaiiizFab' complex under 
different NaCl and methanol concentrations. 
(A) Bromelain:Fab' complex (1:1 molar ratio) under ( ) native standard 
condition, in presence of (••••••) 1.8 M NaCl or (— ••• —) 5% and 
( ) 10% (v/v) methanol concentration was passed through Sephacryl 
S-300 HR column. Elution profile of individual protein components 
(— • —) Fab' and (— •• —bromelain have been shown. 
(B) Molecular weight determination of bromelain:Fab' complex by theoretical 
treatment of Andrews as detailed in methods section 2.3.2. 
(C) Stokes radius determination of bromelain:Fab' complex by theoretical 
treatment of Laurent and Killander as detailed in methods section 2.3.3. 
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concentration was made in view of Sephadex G-lOO collapsing at high alcohol 
concentration. 
4.7 Implications/Conclusion of the study 
This work presents an attempt for the preparation of stable, soluble enzyme 
preparation with the potential for in vivo and industrial applications. Earlier attempts 
were focused on stabilization of enzyme by formation of immunocomplexes (Shami 
et al, 1989,1991; Feinstein et al, 1971) and binding on antibody support (DeAlwis et 
al, 1987; DeAlwis and Wilson, 1987) rendering enzyme preparations resistant to 
inactivation (Jan et al, 2001). However these methodologies had limitations, which 
can well, be overcome by using Fab' monomer instead. This provides a soluble model 
and therefore can be used in homogenous reaction phases, where bromelain and 
various other enzymes find great application. 
Preponderance of hydrophobic interactions between bromelain:Fab' 
complex along with the fact that Fab' monomer has better diffusion capability than 
that of intact IgG half IgG or Fab" dimer makes it an excellent model to be used in 
enzyme therapy and preparation of subunit vaccines that requires a specific, stable 
and fast diffusible carrier in otherwise polar body fluids. 
The anti-edemic, anti-inflammatory and anti-neoplastic properties of 
bromelain have been exploited (Taussig et al, 1975, 1985; Taussig and Batkin, 1988; 
Kumakura et al, 1988) but intravenous and intraperitoneal administration of 
bromelain, despite their merits have been discontinued and the enzyme is currently 
administered orally (Winter, 1990). Complexing bromelain/other vital enzymes or 
antigenic peptides with Fab' derived from humanized IgG (Clark, 2000) will provide a 
further better model to solve several problems associated with enzyme therapy and 
subunit vaccines respectively. 
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Results and Discussion-Ill 
5.1 Effect of TFE on far-UV CD spectrum of acid-induced state 
at pH 2.0 of modified and unmodified preparation of 
bromelain 
Bromelain is a predominantly an alpha helix and beta sheet protein (Reyna 
et al, 1994; Reyna and Arana, 1995). It has a molecular mass of 23.8 kDa (212 amino 
acid residues), contains three disulfides and a single free cysteine residue (Ritonja et 
al, 1989; Rasheedi, 2001; Haq et al, 2003). As reported earlier by Haq et al (2002) 
the modified preparation of bromelain represents an inactive state where all the three 
disulfides are reduced and irreversibly blocked along with one free active site cysteine 
by iodoacetamide treatment. Further, modified preparation of bromelain shows PFI 
state at pH 2.0 and molten globule like structure at pH 0.8. 
5.1.1 Effect of TFE on far-UV CD spectrum of partially folded intermediate 
(PFI) of modified bromelain 
Figure 5.1 A shows the far-UV CD spectra of PFI of modified bromelain in 
presence of various concentration of TFE. There was a 45% loss in the secondary 
structure at pH 2.0 (PFI) compared to that of pH 7.0 (pseudo-native) preparation as 
observed at 208 nm. Furthermore, increasing the concentration of TFE leads to 
increase in MRE value. It is interesting to note that in concentration range of 60-70% 
(v/v) TFE the induced secondary structure approached to almost that of pseudo-native 
state. In contrast there was complete loss of secondary structure in presence of 6.0 M 
GdnHCl. Titration of the PFI with increasing concentration of TFE as monitored at 
208 nm (Figure 5.1 B) indicated the accumulation of secondary structure at all 
concentrations of TFE investigated. 
5.1.2 Effect of TFE on far-UV CD spectrum of acid-denatured state of 
unmodified bromelain 
Figure 5.2 shows the effect of TFE concentrations on far-UV CD spectrum 
of acid-denatured state of unmodified bromelain. As can be seen from the figure there 
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Fig. 5.1 Far-UV CD spectra of modified bromelain preparations. 
(A) Spectra of ( ) PFI (pH 2.0) in presence of (— • —) 30%, (— •• —) 
60%, (— ••• —) 70% (v/v) TFE concentration or ( ) 6.0 M 
GdnHCl. The spectra of (••••••) pseudo-native (pH 7.0) preparation is 
included for comparison. 
(B) Effect of increasing concentration of TFE on PFI as monitored by changes 
in MRE value at 208 nm. 
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Fig. 5.2 Far-UV CD spectra of unmodifled bromelain preparations. 
(A) Spectra of ( ) acid-denatured state (pH 2.0) in presence of (— • —) 
30%, (— •• —) 60%, (— ••• —) 70% (v/v) TFE concentration or 
( ) 6.0 M GdnHCl. The spectra of (••••••) native (pH 7.0) 
preparation is included for comparison. 
(B) Effect of increasing concentration of TFE on acid-denatured state as 
monitored by changes in MRE value at 222 nm. 
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is a partial loss (about 25%) in the secondary structure at pH 2.0 compared to that of 
pH 7.0 (native) preparation at 208 nm. Furthermore, as can be seen from figure, the 
negative trough around 194 nm of acid-denatured state of bromelain indicates the 
presence of unordered structure (Saxena and Wetlaufer, 1971). This suggests that the 
acid-denatured protein at pH 2.0 represents an almost completely unfolded state. With 
increasing concentration of TFE the unordered structure moves towards an ordered 
one with spectral features similar to those of the pH 7.0 preparation at 60-70% (v/v) 
concentration of TFE, indicating the induction of secondary structure. In contrast, 
there was a complete loss of secondary structure in presence of 6.0 M GdnHCl. 
Titration of PFI with increasing concentration of TFE can be better monitored at 222 
nm (Figure 5.2 B) and shows the accumulation of secondary structure at all 
concentration of TFE. 
The above observations suggest induction of secondary structure in the 
acid-induced states of modified and unmodified preparation at 60-70% (v/v) range of 
TFE concentration to a near pseudo-native and native state of bromelain respectively. 
5.2 Effect of TFE on near-UV CD spectrum of acid-induced 
state at pH 2.0 of modified and unmodified preparation of 
bromelain 
5.2.1 Effect of TFE on near-UV CD spectrum of PFI of modified bromelain 
Figure 5.3 A shows near-UV CD spectra of PFI of modified bromelain in 
presence of various concentrations of TFE. The pseudo-native state of bromelain is 
characterized by a positive peak around 280 nm as reported elsewhere (Kamphuis et 
al., 1984; Reyna et al., 1994; Haq et aL, 2002). As can be seen from figure there was 
a considerable loss in tertiary structure/interactions at pH 2.0 (PFI), and complete loss 
in presence of 6.0 M GdnHCl. At low concentration of TFE {30% (v/v)} the spectral 
feature were comparable with those of PFI. At 60% (v/v) TFE however there was a 
significant increase in ellipticity with the spectrum resembling that of the pH 7.0 
(pseudo-native) preparation, presumably due to the formation of a relatively compact 
structure. There was however a total loss of tertiary structure/interactions at 70% (v/v) 
concentration of TFE. Figure 5.3 B shows the titration of PFI with increasing 
concentration of TFE as monitored at 280 nm. A gradual increase in tertiary 
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Fig. 5.3 Near-UV CD spectra of modified bromelain preparations. 
(A) Spectra of ( ) PFI (pH 2.0) in presence of (— • —) 30%, (— •• —) 
60%, (— ••• —) 70% (v/v) TFE concentration or ( ) 6.0 M 
GdnHCl. The spectra of (••••••) pseudo-native (pH 7.0) preparation is 
included for comparison. 
(B) Effect of increasing concentration of TFE on PFI as monitored by changes 
in MRE value at 280 nm. 
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structure/interactions till 30% (v/v) of TFE is followed by a sharp increase till 60%, 
but at 70% there was abrupt loss of the tertiary structure. 
5.2.2 Effect of TFE on near-UV CD spectrum of acid-denatured state of 
unmodified bromelain 
Figure 5.4 A shows the near-UV CD spectra of acid-denatured state of 
unmodified bromelain in presence of various concentration of TFE. At pH 7.0 
bromelain shows a CD spectrum with a positive peak around 286 nm. There was 
considerable loss in tertiary structure/interactions at pH 2.0 and their complete loss in 
presence of 6.0 M GdnHCl. Although at 30% (v/v) TFE the loss is less pronounced, it 
is interesting to note that at 60% (v/v) TFE the preparation attained a structure much 
more compact than that of the pH 7.0 (native) preparation. There was total loss of the 
tertiary structure/interactions at 70% (v/v) concentration of TFE. Figure 5.4 B shows 
the titration of acid-denatured state of unmodified bromelain with increasing 
concentration of TFE as monitored at 286 nm. A gradual increase in MRE value 
(tertiary structure/interactions) till 30% is followed by a sharp increase till 60%; 
however at 70% there was abrupt loss. 
All the above results taken together indicate loss in tertiary 
structure/interactions but substantial retention of secondary structure in acid-induced 
(pH 2.0) states of bromelain preparations subjected to 60-70% (v/v) range of TFE 
concentration. These observations support the existence of molten globule state of 
bromelain in the said range. 
5.3 Effect of TFE on tryptophan fluorescence spectrum of acid-
induced state at pH 2.0 of modifled and unmodified 
preparation of bromelain 
5.3.1 Effect of TFE on tryptophan fluorescence spectrum of PFI of modified 
bromelain 
Figure 5.5 A shows intrinsic emission spectra of bromelain at pH 7.0 
(pseudo-native), pH 2.0 (PFI) and the PFI in presence of 60% (v/v) TFE or 6.0 M 
GdnHCl. The emission spectrum of bromelain at pH 7.0 (pseudo-native) shows a 
maximum at 337 nm, which is indicative of the presence of tryptophans. Bromelain 
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Fig. 5.4 Near-UV CD spectra of unmodified bromelain preparations. 
(A) Spectra of ( ) acid-denatured state (pH 2.0) in presence of (— • —) 
30%, (— •• —) 60%, (— ••• —) 70% (v/v) TFE concentration or 
( ) 6.0 M GdnHCl. The spectra of ( ) native (pH 7.0) 
preparation is included for comparison. 
(B) Effect of increasing concentration of TFE on acid-denatured state as 
monitored by changes in MRE value at 286 nm. 
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Fig. 5.5 Intrinsic emission spectra of modified bromelain under different 
conditions. 
(A) Spectra of (1) PFI (pH 2.0) in presence of (2) 60% (v/v) TFE or (3) 6.0 M 
GdnHCl. The spectra of (4) pseudo-native (pH 7.0) preparation is included 
for comparison. 
(B) Effect of increasing concentration of TFE on PFI as monitored by changes 
in relative fluorescence at 335 nm. 
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contains five tryptophan residues and extensive sequence homology with papain 
suggests that three of these may be buried in hydrophobic core and two located near 
the surface of the molecule (Ritonja et al, 1989, Haq et al, 2002). At pH 2.0, there 
was an almost 45% decrease in fluorescence intensity and a change in A,max to 335 
nm suggesting a blue shift (2 nm). This blue-shifted fluorescence of bromelain at pH 
2.0 can be attributed to the conformational changes in the vicinity of surface exposed 
tryptophans, presumably due to internalization in a more hydrophobic environment 
(Haq et al., 2002). A similar blue-shifted fluorescence at acid pH has been reported 
earlier for glucose isomerase (Pawar and Deshpande, 2000), bovine growth hormone 
(Holzman et al, 1990) and interferon-y (Nandi, 1998). An alternative possibility may 
be that the external tryptophans are quenched differently from the internal tryptophans 
at low pH without getting internalized, resulting in a greater proportion of the 
remaining signal coming from the more buried tryptophans (located in the interior of 
the native protein). Interestingly at 60% (v/v) TFE there was 23% increase in 
fluorescence intensity over that of PFI and shifting of X,max to 333 nm suggesting 
ftirther internalization of surface tryptophans in hydrophobic environment and 
formation of a more compact structure. This blue shift may be strictly due to the 
above stated reason inasmuch as 60% (v/v) TFE + water system has no effect on 
intensity and wavelength of maximal emission of NATA (N-Acetyl L-
Tryptophanamide) thereby this rules out the effect of TFE-water system on indole 
ring. Further, as is evident from figure, denaturation/unfolding in presence of 6.0 M 
GdnHCl leads to a red shift of 5 nm with a decrease in fluorescence intensity 
suggesting completely unfolded state. Titration of PFI with increasing concentration 
of TFE as studied at 335 nm (Figure 5.5 B) indicates disruption of compact structure 
at 60-70% (v/v) range of TFE. 
5.3.2 Effect of TFE on tryptophan fluorescence spectrum of acid-denatured 
state of unmodified bromelain 
Figure 5.6 A shows intrinsic emission spectra of unmodified preparation of 
bromelain at pH 7.0 (native), pH 2.0 (acid-denatured state), the acid-denatured state in 
presence of 60% (v/v) TFE or 6.0 M GdnHCl. At pH 7.0 (native), the preparation 
shows ?tmax at 337 nm suggesting the presence of tryptophans. At 60% (v/v) TFE 
there was 40% increase in fluorescence intensity over the acid-denatured state (Xmax 
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Fig. 5.6 Intrinsic emission spectra of unmodified bromelain under different 
conditions. 
(A) Spectra of (1) acid-denatured state (pH 2.0) in presence of (2) 60% (v/v) 
TFE or (3) 6.0 M GdnHCl. The spectra of (4) native (pH 7.0) preparation is 
included for comparison. 
(B) Effect of increasing concentration of TFE on acid-denatured state as 
monitored by changes in relative fluorescence at 335 nm. 
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335 nm) with a blue shift (Xmax 333 nm) suggesting internalization of tryptophans. 
As can be seen from figure, there was a red shift of 5 nm with a decrease in 
fluorescence intensity on GdnHCl denaturation suggesting the presence of a 
completely unfolded state. Titration of acid-denatured state with increasing 
concentration of TFE as studied at 335 nm (Figure 5.6 B) indicates disruption of 
compact structure at 60-70% (v/v) range of TFE. 
5.4 Effect of TFE on ANS spectrum of acid-induced state at pH 
2.0 of modified and unmodified preparation of bromelain 
5.4.1 Effect of TFE on ANS spectrum of PFI of modified bromelain 
ANS, a fluorescent hydrophobic probe, has higher affinity for the molten 
globule intermediate of protein than for the proteins in native or fully unfolded state 
(Ptitsyn, 1992). We therefore attempted to identify the presence of molten globule 
state in bromelain by investigating the binding of ANS to the protein at various 
conditions and concentrations of TFE. Figure 5.7 A shows that ANS binds maximally 
to PFI in presence of 60% (v/v) TFE, while there was very little or no ANS binding at 
pH 7.0 (pseudo-native) or in presence of 6.0 M GdnHCl. The PFI also showed 
significantly higher ANS fluorescence as compared to the pseudo-native (pH 7.0) 
enzyme, the fluorescence intensity was however lower (21%) than that of the PFI in 
the presence of 60% (v/v) TFE. As ANS is known to bind to hydrophobic surfaces on 
the protein with greater affinity, these observations suggest a remarkable increase in 
the number of solvent accessible nonpolar clusters (Goto and Fink, 1989) at 60% (v/v) 
TFE. It is interesting to note that the emission maximum blue shifts (Stryer, 1965; 
Turner and Brand, 1968) to 485 run in presence of 60% TFE as compared to PFI 
(?imax 490 nm) and pH 7.0 (A,max 505 nm) preparations further suggesting that the 
protein is adopting a some what more compact structure. Very low binding of ANS to 
bromelain at pH 7.0 is apparently related to non-availability of accessible 
hydrophobic clusters, while PFI in presence of 6.0 M GdnHCl may represent a 
denatured state in which hydrophobic clusters are unfolded (Edwin and Jagarmadham, 
1998; Welfie et al, 1999). Titration of PFI with increasing concentration of TFE as 
studied by ANS binding at 490 nm (Figure 5.7 B) indicates slight disruption of 
compact structure at 60-70% (v/v) range of TFE. 
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Fig. 5.7 Fluorescence emission spectra of ANS bound to modified bromelain 
under different conditions. 
(A) Spectra of (1) PFI (pH 2.0) in presence of (2) 60% (v/v) TFE or (3) 6.0 M 
GdnHCl. The spectra of (4) pseudo-native (pH 7.0) preparation is included 
for comparison. 
(B) Effect of increasing concentration of TFE on PFI as monitored by changes 
in ANS binding at 490 nm. 
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5.4.2 Effect of TFE on ANS spectrum of acid-denatured state of unmodified 
bromelain 
As can be seen from figure 5.8 A, acid-denatured state of unmodified 
bromelain shows maximum binding of ANS in presence of 60% (v/v) TFE, while 
there was negligible ANS binding at pH 7.0 (native) and in presence of 6.0 M 
GdnHCl. While the acid-denatured state also showed increase in ANS binding, the 
increase was lower (26%) than that in the presence of 60% (v/v) TFE. This may be 
attributed to the presence of large number of solvent accessible nonpolar clusters in 
presence of 60% (v/v) TFE. Blue shifts of similar kind as explained for modified 
preparation were obtained in acid-denatured state alone and that in presence of 60% 
(v/v) TFE suggesting a compact structure for protein under the condition. Titration of 
acid-denatured state with increasing concentration of TFE as studied by ANS binding 
at 490 nm (Figure 5.8 B) indicates slight disruption of compact structure at 60-70% 
range of TFE. 
Results of fluorescence experiments on both modified and unmodified 
preparation of bromelain are also close indicative of molten globule state at 60-70% 
(v/v) range of TFE. 
5.5 Temperature induced transition of modified bromelain 
preparations 
Figure 5.9 depicts the effect of temperature on pseudo-native (pH 7.0) 
preparation, PFI (pH 2.0) and PFI in presence of 60% or 70% TFE of modified 
bromelain as monitored in near-UV CD region at 280 nm. The thermal unfolding of 
pH 7.0 (pseudo-native) preparation as seen is a co-operative process with Tm value of 
63^0, while it was found to be continuous non-co-operative for PFI with a Tm value of 
48°C. Maximum tertiary structure for PFI was obtained at 30°C, which decreased 
continuously upto 70°C and then tailed off. Furthermore, in the presence of 60% (v/v) 
TFE, PFI showed a shift in Tm value to 58®C with a co-operative behavior 
approaching towards pH 7.0 (pseudo native) preparation. However, ftirther increase to 
70% (v/v) TFE results in non-co-operative transition with a decrease in Tm value to 
51^0. Co-operative unfolding and higher Tm obtained for PFI in presence of 60% (v/v) 
TFE compared to non-co-operative and low Tm in presence of 70% (v/v) TFE suggest 
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Fig. 5.8 Fluorescence emission spectra of ANS bound to unmodified bromelain 
under different conditions. 
(A) Spectra of (1) acid-denatured state (pH 2.0) in presence of (2) 60% (v/v) 
TFE or (3) 6.0 M GdnHCl. The spectra of (4) native (pH 7.0) preparation is 
included for comparison. 
(B) Effect of increasing concentration of TFE on acid-denatured state as 
monitored by changes in ANS binding at 490 rmi. 
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Fig. 5.9 Normalized transition curves for temperature induced transition of 
modified bromelain preparations as monitored in near-UV CD region 
at 280 nm. 
Thermal unfolding curve of: 
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loss of tertiary structure in 60-70% (v/v) range of TFE and complements above 
explained spectral findings. In view of, gradual transition (Carra et al., 1994) and lack 
of co-operative thermal unfolding associated with the molten globule state (Peng and 
Kim, 1994), it also seems reasonable to suggest the formation of molten globule state 
at 60-70% (v/v) concentration range of TFE. Thermal transition was irreversible at 
both pH conditions of modified stem bromelain. Irreversibility in thermal unfolding at 
different pH conditions is also shared by another member of the family, papain 
(Mendiola et al., 1993). Temperature transition studies were undertaken with 
modified preparation only and not unmodified in view of the risk of autolysis. 
Taken together, these results (the presence of high helical content of 
secondary structure, significant loss of tertiary structure, but retention of compactness 
and high magnitude of ANS binding) are suggestive of molten globule state at 60-
70% (v/v) concentration range of TFE both for modified and unmodified stem 
bromelain. Loss of co-operative thermal unfolding in PFI of modified preparation at 
60-70% (v/v) range of TFE further points towards a molten globule state in case of 
modified preparation. It is however, interesting to note that there was considerable 
induction of tertiary structure upto 60% (v/v) TFE, however beyond there was 
complete loss. Earlier works by Haq et al., (2002) suggest acid unfolding behavior of 
bromelain to be irreversible and characteristic of Type I proteins (Fink et al., 1994). 
The reversibility of TFE induced molten globule state to acid-denatured state was 
verified by far-UV CD by diluting 70% (v/v) TFE sample to 7-fold and the spectra 
was compared with that of 10% (v/v) TFE. The process was found to be partially 
reversible. 
For clarity, tabular representation of studies undertaken have been made 
(Table 5.1 A, B). Table 5.1 C compares molten globule identified in modified and 
unmodified preparation of stem bromelain. Molten globule state of these two different 
enzyme preparation show remarkable similarity in percent tertiary structure, intrinsic 
fluorescence intensity and significant ANS binding. It is interesting to note that 
partially folded (Haq et al, 2002) and almost unfolded state of modified and 
unmodified preparations respectively lead to induction of molten globule state at same 
concentration range of TFE. In light of the differences between modified (Haq et al, 
2002) and unmodified preparation, it seems reasonable to assume that 
unfolding/folding behavior of bromelain is independent of disulfide bonds which 
appears to be a paradox when compared to the earlier findings (Tageda et al, 1995; 
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Table 5.1 A Tabular representation of studies undertaken on modified 
bromelain preparation 
Spectral pH 7.0 pH 2.0 Molten Globule* GdnHCl denatured 
study (Pseudo (PFI) (PFI + 60-70% TFE) (PFI + 60-70% TFE 
native) + 6.0 M GdnHCl) 
Far-UVCD 8600 4500 7300 2000 
(208 nm) 
MRE 
Near-UVCD 182 26.8 81.4 -
(280 nm) 
MRE 
Intrinsic 75.4 41 47 34 
Fluorescence 
(335 nm) F.I 
ANS binding - + + + + + -
(490 nm) F.I 
* Values are average of points in range of 60-70% (v/v) TFE. 
• - represents very low ANS binding; ++, +++ represents significantly increased 
binding. 
Table 5.1 B Tabular representation of studies undertaken on unmodified 
bromelain preparation 
Spectral pH7.0 pH2.0 Molten Globule* GdnHCl 
study (Native) (Acid (pH 2.0 + 60-70% TFE) denatured 
denatured) (pH 2.0 + 60-
70% TFE+ 6.0 
M GdnHCl) 
Far-UVCD 6000 2000 4125 600 
(222 nm) 
MRE 
Near-UVCD 128 46 54.6 -
(286 nm) 
MRE 
Intrinsic 62.2 29 37 23 
Fluorescence 
(335 nm) F.I 
ANS binding - + + + + + -
(490 nm) F.I 
* Values are average of points in range of 60-70% (v/v) TFE. 
• - represents very low ANS binding; ++, +++ represents significantly increased 
binding. 
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Table 5.1 C Comparison of spectral studies undertaken for unmodified and 
modified bromelain preparation 
Mpdified bromelain Vnmodifi^d bromelain 
Spectral pH 7.0 Molten pH 7.0 Molten 
studies Globule* Globule* 
Near-UVCD 100% 44.5% 100% 43% 
(MRE) (182) (81) (128) (55) 
Intrinsic 100% 62.6% 100% 59.6% 
Fluorescence (75) (47) (62) (37) 
(F.I) 
ANS binding - -H-t- - + + + 
For comparison values of spectral parameters are represented in percentage relative to 
pH 7.0 preparations which represent 100%. 
* Values are average of points in range of 60-70% (v/v) TFE. 
- represents very low ANS binding; +++ represents 25-35% increased binding 
over Acid-denatured state and PFI of unmodified and modified preparations 
respectively. 
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Haniu et al, 1996; Onda et al, 1997; Xu and Scheraga, 1998; Hober et al., 1997) in 
which disulfide bonds formation has been referred to as the rate limiting step (Fujita 
and Yoshida, 2001) during protein folding. 
5.6 Implications/Conclusion of the study 
Attention has been recently directed towards the study of partially folded 
states that can be adopted by a polypeptide chain under equilibrium conditions (Haq 
et al., 2002, Edwin and Jagannadham, 1998; 2000), in view of their similarity to the 
partially folded kinetic intermediates observed during the folding/unfolding pathways 
of many proteins. 
Study of various conformational states in the unfolding/refolding of multi 
domain protein such as bromelain is important for the imderstanding the principles 
governing protein folding. Molten globules are likely to play a significant role in the 
folding of proteins in vivo and it is expected that when a partially/completely imfolded 
protein is placed under physiological condition, it will rapidly collapse to a compact 
structure such as molten globule. A number of authors have suggested that solvents 
like TFE mimic some characteristics of the in vivo system and therefore attach 
relevance to structural studies performed in the solvent (Waterhous and Johnson, 
1994). 
The study on modified preparation can be summarized as: 
Pseudo native (pH 7.0) ^ PFI (pH 2.0) Molten globule (pH 2.0 + 60-70% TFE) 
The study on umnodified preparation can be summarized as: 
Native (pH 7.0) Acid-denatured state (pH 2.0) Molten globule (pH 2.0 + 60-
70% TFE) 
These studies taken together suggest the presence of identical molten 
globule state in a single polypeptide chain protein under two different conditions 
{modified (disufides reduced and blocked) and unmodified (disulfides intact)} which 
suggest the study to be a paradox to earlier findings which implicate role of disulfides 
in protein folding/unfolding. 
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Summary 
Stem bromelain is a well-studied cysteine proteinase with numerous 
actual/potential clinical as well as industrial applications. The enzyme is unusual in 
containing a lone histidine in the sequence and a single oligosaccharide chain attached 
to the asparagines residue. These have been made use of to favorably and uniformly 
orient the enzymes on solid supports. Con A-Sepharose support was used to favorably 
orient the enzyme via its glycosyl residue and the enzyme was bound to Cu '^^ -IDA-
Sepharose through the single histidine residue The preparation obtained thus exhibited 
high activity on casein, nearly unaltered Km and Vmax and a broader pH activity 
profile as compared to the soluble enzyme. The oriented preparations showed 
enhanced resistant to thermal inactivation and retained remarkably high activity when 
exposed to 60°C for longer duration. They were remarkably stable to mechanical 
agitation and highly reusable. 
In recent years efforts are being made to prepare soluble immobilized 
enzymes for a variety of applications. Attempts were also made to prepare a soluble 
preparation of immobilized bromelain. This was achieved by the binding of the 
enzyme to the univalent Fab' monomer isolated from the polyclonal anti-bromelain 
IgG raised in rabbits. The Fab' were isolated by cleaving the IgG wdth papain 
followed by affinity purification. Incubation of bromelain with the Fab' resulted in the 
formation of the complex that was shown to be a compact structure containing the 
Fab' and bromelain in 1:1 stoichiometry. Complexing with the Fab' resulted in 
significant stabilization of bromelain against thermal inactivation and alkaline pH. 
This makes it a suitable model for employment in homogeneous reaction phases 
where bromelain finds several applications. Further, stability of bromelain:Fab' 
complex against NaCl and methanol was investigated by far and near-UV CD and 
fluorescence measurements. Addition of upto 1.8 M NaCl caused no significant 
changes in fluorescence signals and near-UV CD peak pattern. However, the spectral 
studies together with those using gel filtration suggest the dissociation of the complex 
beyond 5% (v/v) methanol. These results show that hydrophobic interactions play a 
pronounced role in the binding of Fab' to bromelain and electrostatic interactions may 
be less crucial. The results suggest a remarkable potential of the strategy of 
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complexing with monomeric Fab' for obtaining stable and soluble preparation of 
enzymes. 
2,2,2-trifluoroethanol (TFE) denatures proteins but also stabilizes/induces 
a-helical conformation in partially/completely unfolded proteins. Modified bromelain 
preparation, at pH 2.0, exists as partially folded intermediate (PFI). We studied effect 
of increasing concentration of TFE on PFI by circular dichroism (CD), fluorescence 
emission spectroscopy, binding of hydrophobic dye, 1-anilino 8-naphthalene sulfonic 
acid (ANS) and near-UV CD temperature transition studies. Far-UV CD spectra show 
considerable accumulation of secondary structure at 70% (v/v) concentration of TFE 
with significant resemblance to spectral features of pH 7.0 (pseudo-native) 
preparation. Interestingly partially folded intermediate regained some tertiary 
structure/interaction till 60% (v/v) TFE and approached to almost that of native like 
state. Further increase to 70% (v/v) TFE however lead to a complete loss of tertiary 
structure/interaction. Tryptophan fluorescence studies showed induction of some 
compact structure at 60% (v/v) concentration of TFE. Partially folded intermediate in 
presence of 60% (v/v) TFE showed enhanced binding of fluorescent probe than in 
absence. These observations taken together suggest molten globule state at 60-70% 
(v/v) range of TFE and was found to be partially reversible. Thermal transition studies 
in near-UV CD region shows co-operative transition for PFI in presence of 60% (v/v) 
TFE changing to non-co-operative in presence of 70% (v/v) TFE, along with a shift of 
Tm from 58°C to 51°C. Gradual transition and loss of co-operative thermal unfolding 
in 60-70% (v/v) range of TFE fiirther suggest molten globule state in modified 
bromelain preparation. Study of same parameters on unmodified bromelain 
preparation suggest the existence of an identical molten globule state in acid-
denatured unmodified bromelain between 60-70% (v/v) i.e., under similar conditions 
that have been identified in case of modified bromelain preparation (disulfide reduced 
and iodoacetamide treated) of bromelain. Comparison between unmodified and 
modified preparation suggests that bromelain unfolding/folding behavior is 
independent of disulphide bonds, which appears to be a paradox to earlier findings 
that implicate disulfide bond formation as rate limiting step in protein folding. 
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Abstract 
Antienzyme polyclonal antibodies against stem bromelain were raised in male albino rabbits and the Fab' monomers isolated from 
the IgG of the immune sera. Incubation of bromelain with the Fab' resulted in binding and gel filtration of the resulting complex 
suggested a 1:1 stoichiometry. Complexing with the Fab'resulted in significant stabilization of bromelain against thermal inactivation 
and alkaline pH. 
© 2003 Elsevier Science B.V. All rights reserved. 
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1. Introduction 
Lability of enzymes to various forms of inactivation 
continues to remain the principal limitation in their indus-
trial, clinical and analytical applications. Among the large 
number of strategies that are being currently investigated for 
the improvement of the stability of enzymes [1 -3] , the use 
of specific antienzyme antibodies appears versatile and 
promising [4-6] . Both polyclonal [7,8] and monoclonal 
antibodies [9] have been successfiilly employed for stabili-
zation and immobilization of enzyme on solid supports 
[10,11] and as enzyme-antibody aggregates [12-16] . The 
stability of various enzymes including glucose oxidase, 
invertase and catalase to inactivation induced by various 
agents has been remarkably improved using these strategies. 
Large aggregates of enzyme-antibody complexes may 
result when enzyme and polyclonal antibody interact. Alter-
natively, interactions between homooligomeric enzymes and 
their monoclonal antibodies may also result in the formation 
of aggregates, which, being insoluble, are generally not 
ideally suited for action on large molecular weight and 
insoluble substrates and in most clinical applications. 
* Corresponding author. Interdisciplinary Biotechnology Unit, Faculty 
of Life Sciences, Aligarh Muslim University, Aligarh, Pin 202002, Uttar 
Pradesh, India. Tel.: +91-571-270-1979; fax: +91-571-270-1081. 
E-mail address: msaleemuddin@rediffmail.com (M. Saleemuddin). 
A plethora of literature is now available on the usefiil-
ness of antigen binding Fab' fragments of the antibodies in 
the purification of proteins [17] and in clinical usage [18 -
20]. Binding of monomeric Fab' fragment to enzyme is not 
likely to result in the formation of large and insoluble 
aggregates due to inability of the former to form cross-
linkages. It was therefore envisaged that binding of 
Fab' isolated from the antienzjTne IgG may confer sig-
nificant stability to enzymes without rendering them 
insoluble. 
Stem bromelain, an endoproteinase from the pineapple 
stem and used in a variety of clinical applications [21,22], 
has been selected for this study. It has been shown that 
Fab' isolated from the IgG of the sera of rabbits immunized 
with bromelain binds to the enzyme and leads to marked 
improvement in its stability against heat and alkaline pH. 
2. Materials and methods 
2.1. Materials 
Stem bromelain (3.4.22.32). Sephadex G-lOO and 
Sepharose 4B were purchased from Sigma Chemical Com-
pany. Goat antirabbit immunoglobulin (IgG), horseradish 
peroxidase conjugate and its substrate tetramethyl benzi-
dine/HjO: were supplied by Genei laboratories (Banga-
1570-9639/03/$ - see front matter © 2003 Elsevier Science B.V. All rights reserved, 
doi: 10.1016/S1570-9639(02 )00554-X 
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lore, India). All the other chemicals used were of analytical 
grade. 
2.2. Immunization 
Bromelain preparation (300 |ig/0.5 ml) in 20 mM sodium 
phosphate buffer, pH 7.0, was mixed with Freund's com-
plete adjuvant in the ratio of 1:1 and administered subcuta-
neously to rabbits [23]. The animals were rested for 15 days 
and booster doses of antigen, prepared by mixing 150 \ig/ 
0.5 ml solution of antigen with equal volumes of Freund's 
incomplete adjuvant, were subcutaneously given weekly for 
4 weeks. Blood was withdrawn through an ear vein, and clot 
formation was allowed to take place at room temperature for 
6 h. Serum was collected by centrifiigation, decomple-
mented at 56 °C for 30 min and stored at - 2 0 °C. 
Ouchterlony double-diffusion technique was used for the 
detection of antibodies [24], 
2.3. Preparation of the affinity column 
Bromelain was coupled to CNBr-activated Sepharose 4B 
by the method of Porath et al. [25]. The preparation obtained 
thus contained 5 mg bromelain per milliliter of gel. 
2.4. Purification of IgG and Fat/ monomers 
The affinity purification of specific IgG was achieved by 
employing bromelain coupled to Sepharose 4B following 
the published procedure [26]. Briefly, antibromelain anti-
serum was allowed to bind to a bromelain-Sepharose 4B 
affinity column. The column was washed thoroughly with 
0.1 M Tris-HCl and 3.0 M NaCl, pH 8.9, to remove any 
unbound or nonspecifically associated protein. The bound 
IgGs were eluted with 0.1 M glycine-HCl buffer, pH 3.5, 
and the eluate was immediately neutralized with Tris buffer. 
Specific Fab' fragments were similarly isolated by applying 
the papain-treated IgG digest to the affinity column fol-
lowed by washings and subsequent elution. 
IgG from the sera of nonimmunized rabbits were isolated 
by ammonium sulfate fractionation and DEAE cellulose 
chromatography and Fab' isolated by papain digestion fol-
lowing the published procedure [27]. 
the molecular weight and Stokes radius of complex, respec-
tively. 
2.6. Preparation of bromelain/Fab' complex 
Stem bromelain and antibromelain Fab' fragment/non-
specific Fab' were mixed in the desired molar ratio and 
incubated for 6 h at 4 °C before investigating their stability. 
The preparation of stem bromelain incubated with non-
specific Fab' served as control. For pH and temperature 
stability studies, three-fold molar excess of Fab' was used. 
2.7. Activity measurement 
Proteolytic activity of bromelain was measured using 
casein as a substrate [30]. The standard incubation mixture 
contained 0.2 M sodium phosphate buffer of appropriate 
pH, 5 mM L-cysteine, 0.1 M KCl and 9 ng (150 enzyme 
units) of stem bromelain in a total volume of 0.5 ml. The 
enzyme preparation was preincubated for 5 min at 37 °C, 
and the reaction was initiated by the addition of 0.5 ml of 
1% casein. Reaction was stopped with 1 ml of 10% 
trichloroacetic acid. The resulting soluble peptides were 
quantitated by the procedure of Lowry et al [31], One unit 
of bromelain was the amount that resulted in change of 0.01 
O.D. in 15 min under the given condition. 
3. Results and discussion 
Stem bromelain was quite immunogenic and rabbits 
challenged with the enzyme responded by producing pre-
cipitating antibodies in their sera. The antisera gave clear 
single precipitin lines on inununodiffiision, indicating the 
homogeneity of the enzyme preparation. While the preim-
mune serum that served as negative control did not show 
any appreciable binding to bromelain, direct-binding ELISA 
showed a high titer (204173) in the immune sera. Anti-
bodies and Fab' monomers were not inhibitory towards 
bromelain even at high concentration (data not included). 
Several antienzyme antibodies raised in animals have also 
been shown in earlier studies to be noninhibitory towards 
the enzymes [14]. 
2.5. Determination of molecular weight and Stokes radius 3.1. Molecular weight and Stokes radius 
Stem bromelain and specific polyclonal Fab' monomers 
were added in 1:3 molar ratio and incubated for 6 h at 4 °C. 
The molecular weight of the complex formed was deter-
mined by gel filtration on a Sephadex G-lOO column 
(1.7 X 80 cm), which was calibrated using standard molec-
ular weight marker proteins. The complex was eluted with 
0.01 M sodium phosphate buffer, pH 7.0, at a flow rate of 
! 5 ml/h. Fractions were collected and monitored at 280 nm. 
The data was analyzed according to theoretical treatment of 
Andrews [28] and Laurent and Killander [29] for calculating 
The bromelain/Fab' complex emerged from the Sepha-
dex G-lOO with an elution volume corresponding a molec-
ular dimension of 79.4 kDa. Considering that the molecular 
weight of bromelain is 26.6 kDa and that of the Fab', as 
calculated from gel filtration data, is 50.1 kDa (Fig. 1), the 
likely stoichiometry of the complex is 1:1. No high molec-
ular weight adducts were obser\ed suggesting that each 
bromelain molecule may not bind more than one Fab'. This 
suggests that at the protein concentration used, binding of a 
single Fab' on bromelain restricts that of another Fab'. A 
p. Cupla el al. / Biochimica et Biophysica Ada 1646 (JOilJ/ UI-IJ5 133 
0 .35 
0 .30 -
0 .25 -
E 
O 0.20 -
CO 
CM 
(0 
Q 
d 
0 . 1 5 -
0.10 -
0 . 0 5 -
/ \ !: \ / I 
I ••-A • 
0 . 0 0 , r 
60 7 0 
—I 1 1 1 1 1 1 1 1 1 
8 0 9 0 1 0 0 1 1 0 1 2 0 1 3 0 140 150 1 6 0 1 7 0 1 8 0 
Elution Volume (ml) 
Void Volume 
(60 ml) 
Fig. I. Size-exclusion chromatography. ( ) Bromelain; (•• • •) Fab'; and ( — ) bromelain/Fab' complex were passed through Sephadex G-lOO column as 
detailed in Materials and methods. (A) Bromelain/Fab' complex (1:1 molar ratio). (B) Unbound Fab'. Elution positions of molecular weight markers have been 
shown: [GL, 116 kDa ( )] p-galactosidase; [BSA, 66.2 kDa ( )] bovine serum albumin; [OA, 45 kDa, ( )] ovalbumin; [STI, 20.1 kDa, ( )] 
soya bean trypsin inhibitor. 
single molecule of bromelain can theoretically bind several 
Fab', considering that the latter has been obtained from the 
polyclonal IgG. Small dimension of bromelain may also 
prevent the binding of additional Fab' to the enzyme. Aher-
natively, the epitopes (s) of bromelain may be restricted in a 
limited region of the enzyme preventing the binding of ad-
ditional Fab' monomers. The Stokes radius of the complex 
was 38 A, which suggested a compact structure. 
3.2. Effect of temperature 
Bromelain preparation incubated with the Fab' mono-
monomers exhibited significant increase in resistance to 
inactivation induced on exposure to 60 °C. The stabilization 
increased with increase in bromelain/Fab' ratios and reached 
maximum when the bromelain/Fab' ratio was 1:3 (Fig. 2). 
Considering that the complex formed appears to be of 1:1 
stoichiometry, it is likely that optimum complex formation 
occurs at the molar ratio of 1:3. Bromelain activity was not 
significantly altered on incubation with Fab' at various 
molar ratios under standard conditions (data not included). 
The temperature optimum of bromelain remained unaltered 
after incubation with Fab' derived from antibromelain IgG 
or nonspecific IgG (Fig. 3). All three preparations were 
optimally active at 60 "C. Increased retention of activity at 
higher temperatures was exhibited by bromelain prein-
cubated with antibromelain Fab'. Further, the bromelain/ 
Fab' complex showed a clear improvement in the resistance 
to inactivation at 60 °C. More than 50 min were required for 
50% loss of the proteolytic activity in case of bromelain/ 
Fab' complex, while in case of bromelain alone or brome-
1:0 1:1 1:2 1:3 1:4 1:5 
Bromelaln:Fab (molar ratio) 
Fig. 2. Inactivation at 60 °C of free bromelain and bromelain incubated 
with various molar ratio of Fab'. Appropriate quantities (as ment ioned in 
Materials and methods) of free bromelain and bromelain incubated at 
different molar ratios of antibromelain Fab' (1:1; 1:2; 1:3; 1:4; 1:5 molar 
ratio) were incubated at 60 °C for 40 min, cooled to room temperature, and 
the residual activity was determined under standard assay condition. 
Activity of equal aliauots of preparation not subjected to heat inactivation 
was taken as 100 for calculation of percent activity. Each bar represents the 
mean of three experiments carried out in triplicate. S.E. = ± 1.30. 
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Temperature ( C) 
Fig. 3. Effect of temperature on free bromelain and that incubated with Fab". 
Appropriate quantities (as mentioned in Materials and methods) of free 
bromelain and bromelain incubated with three-fold molar excess of 
Fab" were assayed for enzyme activity at indicated temperatures under 
standard condition of pH and substrate concentration. ( • ) Bromelain; (O) 
bromelain incubated with nonspecific Fab'; (T) bromelain complexed with 
antibromelain Fab*. Each point represents the mean of three experiments 
carried out in triplicate. S.E. = ± 1.80. 
lain incubated with nonspecific Fab', only 15-20 min was 
required for such inactivation (Fig. 4). Figs. 3 and 4 have 
been normalized for the activity of individual preparations at 
60 °C inasmuch as the activities in terms of enzyme units at 
this temperature are identical. Bromelain incubated with 
nonspecific Fab' exhibited slightly higher resistance to 
inactivation over bromelain alone. The observed improved 
40 so 
Time (min) 
Fig. 4. Effect of preincubation at 60 °C on thermal inactivation of free 
bromelain and that incubated with Fab'. Appropriate quantities (as 
mentioned in Materials and methods) of free bromelain and bromelain 
incubated with three-fold molar excess of Fab' were incubated at 60 °C for 
the indicated time duration, cooled to room temperamre, and the residual 
activity was determined under standard assay condition. Activity of 
bromelain not subjected to heat inactivation was taken as 100 for 
calculation of percent activity. ( • ) Bromelain: lO) bromelain incubated 
with nonspecific Fab'; (T ) bromelain complexed with antibromelain Fab'. 
Each point represents the mean of three experiments carried out in triplicate. 
S.E. = ± 1.90. 
temperature stability profile of bromelain incubated with 
antibromelain Fab' may be related to the preferential exclu-
sion of the water molecules from protein-protein interface 
or contact areas owing to the nonco\'alent interactions. 
Davies et al. [32] have proved the same based on the study 
on the interaction of the influenza virus lysozyme and 
neuraminadase with their respective Fab' fragment. The data 
suggest that the areas of contact from which water mole-
cules are eliminated may be large enough to cover an entire 
epitope comprising several discontinuous oligopeptides or 
amino acid residues. This may result in effects similar to 
crosslinking and enhancement in protein stability. Protein-
protein interaction in many instances stabilize proteins by 
excluding water from the interactive areas resulting in 
lowered free energy and facilitating the formation of the 
native folded conformation [33], In addition, reduction in 
free energy resulting from bromelain/Fab' interaction 
howsoever moderate may be sufficient to confer stability 
as free energy changes between the folded and unfolded 
state lie in the same range [14,34]. An alternate interesting 
possibility is that Fab' monomers may exhibit chaperon-like 
activity and assist in the refolding of bromelain after ex-
posure to high temperature, as well as inhibit enzyme 
aggregation, as has been shown earlier in case of some 
monoclonal antienzyme antibodies [9], 
3.3. Effect ofpH 
The pH optimum of native bromelain and bromelain 
incubated with nonspecific Fab' was 7.5 (Fig, 5). However, 
bromelain/Fab' complex showed a shift in the pH optimum to 
8.0, Further, the bromelain/Fab' complex retained far greater 
£ 
> 
1 
pH 
Fig. 5. pH activity profiles of free bromelain and that incubated with Fab'. 
Appropriate quantities (as mentioned in Materials and methods) of free 
bromelain and bromelain incubated with three-fold molar excess of 
Fab* were incubated in 0.2 M sodium phosphate buffer (pH 5 - 8 ) and 0.2 
M Tr is -HCI buffer (pH 9 - 1 1 ) , and the activitv- was detennined under 
standard assay condition. ( • ) Bromelain; (O) bromelain incubated with 
nonspecific Fab'; ( • ) bromelain complexed with antibromelain Fab'. Each 
point represents the mean of three experiments carried out in triplicate. 
S.E. = ± 1.70. 
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fraction of proteolytic acti\it\' between pH 9 and 11. Murachi 
and Yamazaki [35] reported no changes in confonnation of 
stem bromelain up to pH 10. and beyond which conforma-
tional change proceeded through at least two mutually dis-
tinguishable stages with a concomitant loss of activity. 
Extended stability in case of complex but not enzyme alone 
and controls in pH range 9 -11 can be attributed to stabiliza-
tion of the bromelain conformation due to protein-protein 
interaction in the former. Fig. 5 has been normalized for the 
highest activity inasmuch as the highest activity at optimum 
pH of different preparations were identical. 
4. Conclusion 
This work presents an attempt for the preparation of 
stable, soluble enzyme preparation with the potential for in 
vivo and industrial applications. Earlier attempts were 
focussed on stabilization of enzyme by formation of immu-
nocomplexes [14-16] and binding on antibody supports 
[10,11]. The anti-edemic, anti-inflammatory and anti-neo-
plastic properties of bromelain have been exploited [36-39] 
but intravenous and intraperitoneal administration of bro-
melain, despite their merits, have been discontinued and the 
en2yme is currently administered orally [22]. Complexing 
the enzymes with Fab' derived especially from a humanized 
IgG [40] may solve several of the problems associated with 
enzyme therapy. 
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Abstract 
2,2,2-Trifluoroethanol (TFE) denatures proteins but also stabilizes/induces a helical conformation in partially/completely un-
folded proteins. As reported earlier from this laboratory, stem bromelain is known to exist as a partially folded intermediate (PFI) at 
pH 2.0. The effect of increasing concentration of TFE on the PFI of bromelain has been investigated by circular dichroism (CD), 
fluorescence emission spectroscopy, binding of the hydrophobic dye 1-anilino 8-naphthalene sulfonic acid (ANS), and near-UV CD 
temperature transition. Far-UV CD spectra show considerable accumulation of secondary structure at 70% (v/v) concentration of 
TFE with spectral features resembling the pH 7.0 preparation. Interestingly the partially folded intermediate regained significant 
tertiary structure/interactions, with increasing concentration of TFE, and at 60% (v/v) TFE approached almost that of the pseudo 
native (pH 7.0) state. Further increase to 70% (v/v) TFE, however, resulted in complete loss of tertiary structure/interactions. Studies 
on tryptophan fluorescence also suggested the induction of some compact structure at 60% (v/v) concentration of TFE. The partially 
folded intermediate showed enhanced binding of the fluorescent probe (ANS) in the presence of 60% (v/v) TFE. Taken together 
these observations suggest a "molten globule" state between 60 and 70% (v/v) TFE. Thermal transition studies in the near-UV CD 
region indicated cooperative transition for PFI in the presence of 60% (v/v) TFE changing to noncooperative transition at 70% (v/v) 
TFE. This was accompanied by a shift in the midpoint of thermal denaturation (r^) from 58 to 51 °C. Gradual transition and loss of 
cooperative thermal unfolding in the 60-70% (v/v) range of TFE also support the existence of the molten globule state. 
© 2003 Elsevier Science (USA). All rights reserved. 
Keywords: Mollcn globule; Tr i f luoroethanol ; Stem bromelain; Circular dichroism 
The amino acid sequence of a protein stores infor-
mation required to spontaneously transform its disor-
dered structure into the native three-dimensional form 
[1]. Study of the folding intermediates and denatured 
states provides an insight to understand how and when 
various forces come into play in directing protein folding 
[2-4]. The development of a broad range of techniques 
has led to the identification and characterization of stable 
folding intermediates of several proteins [5-8]. One such 
intermediate, termed the "molten globule," has been 
shown to be a compact collapsed structure with pro-
nounced secondary structure but lacking rigid tertiary 
structure [9-1 Ij. The characteristic features of a molten 
globule are (a) it is less compact than the native state, (b) 
it is more compact than the unfolded state, (c) it contains 
significant secondary structure, and (d) it has only loose 
tertiary contacts without tight side-chain packing. Re-
cent evidence, however, supports the idea that the molten 
globule may also possess well-defined tertiary contacts 
[12-15]. Proteins in the molten globule state may thus 
contain a high level of secondary structure and a rudi-
mentary, native-like tertiary topology. The structural 
similarity between the molten globule and the native 
proteins may therefore have a significant bearing in the 
understanding of the protein-folding problem [16]. 
Several proteins have been shown to exist in a molten 
globule state using a variety of denaturants [17-19]. A 
variety of alcohols exert distinct effects on proteins. Bi-
nary mixtures of water with alcohols such as methanol, 
ethanol, or 2,2,2-trifluoroethanol (TFE) denature the 
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tertiary and the quaternary structures of proteins while 
enhancing their hehcity [20,21], Several alcohols weaken 
nonlocal hydrophobic interactions while promoting lo-
cal polar interactions (i.e., hydrogen bond) in proteins 
[22,23], Therefore, in many cases, alcohol-induced de-
naturation is accompanied by stabilization of the ex-
tended helical rods in which hydrophobic side chains are 
exposed, but the polar amide groups are shielded from 
the solvent [24,25], Alcohols also induce significantly 
higher helical structures in partially or completely un-
folded protein as compared to folded protein [26], TFE 
is a protein denaturant, which has also been shown to 
induce the molten globule state in many proteins [18,19], 
Among various alcohols, TFE is often preferred in such 
studies because of its high potential in stabilizing the a-
helical structure [27,28], The secondary structures sta-
bilized by TFE are assumed to reflect conformations 
that prevail during early stages of protein folding 
[19,24,28]. Interestingly, a recent report describes the 
existence of a native-like P structure in the partially 
folded state of tendamistat induced by TFE [29]. The 
effectiveness of TFE to induce secondary structure ap-
pears to be related to the three fluorine atoms, which 
appear important for enhancing the effects of the alco-
hol [30]. Thougli, many proteins in their molten globule 
and partially folded states have been characterized, it 
has yet not been possible to generalize the concept of 
molten globule as a universal equilibrium protein fold-
ing intermediate. Characterization of the molten globule 
state is helpful in identifying the transition states be-
lieved to occur between the molten globule and the na-
tive state and between the molten globule and the 
denatured state [31,32]. 
While a detailed study on the refolding aspects of 
papain, a thiol protease, has been made by several 
workers [33,34], few studies on the stem bromelain, a 
cysteine protease from Ananas comosus, are currently 
available. Reyna and Arana [35] proposed that bro-
melain forms may have the same folding pattern as 
that shown by other members of the papain family as 
the spectral characteristics displayed by stem brome-
lain are similar to those observed in papain and 
proteinase n , namely, a bilobal structure with pre-
dominantly ot and antiparallel P sheet domains [36,37]. 
Like other cysteine proteinases, stem bromelain be-
longs to the a + p protein class and the highly similar 
amino acid sequences of papain [38], actinidin [39], 
proteinase n [40], chymopapain [41], and stem bro-
melain [42] indicate that the polypeptide chains of 
these proteins may share a common folding pattern. 
This has been substantiated for the first three pro-
teinases by detailed X-ray diffraction studies [37,42-
44]. Earlier studies from this lab have demonstrated 
the existence of a partially folded intermediate (PFI) 
for stem bromelain at pH 2.0 and a molten globule-
like state at pH 0.8 [45]. In the present communica-
tion, we demonstrate the formation of a molten 
globule-like state when the PFI is subjected to high 
concentrations of TFE. Bromelain has been shown to 
exist in a molten globule-like state between 60 and 
70% (v/v) of TFE having disordered side chain inter-
actions but with considerable secondary structure. The 
observed enhanced binding of ANS to the PFI in the 
presence of 60% (v/v) TFE as compared to PFI alone 
suggested the presence of a large number of solvent-
accessible nonpolar clusters in the former. 
Materials and methods 
Materials 
Stem bromelain (3.4.22.32) lot No. B4882, 2,2,2-tri-
fluoroethanol, and l-anilino-8-naphthalene sulfonic acid 
were purchased from Sigma Chemical Co. (USA). 
Guanidine hydrochloride (GdnHCl) was obtained from 
Qualigens (India). All other reagents were of analytical 
grade. 
Autolysis inhibition 
To avoid complications due to autocatalysis, enzyme 
samples were irreversibly inactivated by the procedure 
of Sharpira and Amon [46] with modifications as re-
ported earlier by our group [45]. Reduction was carried 
out in 0.32 M 2-mercaptoethanol for 4 h at room 
temperature, followed by addition of solid iodoaceta-
mide to give a final concentration of 0.043 M. After 
stirring for 30min at 4°C, the solutions were dialyzed 
overnight against lOmM sodium phosphate buffer, pH 
7.0. The inactive preparation of stem bromelain ob-
tained thus was used throughout the present study. The 
preparation was completely devoid of enzyme activity 
but was almost undisting'uishable in spectral features 
from the native enzyme. The iodoacetamide-modified 
preparation at pH 7.0 was designated the pseudo na-
tive state and used as control in place of the native 
preparation. PFI of inactive preparation was achieved 
by dialyzing against lOmM glycine-HCl buffer, pH 2.0 
[45]. 
Spectrophotometric measurements 
Protein concentration was determined with the help 
of a Hitachi U-1500 Spectrophotometer using an ex-
tinction coefficient £jcm,280nm = t^^]. The molecular 
mass of the protein was taken as 23,800 Da [47]. A stock 
solution of ANS in distilled water was prepared and 
concentration determined using an extinction coefficient 
of £M = 5000M-' cm-' at 350 nm [48]. The molar ratio 
of protein to ANS was 1:50. 
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Circular dicbroism 
All the circular dichroism (CD) measurements were 
carried out at 25 °C on a Jasco spectropolarimeter 
Model J-720 using a SEKONIC XY Plotter (Model 
SPL-430A), with a thermostatically controlled cell 
holder attached to a NESLAB waterbath Model RTE 
110 with an accuracy of ±0.10°C. The instrument was 
equipped with a microcomputer and precalibrated with 
(+)-10-camphorsulfonic acid. The spectra were recorded 
with a scan speed of 20 nm min~' and with a response 
time of 1 s. Each spectrum was recorded as an average of 
two scans. Far-UV CD spectra and near-UV CD spectra 
were taken at a protein concentration of 20nM with 1-
and lO-mm-path-length cells, respectively. C D spectra 
were recorded in the wavelength ranges of 190-250 nm 
for far-UV and 250-310 nm for near-UV. The C D re-
sults are expressed as mean residue ellipticity (MRE) in 
degrees cm^dmor' , which is defined as 
MRE(0) = 0„b,(mdeg)/lO xnx I xCp, 
where 0„bs is the C D in millidegrees, n is the number of 
amino acid residues (212), / is the pathlength of the cell 
in cm, and Cp is the mole fraction. 
For near-UV CD temperature transition studies, a 
water-jacketed 10-mm-path-length cell was used attached 
to the RTE-110 waterbath interfaced with a microcom-
puter. The same protein concentration (20 |iM) was used 
in all CD measurements. The thermal denaturation of 
different preparations was monitored by the ellipticity 
changes at a fixed wavelength (280 nm), as a function of 
temperature. This latter parameter was continuously 
varied at a selected constant rate (1.5 "C/min) by carefully 
adjusting the heating control of the water bath. Each 
reading at the desired temperature was recorded after 
an incubation time of lOmin at that temperature. 
Fhtorimetry 
Intrinsic fluorescence and ANS binding were studied 
using a Shimadzu spectrofluorometer Model RF-540 
equipped with a data recorder DR-3. The concentration 
of stem bromelain preparations used was 20 nM. Req-
uisite volumes of TFE, GdnHCl, and buffer were taken. 
For the intrinsic tryptophan fluorescence, the excitation 
wavelength was set at 280 nm and the emission spectra 
were recorded in the range 300-400 nm. Binding of A N S 
to stem bromelain preparations was studied by exciting 
the dye at 380 nm and the emission spectra were re-
corded from 400 to 600 nm. Excitation and emission slit 
widths were 5 nm. Since ANS shows emission in TFE, 
all spectra were corrected for blanks. 
Result and discussion 
Effect of TFE on CD spectrum of PFI of stem bromelain 
The stem bromelain is predominantly an a helix and 
P sheet protein with 23% ot helix, 18% antiparailel P 
sheet, 5% parallel p sheet, 18% turns, and the remaining 
35% as other structures [35,36]. It has a molecular mass 
of 23,800 Da (212 amino acid residues), contains 
three disulfides and a single free cysteine residue. As 
reported earlier from this laboratory [45], stem brome-
lain forms PFI at pH 2.0 and a molten globule-like 
structure at pH 0.8. Fig. lA shows the far-U'V C D 
190 W a v e l e n g t h ( n m ) 
250 
20 30 40 SO 
% (v/v) TFE 
Fig. 1. Far-UV C D spectra of stem bromelain preparations, (A) Spectra of ( — ) PFI (pH 2.0) in the presence of ( — ) 30%, (—-) 60%, or ( ) 70;„ 
(v/v) TFE concentration or ( ) 6 M GdnHCl , TTie spectra of (• • •) pseudo native (pH 7,0) preparation is included for comparison, (B) Effect of 
increasing concentration of T F E on PFI as monitored by changes in M R E value at 208 nm. 
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spectra of PFI of stem bromelain in the presence of 
various concentration of TFE. There was an almost 50% 
loss in the secondary structure at pH 2.0 (PFI) as 
compared to that of the pH 7.0 (pseudo native) prepa-
ration as observed at 208 nm. Furthermore, increasing 
the concentration of TFE leads to increase in MRE 
value. It is interesting to note that in the concentration 
range of 60-70% (v/v) TFE the induced secondary 
structure approached almost that of the pseudo native 
state. In contrast there was a complete loss in secondary 
structure in the presence of 6 M GdnHCl. Titration of 
PFI with increasing concentration of TFE as moni-
tored at 208nm (Fig. IB) indicated the accumulation 
of secondary structure at all concentrations of TFE 
investigated. 
Fig. 2A shows near-UV CD spectra of PFI of stem 
bromelain in the presence of various concentrations of 
TFE. The native state of stem bromelain is character-
ized by a positive peak around 280 nm as also reported 
elsewhere [36,37,45]. As can be seen in the figure there 
was a considerable loss in tertiary structure/interactions 
at pH 2.0 (PFI) and complete loss in the presence of 
6 M GdnHCl. At low concentration of TFE (30% (v/v)) 
the spectral features were comparable with those of 
PFI and it is interesting to note that at 60% (v/v) TFE 
there was a significant increase in ellipticity with the 
spectrum resembling that of the pH 7.0 preparation, 
presumably due to the formation of a relatively com-
pact structure. There was, however, a total loss of 
tertiary structure/interactions at 70% (v/v) of TFE. Fig. 
2B shows titration of PFI with increasing concentra-
tion of TFE as monitored at 280 nm. A gradual in-
crease in tertiary structure/interactions up to 30% (v/v) 
of TFE is followed by a sharp increase up to 60% but 
at 70% (v/v) TFE there was abrupt loss of the tertiary 
structure. All the above results taken together indicate 
loss in tertiary structure but substantial retention of 
secondary structure in the 60-70% (v/v) range of TFE 
concentrations. 
Effect of TFE on tryptophan fluorescence spectrum of PFI 
of stem bromelain 
Fig. 3A shows intrinsic emission spectra of stem 
bromelain at pH 7.0, pH 2.0 (PFI), and PFI in the 
presence of 60% (v/v) TFE or 6 M GdnHCl. The emis-
sion spectrum of stem bromelain at pH 7.0 shows a 
maximum at 337 nm, which is indicative of the presence 
of tryptophan residues. Stem bromelain contains five 
tryptophan residues [42] and extensive sequence ho-
mology with papain suggests that three of these may be 
buried in the hydrophobic core and that two may be 
located near the surface of the molecule [45]. At pH 2.0 
there was an almost 40% decrease in fluorescence in-
tensity and a change in A a^x to 335 nm suggesting a blue 
shift (2 nm). This blue-shifted fluorescence of stem bro-
melain at pH 2.0 can be attributed to the conforma-
tional changes in the vicinity of surface-exposed 
tryptophans, presumably due to internalization in a 
more hydrophobic environment [45]. A similar blue-
shifted fluorescence has been reported earlier for glucose 
isomerase [49], bovine growth hormone [50], and inter-
feron-y [51]. An alternative possibility is that the sur-
face-exposed tryptophans are quenched diflerently from 
the internal tryptophans at low pH without internalizing 
them, leading to a greater proportion of the remaining 
signal coming from the more buried tryptophans that 
are located in the interior of the native protein. Inter-
+200 
W Q v e l e n g t h ( n m ) 
o 
E •o 
Ul 
s 
20 30 40 50 
% ( V / V ) T F E 
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Fig. 3. Intrinsic emission spectra of stem bromelain under different conditions. (A) Sf>ectra of (1) PFI (pH 2.0) in the presence of (2) (v/v) T F E or 
(3) 6 M GdnHCl . The spectra of (4) pseudo native (pH 7.0) preparat ion is included for comparison. (B) Effect of increasing concentration of T F E on 
PFI as monitored by changes in relative fluorescence a t 335 nm. 
estingly at 60% (v/v) TFE concentration there was a 25% 
increase in fluorescence intensity over that of PFI and a 
shifting of /ma* to 333 nm, suggesting further internali-
zation of the surface tryptophans in the hydrophobic 
environment and formation of a more compact struc-
ture. In addition the 60% (v/v) TFE + water system has 
no effect on intensity and wavelength of maximal emis-
sion of A^-acetyl L-tryptophanamide (NATA) thereby 
ruling out the possible effects of the TFE-water system 
on the indole ring. As evident from the Fig. 3A, expo-
sure to 6 M GdnHCl leads to a red shift of 5 nm with a 
decrease in fluorescence intensity, suggesting a com-
pletely unfolded state. Titration of the PFI of bromelain 
with increasing concentration of TFE as studied at 
335 nm (Fig. 3B) indicates disruption of compact 
structure at the 60-70% (v/v) range of TFE. 
Effect of TFE on ANS spectrum of PFI of stem bromelain 
ANS, a fluorescent hydrophobic probe, has higher 
affinity for the molten globule intermediate of protein 
than for the proteins in the native or fully unfolded state 
[52]. We therefore attempted to identify the presence of 
the molten globule state in bromelain by investigating 
the binding of ANS to the protein under various con-
ditions and concentrations of TFE. Fig. 4A shows that 
ANS binds maximally to PFI in the presence of 60% (v/ 
v) TFE, while there was very little or no A N S binding at 
pH 7.0 or in the presence of 6 M GdnHCl. The PFI also 
showed significantly higher ANS fluorescence than the 
pseudo native (pH 7.0) enzyme; the increase was, how-
ever, lower (23%) than that of the PFI in the presence of 
60% (v/v) TFE. As ANS binds to hydrophobic surfaces 
on the protein with greater affinity, these observations 
suggest a remarkable increase in the number of solvent-
accessible nonpolar clusters [53] o f the PFI at 60% (v/v) 
TFE. It is interesting to note that the emission maxi-
mum blue shifts [54,55] to 485 nm in the presence of 60% 
TFE as compared to those of PFI (490 nm) and pH 7.0 
(505 nm) preparations, further suggesting that the pro-
tein is adopting a somewhat niore compact structure. 
Verj' low binding of ANS to bromelain at pH 7.0 is 
apparently related to nonavailability of accessible hy-
drophobic clusters, while PFI in the presence of 6 M 
GdnHCl may represent a denatured slate in which hy-
drophobic clusters are unfolded [56,57]. Titration of PFI 
with increasing concentration of TFE as studied by 
ANS binding at 490 nm (Fig. 4B) indicates slight dis-
ruption of compact structure at the 60-70% (v/v) range 
of TFE. Results of fluorescence experiments are also 
indicative of the molten globule state at the 60-70% (v/v) 
range of TFE. 
Temperature-induced transition of stem bromelain prep-
arations 
Fig. 5 depicts the effect of temperature on four dif-
ferent preparations of stem bromelain as monitored in 
the near-UV CD region at 280 nm. The thermal un-
folding of the pH 7.0 preparation as seen is a coopera-
tive process with a T^ value of 63 °C, while it was found 
to be continuously noncooperative for PFI with a Tm 
value of 48 °C. Maximum tertiary structure for PFI was 
observed at 30 °C, which decreased continuously up to 
70 °C and then tailed ofl". Furthermore, in the presence 
of 60% (v/v) TFE, PFI showed a shift in the 7"n, value to 
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58 °C with a cooperative behavior approaching that of 
the native pH 7.0 preparation. However, further in-
crease to 70% (v/v) TFE resuhs in noncooperative 
transition with a decrease in the T^ value to 51 °C. 
Cooperative unfolding and higher obtained for PFI 
in the presence of 60% (v/v) TFE compared to nonco-
operative and low T„ in the presence of 70% (v/v) TFE 
suggest loss of tertiary structure in the 60-70% (v/v) 
range of TFE and complements the above-explained 
spectral findings. In view of the known gradual transi-
tion [58] and lack o f cooperative thermal unfolding as-
sociated with the molten globule state [59], it also seems 
reasonable to suggest the formation of the molten 
globule stem bromelain state at the 60-70% (v/v) con-
centration range of TFE. Thermal transition was irre-
versible under both pH conditions of stem bromelain. 
Irreversibihty in thermal unfolding under different pH 
conditions is also shared by another member of the 
family, papain [34], 
Our earlier studies suggested that the acid-induced 
unfolding behavior of stem bromelain was irreversible 
and characteristic of Type I proteins [45] as classified by 
Fink et al. [60], The reversibility of the TFE-induced 
molten globule state to PFI was investigated by far-UV 
C D and was found to be partially reversible. Taken 
together, these results, i.e., the presence of high helical 
content of secondary structure, significant loss of ter-
tiary structure, but retention of compactness, high 
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magnitude of A N S binding, and loss of cooperative 
unfolding at the 60-70% (v/v) concentration range of 
TFE are clearly suggestive of a molten globule state of 
bromelain in this range. It is, however, interesting to 
note that there was considerable induction of tertiary 
structure up to 60% (v/v) TFE; however, beyond it there 
was complete loss. 
Implications in protein folding 
The study of various conformational states in the 
unfolding/refolding of multidomain proteins such as 
stem bromelain is important for understanding the 
principles governing protein folding. Molten globules 
are likely to play a significant role in folding of proteins 
in vivo. It is expected that when a partially/completely 
unfolded protein is placed under native-like conditions, 
it will rapidly collapse to a compact structure such 
as the molten globule. A number of authors have 
suggested that solvents such as T F E mimic some 
characteristics of the in vivo system and therefore at-
tach relevance to structural studies performed in this 
solvent [61], 
Recently attention has been directed toward the study 
of partially folded states that can be adopted by a 
polypeptide chain under equilibrium conditions [45] 
because of the fact that these intermediates are similar to 
the partially folded kinetic intermediates observed in the 
folding/unfolding pathway of many proteins. The pres-
ent study can be summarized as 
Native (pH 7.0) ^ PFI (pH 2.0) 
Molten globule (pH 2.0 
+ 60-70% TFE). 
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11 Abstract 
12 A denatured state of unmodified preparation of stem bromelain representing a structureless denatured form has been characterized at 
13 pH 2.0 and the effect of increasing concentration of TFE on the acid-denatured state has been investigated by circular dichroism (CD), 
14 fluorescence emission spectroscopy and binding of the hydrophobic dye, 1 -anilino-8-naphthalene sulfonic acid (ANS). Far-UV CD spectra 
15 show considerable accumulation of secondary structure when the acid-denatured bromelain is subjected to 70% (v/v) TFE and exhibited 
16 close resemblance to spectral features of those of pH 7.0 preparation. Interestingly, the acid-denatured state also regained some tertiary 
17 structure/interactions, with increasing concentration of TFE and at 60% (v/v) TFE, these approached almost those of the native like state. 
18 However, further increase to 70% (v/v) TFE resulted in complete loss of tertiary struqture/interactions. Tryptophan fluorescence emission 
19 studies also suggested the induction of significant compact structure at 60% (v/v) cpncentration of TFE. In addition the acid-denatured 
20 state showed enhanced binding of ANS in presence of 60% (v/v) TFE. Taken together tfiese observations suggest the existence of a molten 
21 globule state in acid-denatured bromelain between 60 and 70% (v/v) TFE. A similar molten globule state under identical conditions has 
22 been identified in reduced and carboxymethylated preparation of stem bromelain as reported in our earlier communication [Arch. Biochem. 
23 Biophys. 413 (2003) 199], Comparison suggests unfolding/folding behavior of the bromelain to be independent of the intactness of the 
24 disulfide bonds. 
25 © 2003 Published by Elsevier B.V. 
27 Keywords: Molten globule; Trifluoroethanol; Stem bromelain 
29 1. Introduction 
30 Acid denaturation of several protein results in structure-
31 less denatured states that are often less unfolded than the 
32 completely unfolded forms obtained either in 9.0 M urea or 
33 6.0 M GdnHCl [1-3]. The major driving force for unfolding 
34 during acid denaturation is intramolecular charge repulsion, 
35 which may or may not overcome the interactions favoring 
36 the folded states such as hydrophobic forces, salt bridges 
37 and metal ion-protein interaction [4]. The mechanism of 
Abbrevialions: TFE, 2,2,2-trifluoroethanol; ANS, I-anilino-8-naphtha-
Icnc sulfonic acid; GdnHCl, guanidinium hydrochloride; CD, circular 
dichroism 
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denaturation of a given protein at low pH is complex and 38 
may involve intricate interplay between a variety of stabi- 39 
lizing and destabilizing force leading to a compact struc- 40 
ture, characteristic of molten globule or partially folded in- 41 
termediate [5]. Alternatively an almost unfolded state may 42 
also be obtained [6]. The information necessary to drive 43 
a disordered/denatured protein spontaneously to its native 44 
three-dimensional structure under physiological conditions 45 
is known to be encoded within its amino acid sequence [7]. 46 
Study of folding intermediates and denatured states provide 47 
an insight to understand as to how and when different forces 48 
come into play to direct protein folding [8,9]. The develop- 49 
ment of broad range of techniques has led to the identifica- so 
tion and characterization of stable intermediates in several 51 
proteins [10-12]. One such stable intermediate state, termed 52 
as the molten globule has been shown to be a compact col- 53 
lapsed structure that has pronounced secondary structure but 54 
1 0141-8130/$ - see front matter © 2003 Published by Elsevier B.V. 
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55 largely disordered tertiary structure [13,14]. Thus, the struc-
56 tural similarity between the molten globule and native pro-
57 teins seems to have a significant bearing on the understand-
58 ing oif the protein-folding problem [15]. 
59 Binary mixtures of water with alcohols like methanol, 
60 ethanol, or TFE have been shown to cause conformational 
61 transition of proteins into a new stable conformational states 
62 with high a-helical content and disrupted tertiary and qua-
63 ternary structure resembling that of the molten globule in-
64 termediate [5,16,17]. Alcohols weaken non-local hydropho-
65 bic interactions and while enhancing local polar interactions 
66 (i.e. hydrogen bond) of proteins [18,19]. Alcohol-induced 
67 denaturation may therefore result in stabilization of the ex-
es tended helical rod in which hydrophobic side chains are ex-
69 posed, and polar amide groups shielded from the solvent 
70 [20,21]. Alcohols induce significantly higher helical struc-
71 tures in partially or completely unfolded proteins as com-
72 pared to those in the folded proteins [22], Among various 
73 alcohols, TFE is often preferred because of its remarkable 
74 potential in stabilizing the a-helical structure [1,23,24]. The 
75 ability of TFE to induce secondary structure is due to three 
76 fluorine atoms, which are important for enhancing the ef-
77 fects of alcohol [25], The secondary structures stabilized by 
78 TFE are assumed to reflect conformations that prevail during 
79 early stages of protein folding [20,24]. Though, many pro-
80 teins in their molten globule and partially folded states have 
81 been characterized, it has yet not been possible to generalize 
82 the concept of molten globule as universal equilibrium pro-
83 tein folding intemediate. Characterization of molten glob-
84 ule state is helpful in identifying the other transition states 
85 believed to be located between molten globule and native 
B6 state as well as between the molten globule and the dena-
87 tured state [26,27]. 
88 Spectra! properties of stem bromelain like those of pa-
89 pain and proteinase Q suggest a bilobal structure with pre-
90 dominantiy a and antiparallel p domains [28,29]. Reyna 
91 and Arana [30] therefore proposed that bromelain may ex-
92 hibit the folding pattern shown by other members of pa-
93 pain family. Stem bromelain belongs to the a -f p protein 
94 class as other cysteine proteinases and the highly similar 
95 amino acid sequences of papain [31], actinidin [32], pro-
96 teinase fi [33], chymopapain [34] and stem bromelain [35] 
97 indicate that the polypeptide chains of these proteins share 
98 common folding patterns. This has been confirmed for the 
99 first three proteinases by detailed X-ray diffraction studies 
100 [29,36,37]. Earlier studies on modified preparation of stem 
101 bromelain from this laboratory have demonstrated a par-
102 tially folded intermediate (PFI) at pH 2.0 and a molten glob-
103 ule like state at pH 0.8 [38]. A molten globule state is also 
104 achieved when PFI obtained at pH 2.0 is exposed to 60-70% 
105 TFE concentration [1]. In the present communication, ev-
106 idence is presented for the induction of an acid-denatured 
107 state of unmodified preparation of stem bromelain at pH 2.0 
108 which presumably represents a structureless denatured state 
109 but is clearly less unfolded than the completely unfolded 
110 state obtained in 6.0 M GdnHCl. This almost unfolded state 
when subjected to high concentration of TFE leads to the i i i 
formation of a molten globule like state between 60 and 112 
70% (v/v) of TFE. The molten globule like form exhibited 113 
disordered side chain interactions but retained considerable 114 
secondary structure and relatively more exposed hydropho- 115 
bic surface and therefore more ANS binding capacity than 116 
acid-denatured state at pH 2.0. It is interesting to note that 117 
almost identical molten globule state is achieved when par- 118 
tially folded and almost unfolded states at pH 2.0 of mod- 119 
ified [1] and unmodified preparation, respectively, are sub- 120 
jected to 60-70% (v/v) concentration of TFE suggesting that 121 
disulfide bonds may be less crucial for bromelain unfolding/ 122 
folding. 123 
2. Materials and methods 124 
2.1. Materials 125 
Stem bromelain (3.4.22.32) lot no. B4882, TFE and ANS 126 
were purchased from Sigma Chemical Company, USA. 127 
GdnHCl was obtained from Qualigens, India. All other 128 
reagents were of analytical grade. 129 
2.2. Sample preparation 130 
Stem bromelain contains three disulfides and a single free 131 
cysteine residue [1]. Unmodified preparation represents na- 132 
tive active state while the modified preparation refers to 133 
pseudo-native state [1], which has been irreversibly inacti- 134 
vated by reduction of three disulfides by 2-mercaptoethanol 135 
followed by iodoacetamide treatment [39]. The treatment 136 
has been shown to block cysteines of three reduced disul- 137 
fides and a single free cysteine [1,38]. In the present com- i38 
munication, studies have been undertaken with unmodified 139 
preparation. The enzyme solutions of unmodified prepara- 140 
tion of bromelain were prepared in 10 mM sodium phosphate 141 
buffer, pH 7.0. Acid-denatured state of enzyme prepara- 142 
tion was achieved by dialyzing against 10 mM glycine-HCI 143 
buffer, pH 2.0. m 
2.3. Spectrophotometric measurements 145 
Protein concentration was determined on a Hitachi 146 
U-1500 Spectrophotometer using an extinction coefficient 147 
®lcm 280 nm = molecular mass of the protein 148 
was taken as 23,800 Da [40]. A stock solution of ANS in 149 
distilled water was prepared and concentration determined 150 
using an extinction coefficient of em = 5 0 0 0 M ~ ' c m " ' 151 
at 350 nm [41]. The molar ratio of protein to ANS 152 
was 1:50. 153 
2.4. Circular dichroism 154 
All the CD measurements were carried out at 25 °C on 155 
a Jasco Spectropolarimeter Model J-720 using a SEKONIC 156 
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XY Plotter (model-SPL-430A), with a thermostatically con-
trolled cell holder attached to a NESLAB Waterbath Model 
RTE 110 with an accuracy of ±0.10°C. The instrument 
was equipped with a microcomputer and precalibrated with 
(-l-)-lO-camphorsulfonic acid. The spectra were recorded 
with a scan speed of 20 nm min~' and with a response time 
of 1 s. Each spectrum was recorded as an average of two 
scans. Far-UV CD spectra and the near-UV CD spectra were 
taken at a protein concentration of 20 fJiM with 1 and 10 mm 
path length cell, respectively. CD spectra were recorded 
in wavelength range of far-UV 190-250 and for near-UV 
250-300. The CD results are expressed as mean residue el-
lipticity (MRE) in degcm^ dmol"', which is defined as 
MRE(0) = o^bs 
10 X n X 1 X Cn 
where 0obs is the CD in millidegrees (mdeg), n is the number 
of amino acid residue (212), / is the path length of the cell 
in cm and Cp is the mole fraction. 
174 2.5. Fluorimetry 
175 Intrinsic fluorescence and ANS binding was studied us-
176 ing a Shimadzu Spectrofluorometer Model RF-540 equipped 
177 with a data recorder DR-3. The concentration of stem brome-
178 lain preparations used was 20jji,M. Requisite volumes of 
179 TFE and GdnHCl were taken. For the intrinsic tryptophan 
180 fluorescence, the cxcitation wavelength was set at 280 nm 
181 and the emission spectra recorded in the range of 300-400. 
182 Binding of ANS to stem bromelain preparations was stud-
183 ied by exciting the dye at 380 nm and the emission spectra 
184 recorded from 400 to 600 nm. Excitation and emission slit 
185 widths were 5 nm. Since ANS shows emission in TFE, all 
186 spectra were corrected for blanks. 
187 3. Results and discussion 
188 3.1. Effect of TFE on far-UV CD spectrum of 
189 acid-denatured stale of unmodified stem bromelain 
190 Fig. 1 shows the effect of TFE concentrations on far-UV 
191 CD spectra of the acid-denatured state of unmodified brome-
192 lain. As can be seen from the figure there is a partial loss 
193 (25%) in the secondary structure at pH 2.0 compared to 
194 that of the pH 7.0 preparation at 208 nm. Furthermore, the 
195 negative trough around 194nm of acid-denatured state of 
196 bromelain indicates the presence of unordered structure [42]. 
197 This suggests that the acid-denatured protein at pH 2.0 rep-
198 resents an almost unfolded state. With increasing concen-
193 tration of TFE the unordered structure moves towards or-
200 dered one with spectral features similar to those of the pH 
201 7.0 preparation at 60-70% (v/v) concentration of TFE sug-
202 gesting the induction of secondary structure. In contrast, 
203 there was complete loss of structure in presence of 6.0 M 
204 GdnHCl. 
Wavelen9lh(nm) 2 50 
Fig. 1. Far-UV CD spectra of unmodified slem bromelain preparations. 
Spectra of (—) acid-denatured state (pH 2.0) in presence of {• ) 30%, 
( ) 60%, ( ) 70% (v/v) TFE concentration or ( ) 6.0 M 
GdnHCl are compared to that of (• • •) native (pH 7.0) preparation. 
3.2. Effect of TFE on near-UV CD spectrum of 
acid-denatured state of unmodified stem bromelain 
205 
206 
Fig. 2A shows the near-UV CD spectra of acid-denatured 207 
state of unmodified bromelain in presence of various con- 20B 
centration of TFE. At pH 7.0 bromelain shows a, positive 209 
CD spectrum with a positive peak around 286 nm. There 210 
was considerable loss in tertiary structure/interactions at pH 211 
2.0 and their complete loss in presence of 6.0 M GdnHCl. 212 
Although at 30% (v/v) TFE the loss is less pronounced, it 213 
is interesting to note that at 60% (v/v) TFE the prepara- 2 u 
tion attained a much more compact structure compared to 215 
that of the pH 7.0 preparation. There was. a total loss of the 216 
tertiary structure/interactions at 70% (v/v) concentration of 217 
TFE. Fig. 2B shows the titration of acid-denatured state of 218 
unmodified bromelain with increasing concentration of TFE 219 
as monitored at 286 nm. A gradual increase in MRE value 220 
(tertiary structure/interactions) till 30% is followed by a 221 
sharp increase till 60%, however at 70% there was an abrupt 222 
loss. 223 
Taken together these results indicate loss in tertiary struc- ?24 
ture/interactions but substantial retention of secondary struc- 225 
ture in acid-deivatured (pH 2.0) state of bromelain subjected 226 
to 60-70% (v/v) range of TFE concentration, which is in- 227 
dicative of a molten globule state in this range. 228 
3.3. Effect of TFE on tryptophan fluorescence spectrum of 229 
acid-denatured state of unmodified stem bromelain 230 
Fig. 3A shows intrinsic emission spectra of unmodified 231 
preparation of bromelain at pH 7.0, pH 2.0 (acid-denatured 232 
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Fig. 2. Near-UV CD spectra of unmodified stem bromelain preparations. (A) Spectra of (—) acid-denatured state (pH 2.0) in presence of ( ) 30%, 
( ) 60%, ( ) 70% (v/v) TFE concentration or ( ) 6.0 M GdnHCI are compared to that of (• • •) native (pH 7.0) preparation. (B) Effect of 
i.icrcasing coiii;cnltation of TFE on acid-dcnatured state as monitored by changes in MRE value at 286 nm (maximum-value discrete datapoint correspond 
the actua' maximum). 
233 State), acid-denatured state in presence of 60% (v/v) TFE 
234 or 6.0 M GdnHCI. At pH 7.0, the preparation shows X^ax 
235 at 337 nm suggesting the presence of tryptophans. Stem 
236 bromelain contain five tryptophans [35] and its extensive 
237 sequence homology with papain suggests that three among 
238 these may be buried in the hydrophobic core and two lo-
239 cated near the surface [38]. At 60% (v/v) TFE there was 40% 
240 increase in fluorescence intensity over acid-denatured state 
241 (Xmax 335 nm) with a blue shift (Xmax 333 nm) suggesting 
242 internalization of tryptophan. This blue shift can be strictly 
attributed to the internalization of tryptophan inasmuch as 243 
60% (v/v) TFE 4- water system has no effect on intensity 244 
and wavelength of maximal emission of NATA (N-acetyl 245 
L-tryptophanamide). As can be seen from figure, there was 246 
a red shift of 5 nm with a decrease in fluorescence inten- 247 
sity on GdnHCI denaturation suggesting the formation of a 248 
completely unfolded state. Titration of acid-denatured state 249 
with increasing concentration of TFE as studied at 335 nm 250 
(Fig. 3B) indicates disruption of compact structure in the 251 
acid-denatured state at 60-70% (v/v) range of TFE. 252 
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Fig. 3. Intrinsic emission spectra of unmodified stem bromelain under different conditions. (A) Spectra of (I) acid-denatured state (pH 2.0) in presence 
of (2) 60% (v/v) TFE or (3) 6.0 M GdnHCl are compared to that of (4) native (pH 7.0) preparation. (B) Effect of increasing concentration of TFE on 
acid-denatured state as monitored by changes in relative fluorescence at 335 nm (maximum-value discrete datapoint conespond the actual maximum). 
253 3.4. Effect of TFE on ANS spectrum of acid-denatured 
254 state of unmodified stem bromelain 
255 As can be seen from Fig. 4A, the acid-denatured state of 
256 unmodified bromelain shows maximum binding of ANS in 
257 presence of 60% (v/v) TFE, while there was negligible ANS 
258 binding at pH 7.0 or in presence of 6.0 M GdnHCl. While 
259 the acid-denatured state also showed increase in ANS bind-
260 ing, the increase was lower (26%) than in presence of 60% 
261 (v/v) TFE. This may be attributed to the presence of large 
262 number of solvent accessible non-polar clusters in presence 
263 of 60% (v/v) TFE. It is interesting to note that the emission 
maximum blue shifts [43,44] to 485 nm in presence of 60% 264 
TFE as compared to PFI (Xmax 490 nm) and pH 7.0 prepa- 265 
ration (Xmax 505 nm) further suggesting that the protein is 266 
adopting a some what more compact structure. Very low 267 
binding of ANS to bromelain at pH 7.0 is apparently related 268 
to the non-availability of accessible hydrophobic clusters 269 
while the acid-denatured state at pH 2.0 in presence of 6.0 M 270 
GdnHCl represent a completely unfolded state in which any 271 
accessible hydrophobic patches are also unfolded [45,46]. 272 
Titration of acid-denatured state with increasing concentra- 273 
tion of TFE as studied by ANS binding at 490 nm (Fig. 4B) 274 
indicates slight disruption of compact structure at 60-70% 275 
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Fig. 4. Fluoresccncc emission spcctra of ANS bound to unmodified stem bromelain under different conditions. (A) Spcctra of (1) acid-denaturcd state (pH 
2.0) in presence of (2) 60% (v/v) TFE or (3) 6.0 M GdnHCl are compared to that of (4) native (pH 7.0) preparation. (B) Effect of increasing concentration 
of TFE on acid-denatured state as monitored by changes in ANS binding at 490 nm (maximum-value discrete datapoint correspond the actual maximum). 
276 range of TFE. Results of fluorescence experiments are also 
277 suggestive of a molten globule state at 60-70% (v/v) range 
278 of TFE. 
279 To summarize the accumulation of secondary structure, 
280 significant loss of tertiary structure, with the retention of 
281 compactness and high magnitude of ANS binding at 60-70% 
282 (v/v) of TFE are clearly suggestive of a molten globule state 
283 in this range. It is however, interesting to note that there was 
considerable induction of tertiary structure upto 60% (v/v) 284 
TFE, however beyond it there was complete loss. 285 
Table 1 compares molten globule identified in modified 286 
[1] and unmodified preparation of stem bromelain. Molten 287 
globule state of these two different enzyme preparation show 288 
remarkable similarity in percent tertiary structure, intrin- 289 
sic fluorescence intensity and shows significant ANS bind- 290 
ing. It is interesting to note that partially folded [1,38] and 291 
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Tabic 1 
Studies undertaken for unmodified and modified preparation 
Spectral studies pH 7.0 (unmodified) pH 7.0 (modified)' Molten globule'' (unmodified) Molten globule'' (modified)' 
Near-UV CD (MRE) 100% (128) 100% (182) 43% (55) 44.5% (81) 
Intrinsic fluorescence (FI) 100% (62) 100% (75) 59.6% (37) 62.6% (47) 
ANS binding - - + + + + + + 
- : represents very low ANS binding; + + + : represents 25 -35% increased binding over aeid-denatured state and PFI of unmodified and modified pre-
paration, rcspeetively. 
•[1]. 
Values are average of points in range of 60-70% (v/v) TFE. 
292 a m o s t u n f o l d e d s t a t e o f m o d i f i e d a n d u n m o d i f i e d p r e p a r a -
293 t i o n , r e s p e c t i v e l y , l e a d t o i n d u c t i o n o f m o l t e n g l o b u l e s t a t e 
294 at s a m e c o n c e n t r a t i o n r a n g e o f T F E . In l i g h t o f t h e d i f f e r -
295 e n c e s b e t w e e n m o d i f i e d [ 1 , 3 8 ] a n d u n m o d i f i e d p r e p a r a t i o n 
296 as d e t a i l e d in S e c t i o n 2 , it s e e m s r e a s o n a b l e t o a s s u m e that 
297 u n f o l d i n g / f o l d i n g b e h a v i o r o f b r o m e l a i n i s i n d e p e n d e n t o f 
298 d i s u l f i d e b o n d s w h i c h h a p p e n s t o b e a p a r a d o x t o e a r l i e r 
299 findings [ 4 7 - 5 1 ] w h e r e d i s u l f i d e b o n d s f o r m a t i o n h a s b e e n 
300 re ferred t o as rate l i m i t i n g s t e p [ 5 2 ] in p r o t e i n f o l d i n g . 
301 4 . I m p l i c a t i o n s i n p r o t e i n f o l d i n g 
302 M o l t e n g l o b u l e s are l i k e l y t o p l a y a s i g n i f i c a n t r o l e in 
303 t h e f o l d i n g o f p r o t e i n s in v i v o . It i s e x p e c t e d that w h e n a 
304 s t ruc ture l e s s d e n a t u r e d p r o t e i n i s p l a c e d u n d e r n a t i v e l i k e 
305 c o n d i t i o n , it w i l l r a p i d l y c o l l a p s e t o a c o m p a c t s t ruc ture s u c h 
306 a s m o l t e n g l o b u l e . A n u m b e r o f a u t h o r s h a v e s u g g e s t e d that 
307 s o l v e n t l i k e T F E m i m i c s o m e c h a r a c t e r i s t i c s o f t h e in v i v o 
308 s y s t e m a n d t h e r e f o r e a t t a c h r e l e v a n c e t o s tructura l s t u d i e s 
309 p e r f o r m e d in th i s s o l v e n t [ 5 3 ] . T h e p r e s e n t s t u d y c a n b e 
31® s u m m a r i z e d a s 
312 N a t i v e ( p H 7 . 0 ) ->• A c i d - d e n a t u r e d s ta te ( p H 2 . 0 ) 
313 ^ M o l t e n g l o b u l e ( p H 2 . 0 + 6 0 - 7 0 % T F E ) . 
314 Furthermore , c o m p a r i s o n o f m o l t e n g l o b u l e o b t a i n e d in 
315 m o d i f i e d a n d u n m o d i f i e d p r e p a r a t i o n s u g g e s t t h e s t u d y t o 
316 b e a p a r a d o x t o ear l i er findings, w h i c h i m p l i c a t e r o l e o f 
317 d i s u l f i d e s in pro te in u n f o l d i n g / f o l d i n g . 
318 A c k n o w l e d g e m e n t s 
319 F a c i l i t i e s p r o v i d e d b y A l i g a r h M u s l i m U n i v e r s i t y are 
320 g r a t e f u l l y a c k n o w l e d g e d . P.G. i s S e n i o r R e s e a r c h F e l l o w 
321 o f t h e C o u n c i l o f Industr ia l R e s e a r c h , N e w D e l h i , Ind ia . 
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Oriented immobi l i za t ion of s t e m bromela in 
p. Gupta and M. Saleemuddin 
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202002 
Limited accessibility to macromolecular substrate is one of the major obstacles 
of using enzymes that act on macromolecular substrates in the immobilized 
state. While the problem can be alleviated using a long spacer between the 
support matrix and the enzyme, random orientation on the support seriously 
interferes with Its action on large molecular weight substrates. Favorable 
orientation of enzymes on solid supports has therefore been attempted with 
significant success in the recent years. Immobilization on specific monoclonal 
antibody supports or via the artificially introduced lone sulfhydryls have been 
among the more popular approaches In this regard. Favorably immobilized 
enzymes exhibit more simple kinetic properties and in many instances are 
more resistant to inactivation induced by various agents. Bromelain is a basic, 
33 kDa glycoproteinic thiol proteinase obtained from the stem of pineapple 
plant {Ananas comosus). Bromelain is unusual in that it contains a single 
oligosaccharide chain attached to the polypeptide. The oligosaccharide does 
not take part in bromelain action on its substrate proteins. This property was 
made use of to favorably orient bromelain on Sepharose support precoupled 
with the lectin concnavalin A. The preparation obtained thus exhibited high 
activity on casein, low Km and a broader pH- activity profile as compared to the 
soluble bromelain. The oriented preparation was remarkable more resistant to 
thermal inactivation as evident from a ten degree increase in temperature 
optimum and retention of remarkably high activity when exposed to sixty 
degrees for longer duration. 
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